2021 Annual Report
April 27, 2022
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 10-K
________________________________________
(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-32598
_______________________________________
Entegris, Inc.
(Exact name of registrant as specified in its charter)
_______________________________________
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
41-1941551
(I.R.S. Employer
Identification No.)
129 Concord Road, Billerica, Massachusetts 01821
(Address of principal executive offices and zip code)
(978) 436-6500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Common Stock, $0.01 Par Value
Trading Symbol(s)
ENTG
Name of Exchange on which Registered
The Nasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
_______________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☒ Yes ☐ No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Non-Accelerated Filer
☒
☐
Accelerated Filer
Smaller reporting company
Emerging growth company
☐
☐
☐
If an emerging growth company, indicate by check mark if registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of voting stock held by non-affiliates of the registrant, based on the last sale price of the Common Stock on July 3, 2021, the last business day of
registrant’s most recently completed second fiscal quarter, was $13,985,301,409. Shares held by each officer and director of the registrant and by each person who owned 10
percent or more of the outstanding Common Stock have been excluded from this computation in that such persons may be deemed to be affiliates of the registrant. The
determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.
As of January 31, 2022, 135,516,966 shares of the registrant’s Common Stock were outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s Definitive Proxy Statement for its 2022 Annual Meeting of Stockholders scheduled to be held on April 27, 2022, or the 2022 Proxy Statement,
which is scheduled to be filed with the Securities and Exchange Commission, or SEC, not later than 120 days after December 31, 2021, are incorporated by reference into Part III
of this Annual Report on Form 10-K. With the exception of the portions of the 2022 Proxy Statement expressly incorporated into this Annual Report on Form 10-K by reference,
such document shall not be deemed to constitute part of this Annual Report on Form 10-K.
Auditor Name
KPMG LLP
Auditor Location
Minneapolis, Minnesota
Auditor Firm ID
185
ENTEGRIS, INC.
INDEX TO ANNUAL REPORT ON FORM 10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021
PART I
Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.
Caption
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services
Exhibits and Financial Statement Schedules
Form 10-K Summary
Signatures
Index to Financial Statements
Page
1
15
31
32
32
32
33
34
35
48
49
49
49
52
52
52
54
54
55
55
56
59
60
F-1
Item 1. Business.
OUR COMPANY
PART I
Entegris, Inc. (“Entegris”, “the Company”, “us”, “we”, or “our”) is a leading supplier of advanced materials and process
solutions for the semiconductor and other high-technology industries. Our mission is to help our customers improve their
productivity, performance and technology by providing enhanced materials and process solutions for the most advanced
manufacturing environments. We leverage our unique breadth of capabilities to create mission-critical microcontamination
control products, specialty chemicals and advanced materials handling solutions that maximize manufacturing yields, reduce
manufacturing costs and enable higher device performance for our customers.
Semiconductors, or integrated circuits, are key components in the electronic devices that have changed the way we live,
communicate and work. Products and applications like smartphones, 5G wireless technology, cloud computing, the Internet of
Things, machine learning and artificial intelligence, autonomous vehicles and virtual reality will increasingly require faster,
more powerful and more energy efficient semiconductors and we believe will ultimately drive global chip demand.
To meet the requirements for improved chip performance and density, semiconductor manufacturing processes have rapidly
become increasingly complex by moving to smaller geometries, adopting new device architectures and utilizing new and
innovative materials. These complex processes require new materials of ever-increasing purity, quality and stability to improve
and maximize yields. We expect to benefit from these two intersecting themes of the growing importance of process materials
and materials purity, and the impact they have on semiconductor performance, cost and reliability. We believe these trends are
leading to increasing materials content per wafer and filtration opportunity per wafer, which are growth opportunities for us.
Our customized materials solutions enable the highest levels of performance essential to the manufacture of semiconductors. As
our customers introduce more complex architectures and search for new materials with better electrical and structural properties
to improve the performance of their devices, they rely on Entegris as a trusted partner to address these challenges. We
understand these challenges and have solutions to address them, such as our advanced deposition materials, implant gases,
formulated cleaning chemistries and selective etch chemistries. Our customers also require greater end-to-end materials purity
and integrity in their manufacturing processes that, when combined with smaller dimensions and more complex architectures,
can be challenging to achieve. To enable the use of new metals and the further miniaturization of chips, and to maximize yield
and increase long-term device reliability, we provide products such as our advanced liquid and gas filtration and purification
products that help to selectively remove new classes of contaminants throughout the semiconductor supply chain. In addition, to
ensure purity levels are maintained across the entire supply chain, from bulk manufacturing, to transportation to and delivery
through a fab, to application onto the wafer, we provide high-purity packaging, fluid monitoring and materials handling
products.
Our business is organized and operated in three operating segments, which align with the key elements of the advanced
semiconductor manufacturing ecosystem. The Specialty Chemicals and Engineered Materials, or SCEM, segment provides
high-performance and high-purity process chemistries, gases and materials, and safe and efficient delivery systems to support
semiconductor and other advanced manufacturing processes. The Microcontamination Control, or MC, segment offers solutions
to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-
technology industries. The Advanced Materials Handling, or AMH, segment develops solutions to monitor, protect, transport
and deliver critical liquid chemistries, wafers and other substrates for a broad set of applications in the semiconductor industry,
life sciences and other high-technology industries. While these segments have separate products and technical know-how, they
share common business systems and processes, technology centers and strategic and technology roadmaps. With the
technology, capabilities and complementary product portfolios from these three segments, we believe we are uniquely
positioned to collaborate across divisions to create new, co-optimized and increasingly integrated solutions for our customers.
For example, our SCEM segment offers a highly selective nitride etch chemistry, our MC segment provides a liquid filter that is
specifically matched to that formulation and our AMH segment ensures the integrity of the product as it is moved to and
through the fab environment.
We believe that our platform is differentiated and resilient for several reasons. First, approximately 69% of our revenue during
2021 was unit driven or recurring in nature, from products consumed as a result of the semiconductor manufacturing process.
Our revenue is therefore generally more impacted by overall global semiconductor demand than the sales of semiconductor
capital equipment. Second, our solutions are increasingly specified and tailored to meet our customers’ unique process
conditions, and therefore switching away from our products may be costly and time consuming and may introduce risk to
manufacturing yields. Third, our product portfolio is broad and not overly concentrated on any single product or product
platform. As of December 31, 2021, we offered over 20,000 standard and customized products, and in 2021 no single product
platform represented more than 4% of our net sales. Fourth, our customer base is diverse, and we are not overly dependent on
1
any one single customer. Our customers are represented across the semiconductor supply chain, from chemical manufacturers,
to equipment manufacturers, to semiconductor manufacturers. During 2021, only one customer accounted for over 10% of our
net sales, while our top 10 customers accounted for approximately 43% of our net sales. Lastly, we believe our strong financial
profile will allow us to invest in the research and development and advanced manufacturing capabilities necessary to maintain
and expand our technology leadership and to drive organic growth. As we have done in the past, we expect to expand upon our
product portfolio, increase our scale and strengthen our position as a leading supplier to our customers.
In recent years, we have also sought to diversify outside of the semiconductor industry by taking advantage of our core
capabilities in material science and material purity to provide critical products for the life sciences industry. During that time,
we partnered with several leading companies in the life sciences industry to help guide our development efforts. In just a few
short years, we brought to market our Aramus high-purity bag assemblies that are used in the production of biologics, including
COVID-19 vaccines. Going forward we will seek to expand the use of these solutions into non-COVID biologics. In addition,
we expect to provide ancillary solutions around our Aramus bags, and also plan to expand our filter offerings for bioprocessing
applications.
PROPOSED MERGER
On December 14, 2021, we entered into a definitive Agreement and Plan of Merger, or the merger agreement, with our wholly-
owned subsidiary, Yosemite Merger Sub, Inc, or merger sub, and CMC Materials, Inc., or CMC, a leading global supplier of
consumable materials to semiconductor manufacturers and pipeline companies. Pursuant and subject to the terms and
conditions of the merger agreement, upon completion of the transaction, merger sub will merge with and into CMC, with CMC
surviving and continuing as a wholly-owned subsidiary of Entegris. At the effective time of the proposed merger, each
outstanding share of common stock of CMC (with certain exceptions set forth in the merger agreement) will be converted into
the right to receive $133.00 in cash and 0.4506 shares of common stock of Entegris, plus cash in lieu of any fractional shares.
The transaction is subject to certain conditions, including the affirmative vote of holders of a majority of the outstanding shares
of common stock of CMC approving the adoption of the merger agreement and the receipt of approvals under United States and
certain foreign antitrust and competition laws. We have agreed to operate our business in the ordinary course during the period
between the execution of the merger agreement and the effective time of the proposed merger, subject to specific exceptions set
forth in the merger agreement, and have agreed to certain other customary restrictions on operations, as set forth in the merger
agreement.
In connection with the proposed merger with CMC, we have entered into an amended and restated commitment letter with
Morgan Stanley Senior Funding, Inc. and certain other financial institutions providing for a senior secured first lien term loan B
facility in an aggregate principal amount of up to $4 billion and a senior unsecured bridge term loan facility in an aggregate
principal amount of up to $895 million. Commitments under the bridge facility will be reduced by, among other things, the
aggregate gross cash proceeds in excess of $300 million resulting from any issuance or sale by Entegris of certain securities,
including senior unsecured notes or other debt securities or other indebtedness for borrowed money, equity securities and
equity-linked securities.
THE SEMICONDUCTOR ECOSYSTEM
The manufacture of semiconductors requires hundreds of highly complex and sensitive manufacturing steps, during which a
variety of materials are repeatedly applied to a silicon wafer to build integrated circuits on the wafer surface. We serve the
semiconductor ecosystem by providing specialty materials and chemicals utilized in many process steps, offering a broad range
of products to monitor, protect, transport and deliver these critical process materials during the manufacturing process and
providing systems to purify liquid chemistry and gases throughout the manufacturing process. The areas of the semiconductor
ecosystem that rely most heavily on our products and solutions are described below.
Etch and Resist Strip. During the etch process, specific areas of the thin film that have been deposited on the surface of a
wafer are removed to leave a desired circuit pattern. After the etch process, the hardened resist needs to be completely removed,
which requires the use of ultra-high purity chemicals of precise composition. In order to maintain manufacturing yields and
avoid defective products, these chemicals must be maintained at very high purity levels without the presence of foreign material
such as particles, ions or organic contaminants. Several of our products are utilized by semiconductor manufacturers during and
after the etch process, including:
•
•
Formulated chemical solutions to remove photoresists and post-etch residues;
Filters and purifiers, which help to ensure the purity of formulated cleaning chemistries and to achieve desired yields
in the etch processing steps; and
2
•
Precision-engineered coatings to provide barriers to corrosive chemistries in the etch environment, protect surfaces
from erosion and minimize particle generation.
In addition to being utilized throughout the etch process, semiconductor manufacturers require ultra-high purity chemicals of
precise composition to clean wafers before and after several of the processes described below. Our proprietary formulated
cleaning chemistries are used in these wet cleaning processes, and our liquid filters and purifiers ensure the purity of these
chemicals.
Deposition. Deposition is a process during which certain materials are transferred to the surface of a wafer. Deposition
processes include physical vapor deposition, or PVD, where a thin film is deposited on a wafer surface in a low-pressure gas
environment; chemical vapor deposition, or CVD, where a thin film is deposited on a wafer surface by exposing it to one or
more volatile precursors which react with the wafer surface; atomic-layer deposition, or ALD, where a thin film is deposited on
a wafer surface by exposing it to one or more precursors which react through a series of sequential, self-limiting reactions; and
electro-plating, where a metal layer, such as copper, is deposited on a wafer surface using chemical baths. We provide products
that are used during each of these deposition processes that are critical to enabling new device architectures, ensuring device
performance and achieving the targeted manufacturing yields of semiconductor manufacturers, including:
•
•
Advanced precursor materials and electro-plating chemicals, which are utilized to meet the semiconductor industry’s
composition, uniformity and thickness requirements of deposited films; and
Filtration and purification products, which are used to remove contaminants during the deposition process,
consequently reducing defects on wafers.
Photolithography. Photolithography is a process that uses light to print complex circuit patterns onto the wafer and is repeated
many times throughout the semiconductor manufacturing process. To print the projected optical pattern, the wafer is coated
with a thin film of light-sensitive material, called photoresist. Light is projected to expose the photoresist, which is then
developed to create a stenciled image pattern. We offer products that semiconductor manufacturers use throughout the
photolithography process, including:
•
•
Liquid filtration and liquid packaging and dispense systems designed to ensure the pure, accurate and uniform dispense
of photoresists onto the wafer, enabling manufacturers to achieve acceptable yields in the manufacturing process; and
Gas microcontamination control systems designed to eliminate airborne contaminants that often disrupt effective
photolithography processes.
Ion Implant. Ion implantation is a key technology for forming transistors and is used many times during semiconductor
fabrication. During ion implantation, wafers are bombarded by a beam of electrically-charged ions which change the electrical
properties of the exposed surface films. Those of our products that are used during the ion implant process include:
•
•
Safe Delivery Source®, or SDS®, and Vacuum Actuated Cylinders, or VAC®, gas delivery systems designed to
ensure the safe, effective and efficient delivery of the toxic gases necessary for the implant process; and
Electrostatic chucks and proprietary low temperature plasma coating processes for core components, which are critical
elements of ion implantation equipment.
Chemical Mechanical Planarization. Chemical mechanical planarization, or CMP, is a polishing process used by
semiconductor manufacturers to planarize, or flatten, many of the layers of material that have been deposited on silicon wafers.
We offer a broad range of products used by semiconductor manufacturers during and immediately following the CMP process,
including:
•
•
•
•
•
CMP slurry products, which are used for polishing ultra-hard surface materials, including silicon carbide, or SiC, and
gallium nitride, or GaN, substrates;
Formulated cleaning chemistries, which remove residue from wafer surfaces after the CMP process and prevent
subsequent corrosion;
Filtration and purification solutions, which are used to remove select particles and contaminants from slurries and
cleaning chemistries that can cause defects on a wafer’s surface;
Roller brushes, which are used in conjunction with our formulated cleaning chemistries to clean the wafer after
completion of the CMP process in order to prepare the wafer for subsequent operations; and
Pad conditioners, which are used to prepare the surface of the CMP polishing pad prior to every polishing cycle.
Wafer Solutions. Our wafer and reticle carriers are high-purity “micro-environments” that carry wafers between manufacturing
process steps. These products protect wafers from damage or abrasion and minimize contamination during transportation and
3
automated processing. Front-end wafer processing can involve hundreds of steps and take several weeks. Protection of the
processed wafer between steps is essential, as a single batch of fully processed 200 mm or 300 mm wafers transported in one of
our products can be worth over a million dollars.
Chemical Containers. Semiconductor manufacturing and other high-technology manufacturing processes utilize large volumes
of high-purity, corrosive and hazardous chemicals. We provide solutions for the handling of such chemicals, including:
•
•
Ultra-high purity chemical container products, such as drums, flexible packaging and associated coded connection
systems, which are designed to maintain chemical purity, maximize utilization and ensure safe transport, containment
and dispense of valuable, ultra-clean process fluids, from bulk chemical manufacturing to point-of-use in the
manufacturing process; and
Ultra-pure valves, fittings, tubings and sensing and control products, which are used to distribute these chemicals
around the fab and in wet process tools.
Other Markets. Many of the processes used to manufacture semiconductors are also used to manufacture flat panel displays,
high-purity chemicals, solar cells, optical magnetic storage devices and light-emitting diodes, or LEDs, resulting in the need for
similar filtration, purification, control and measurement capabilities. We seek to leverage our products, technologies, expertise
and core capabilities to address these important market opportunities and pursue opportunities in certain life sciences
applications.
INDUSTRY TRENDS
Emerging Applications. The market for semiconductors has grown significantly over the past few decades, and we expect this
trend to continue. We believe that smartphones (including 5G), the Internet of Things and emerging applications in cloud
computing, machine learning and artificial intelligence, high performance computing, autonomous vehicles and virtual reality
will drive growth in the demand for semiconductors, drive wafer starts and create significant opportunities for our products.
Existing applications in data processing, wireless communications, broadband infrastructure, personal computers, handheld
electronic devices and other consumer electronics are also expected to drive demand for semiconductors, and in turn, our
products, especially in light of the increased prevalence of work-from-home and remote learning caused by the COVID-19
pandemic. For further information about our industries, see the “Risk Factors—Risks Related to Our Business and Industry”
section of this Annual Report on Form 10-K, including under the heading “The industries we serve are constantly evolving, and
any failure to manage our business effectively during periods of rapid change may adversely affect our business performance
and results of operations.”
Manufacturing Complexity and Architecture. The emerging applications described above require more powerful, faster and
more energy-efficient semiconductors. Semiconductor architectures are changing, with transistor design increasing in
complexity, the use of multilayered patterning (for example, extreme ultraviolet lithography), structures such as FinFET, 3D
NAND and gate-all-around, and shrinking dimensions. These advanced architectures require more process steps, more novel
materials and more sophisticated contamination control to manufacture semiconductors. We believe that demand for our
materials and consumable products will benefit from the increase in process steps in lithography, deposition, CMP and etch and
clean required to manufacture leading-edge semiconductors.
Additionally, new materials have played a significant role in enabling improved device performance, and we expect this trend
to continue. As dimensions get smaller, more novel materials will be required to enable transistor connectivity. For example,
leading-edge semiconductor manufacturers are moving towards atomic layer scale, where the precision of the manufacturing
process and purity of the materials used is vital to maintain device integrity. These materials need to be supplied and delivered
at ever-increasing levels of purity and control, from point-of-production to point-of-dispense on the wafer. We expect the trend
for new materials supplied at high levels of purity to drive demand for our advanced materials and our products and solutions
designed to purify, monitor, protect, transport and deliver critical materials. To address the challenges related to advanced
technology nodes, we collaborate with our customers to develop new materials, to enhance our filtration and purification
capabilities and to introduce advanced materials packaging and monitoring capabilities.
Materials Handling Solutions. To minimize the potential for damage or degradation to their materials and to protect their
investment in processed wafers, our semiconductor customers have become increasingly focused on materials handling
solutions that enable them to safely store, handle, process and transport critical materials throughout the manufacturing process.
We believe that this trend provides opportunities for us to utilize our breadth of capabilities to provide innovative materials
management, purification, wafer transport and process solutions to semiconductor customers to enable them to successfully
manage this growing complexity.
4
Reliance on Trusted Suppliers. Our customers require that their key materials suppliers demonstrate greater capabilities and
efficiencies in their processes, including sustainability, scalability, flexible manufacturing, quality control, supply chain
management and the ability to effectively collaborate on solutions to problems. We have responded to these demands by
deploying resources in strategic locations to enable us to align with customer requirements and drive operational excellence.
For example, in 2020 we continued to invest in our laboratory in Taiwan by adding key wafer processing and analytical
equipment to support clean formulation development and advanced filter evaluations. To continue to accelerate the
development cycle, we have focused on building models that simulate the performance of certain of our cleaning products. In
China, during 2021 we continued to invest in our manufacturing capabilities and technical applications development. In
addition, during 2021 in Taiwan we started construction on a new manufacturing and enhanced technology facility, which we
expect will be our largest such facility in the world, adding significant scale in a key region. We believe that, as semiconductor
manufacturers require greater capabilities of their supply partners, we will be able to leverage our manufacturing, operational
and technical capabilities, along with our broad technology portfolio and expanding scale, to become an increasingly important
strategic supplier to our customers.
Continued Consolidation. Our customer base within the semiconductor industry has consolidated in recent years through
mergers and acquisitions. As a result, the importance of maintaining and developing strong and close relationships with our
customers becomes even more essential. While continuing to strengthen these relationships, we also seek to further broaden our
customer base by leveraging our products, technologies, expertise and core capabilities in serving semiconductor applications to
address adjacent market opportunities, including in manufacturing processes for flat panel displays, high-purity chemicals, solar
cells, optical magnetic storage devices, LEDs and products for life sciences applications. For further information, see the “Risk
Factors—Risks Related to Our Business and Industry” section of this Annual Report on Form 10-K under the heading “A
significant portion of our sales is concentrated on a limited number of key customers and our net sales and profitability may
materially decline if we lost one or more of these customers.”
OUR COMPETITIVE STRENGTHS
Strong Technology Portfolio. In the highly competitive semiconductor industry, manufacturers seek partners that are
applications experts with broad technology portfolios to collaborate with from product conception to high volume
manufacturing. To that end, we are committed to being able to provide our customers with innovative solutions for their
manufacturing needs. For example, we have introduced sub-5 nanometer filtration products, advanced deposition materials for
next generation transistor and interconnect technologies, advanced reticle pods for extreme ultra-violet, or EUV,
photolithography applications, advanced 300 millimeter wafer carriers and advanced coatings to meet the rigorous demands
related to the manufacturing of advanced technology nodes faced by our customers. Given the competitive nature of the
semiconductor industry, we continuously seek to engage with leading logic and memory manufacturers to further advance their
technology roadmaps.
To sustain our competitive advantage, in addition to being applications experts, we must develop, maintain and protect our
critical intellectual property, including with patents, know-how and trade secrets. To add to our already robust patent portfolio
that consisted of over 2,840 patents worldwide as of December 31, 2021, during 2021 we filed new patent applications across
the globe covering inventions and technologies related to EUV, precursors, deposition materials, purification and filtration,
micro-environments, delivery systems and life sciences.
Comprehensive and Diverse Product Offerings. As semiconductor manufacturers drive towards more advanced technology
nodes, our customers seek suppliers that can provide a broad range of customized, reliable, flexible and cost-effective products
and materials, as well as the technological and application design expertise necessary to enhance their productivity, quality and
yield. We believe our comprehensive offering of materials and products creates a competitive advantage as it enables us to meet
a broad range of customer needs and provide a single source of product offerings for semiconductor device and equipment
manufacturers, which can often translate to shorter time-to-solution and time-to-market for our customers. Additionally, our
broad product and solution portfolio allows us to serve many aspects of the semiconductor manufacturing ecosystem and to
create synergies among some of our products. For example, our highly selective nitride etch formulations used in 3D NAND
applications have been co-developed with specifically functionalized filter membranes designed to ensure the highest process
performance. Additionally, our sensing technology detects active components in the etch chemistry and allows customers to
control the bath lifetime. Further, as the semiconductor industry looks to new metals for interconnect components, for example
molybdenum and ruthenium, we believe our portfolio of deposition, clean, filtration and delivery products will become even
more critical to enhancing our customers’ device performance and yield.
To further strengthen and improve our product offerings, we are committed to significant investment in research and
development initiatives, having spent approximately $167.6 million, $136.1 million and $121.1 million on such activities in
2021, 2020 and 2019, respectively, representing 7.3%, 7.3% and 7.6% of our net sales, in 2021, 2020 and 2019, respectively.
Our research and development expenditures have been increasingly directed towards innovation for advanced technology
5
nodes, and in 2021, a significant portion of our research and development expenditures were focused at the leading edge. We
plan to continue making substantial investments in research and development activities and expect our spending on such
initiatives, as a percentage of revenue, to increase in the coming years.
Global Infrastructure. Complementing our strong technology portfolio and diverse product offerings, we have a global
infrastructure of design, manufacturing, logistics, distribution, service and technical support facilities to meet the needs of our
global customers. For example, during 2021 we started construction on a new manufacturing and enhanced technology facility,
which we expect will be our largest such facility in the world, in Taiwan. We expect that initial commissioning operations will
begin in late 2022, with production ramping thereafter. The new Taiwan facility will add to various recent and ongoing
expansions of and investments in our manufacturing operations and advanced technology centers in the United States, Taiwan,
Japan and South Korea designed to increase our local manufacturing capacity and to support our customers in these regions, to
be even more responsive to their emerging needs and to help accelerate their development cycles and product ramps. Further,
we have established or acquired new facilities in China to serve the semiconductor and life sciences industries in that country,
expanded our manufacturing capacity in Malaysia and expanded our presence in Singapore to enhance our global and regional
management of supply chain and manufacturing processes. Finally, we have completed a number of new capacity and
technology development investments and expansions in the United States to support our customers in the life sciences industry.
For more information on our advanced manufacturing capabilities, see the “—Manufacturing” section below. We service our
customer relationships in Asia, North America, Europe and the Middle East predominantly via direct sales and support
personnel and to a lesser extent through selected independent sales representatives and distributors.
Our expansive global presence allows us to meet our customers where they operate, which has enabled us to build strong
relationships with them. Our customers include logic and memory semiconductor manufacturers, original equipment
manufacturers, or OEMs, and semiconductor materials suppliers. These customer relationships provide us with significant
collaboration opportunities at the early product design stage, which facilitate our ability to introduce new products and
applications. For example, we work with our key customers in the development of advanced manufacturing processes to
identify and respond to their requests for current and future generations of products for emerging applications requiring cleaner
materials. Similarly, we also collaborate with our customers to develop systems that maintain the integrity and stability of
materials during transport and throughout the manufacturing process. We believe that our customer base will continue to be an
important source of new product development opportunities. Due to the specialized nature of our products, complexity of our
customers’ manufacturing processes, customer qualification requirements and costs associated with re-formulation and re-
qualification, we believe we have a strong position with our customers.
Operational Excellence. Our customers are increasingly focused on the effectiveness, dependability and consistency of their
supply chains. We remain committed to operational excellence and are especially focused on the following priorities that we
believe enable us to perform at the high level that our customers expect.
•
•
Use of manufacturing equipment and facilities incorporating leading-edge technology, including advanced cleanroom
and cleaning procedures. As our customers introduce more complex architectures and search for new materials with
better electrical and structural properties to improve the performance of their devices, our equipment, technology and
processes must evolve to keep pace. In response, we have invested heavily in leading-edge manufacturing facilities,
which are located in strategic regions throughout the world. With our global presence, we are able to efficiently utilize
our portfolio of manufacturing facilities to meet our customers’ needs quickly and efficiently.
Implementation of automated manufacturing, quality and supply chain management systems. In recent years, we have
made significant investments in quality systems to help drive automation of our processes. During this time, we have
implemented standardized manufacturing systems to stress optimization of equipment effectiveness, predictive
maintenance and direct labor productivity, automated quality systems that provide both process monitoring and
statistical process control throughout the manufacturing process as well as predictive quality data to mitigate against
potential quality deficiencies and supply chain management systems designed to ensure a reliable and responsive
supply of high-quality raw materials. These systems generate large amounts of data, which we utilize to further
enhance our quality, productivity and stability. Our focus on quality is evidenced by our sigma level moving from less
than four in 2010 to greater than five in 2021, which represents a significant improvement in quality performance and
reduction in defective parts produced. In addition, over the last several years we have earned awards from our
customers for our performance and focus on continuous improvement.
• Maintaining an agile manufacturing organization. Our manufacturing workforce is capable of the rapid design and
development of prototypes of new and derivative products, as well as promptly responding to customer feedback
concerning prototypes so that we can quickly commercialize and ramp our production within very tight process
windows required by our customers. We believe that our focus on disciplined execution and timeliness in customer
interactions enables us to build even deeper connections with our customers, which in turn allows us to further
understand their technical roadmaps and to help them overcome technical hurdles.
6
OUR BUSINESS STRATEGY
We intend to build upon our position as a leading supplier of advanced materials and process solutions for the semiconductor
and other high-technology industries to expand our core business and to grow in other high value-added manufacturing process
markets. Our strategy includes the following key elements.
Commitment to Technology Leadership. We seek to continuously improve our products and develop new products as our
customers’ needs evolve. As semiconductor devices become smaller and more powerful and new materials and processes are
deployed to produce them, we seek to expand our technological capabilities by developing advanced products that address our
customers’ requirements for greater purification, protection and transport of high value-added materials and by developing
advanced materials for use in critical fabrication processes.
Leveraging Our Expertise. We leverage our broad expertise across our portfolio of advanced materials, materials handling
and purification capabilities to create innovative and new solutions to address unmet customer needs. For example, certain of
our formulated cleaning chemistry products are developed and manufactured by our SCEM segment, with collaboration from
our MC segment, packaged with our ultra-clean container and connector system made by our AMH segment, and delivered to
the process tools through fluid handling systems also made by our AMH segment. Furthermore, in process tools, these
chemistries may go through one or several purification systems produced by our MC segment to eliminate particles and
contaminants. Similarly, our advanced deposition materials business requires comprehensive capabilities across a number of
disciplines, including the synthetization of unique molecules, specialized knowledge of how to purify these materials and the
capability to safely transport and deliver them onto the wafer at a high throughput. We seek to utilize our expertise in areas of
strategic and increasing importance to semiconductor manufacturers, such as developing advanced materials and ensuring the
purity of high-value materials, and our ability to work collaboratively across our three segments enables us to quickly and
effectively develop optimized and complementary solutions for our customers.
Operational Excellence. Our strategy is to continue to develop our advanced manufacturing capabilities into a competitive
advantage with our customers by conducting our manufacturing operations in a manner that ensures the safety of our employees
and of the individuals using our products and by continuing to focus on the other priorities noted in the “—Our Competitive
Strengths—Operational Excellence” section above.
Continued Focus on Customers. We view the strong relationships we have with our customers, which include leading logic
and memory semiconductor manufacturers, OEMs and semiconductor materials suppliers, as critical to our long-term success.
We intend to reinforce and further strengthen these relationships through, among other things, collaborations and joint
development. Customer intimacy enables us to respond rapidly and thoroughly to their manufacturing challenges and enables us
to bring forth new products that serve existing needs.
Safety. A core component of our strategy is our intense focus on the safety of our employees and of the individuals using our
products. With respect to employee safety, we have put in place proactive programs designed to build a culture of safety in our
facilities. And while the well-being of our employees is always at the top of our mind, we also design our products with the
safety of the people who are using them in mind. To illustrate, our Aramus high-purity bags for biologics are designed to
withstand cryogenic temperatures and to not break down in extremely cold environments. By reducing ruptures during
transportation, our bags enable the effective distribution of vaccines, including those that may be used in the battle against the
COVID-19 pandemic, which may allow quicker access to a vaccine when compared to the use of traditional technologies. Also,
our Safe Delivery Source products are designed to minimize potential leaks during transportation and use of hazardous gases,
features which provide significant safety, environmental and productivity benefits over traditional high-pressure cylinders.
Corporate Social Responsibility. We are embedding our corporate social responsibility program into our business strategy.
Our program is built around the four core pillars of Innovation, Safety, Personal Development and Inclusion and Sustainability.
The program includes goals, which are aligned to each of the four pillars, to guide it towards 2030. During 2021, we released
our first annual corporate social responsibility report providing a comprehensive overview of our progress toward reaching our
2030 goals and outlining our baseline performance in 2020 across each of the four pillars. The 2020 annual corporate social
responsibility report is published on our website at http://www.Entegris.com under “About Us - Corporate Social
Responsibility.”
Adjacent Markets. We leverage the expertise that we have gained from serving the semiconductor industry to develop
products for other industries that employ similar technologies and production processes and that utilize materials integrity
management, high-purity fluids and integrated dispense systems. For example, outside of the semiconductor industry our
products are used in manufacturing processes for biologics, flat panel displays, high-purity chemicals, solar cells, optical
magnetic storage devices, LEDs and products for other life sciences and aerospace applications. We plan to continue to identify
and develop products that address needs in adjacent markets. We believe that by utilizing our unique technical capabilities in
advanced materials and contamination control and core manufacturing excellence to provide solutions across multiple
industries, we are able to increase the total available market for our products and increase our return on R&D investments.
7
Strategic Acquisitions, Partnerships and Related Transactions. We will continue to pursue strategic acquisitions and
business partnerships that enable us to address gaps in our product offerings, secure new customers, diversify into
complementary product markets, broaden our technological capabilities and product offerings, access local or regional markets
and achieve benefits of increased scale. For example, we strengthened and broadened our specialty chemicals and engineered
materials product offerings while also addressing gaps in our portfolio when we acquired BASF’s precision microchemicals
business in 2021 and Sinmat, Inc., or Sinmat, in 2020 (CMP slurries in hard substrate applications) and Digital Specialty
Chemicals, or DSC, and MPD Chemicals, or MPD, in 2019 (specialty chemicals). Similarly, we made several targeted
acquisitions to diversify and expand our filtration and purification portfolio with the acquisitions of Hangzhou Anow
Microfiltration Co., Ltd., or Anow, in 2019, the SAES Pure Gas business from SAES Getters S.p.A. in 2018, and the water and
chemical filtration product line for microelectronics applications from W. L. Gore & Associates, Inc. in 2017. Finally, we added
a suite of analytical instruments utilized in chemistry management and monitoring in semiconductor manufacturing processes to
our product portfolio with our acquisitions of Global Measurement Technologies, Inc. in 2020 and Particle Sizing Systems,
LLC in 2018. Our 2014 acquisition of ATMI, Inc., or ATMI, serves as an example of a strategic transaction that significantly
increased our scale, as the acquisition brought a whole new portfolio of technologies and materials products to serve our
semiconductor customers. Similarly, our proposed acquisition of CMC would significantly increase our scale and broaden our
product and technology portfolio. Further, as the dynamics of the markets that we serve shift, we will reevaluate our existing
businesses and may decide to restructure or replace one or more businesses, such as the sale of our small cleaning business in
France in 2018 and exiting our small cleaning business in Taiwan in 2020. Finally, we regularly evaluate opportunities for
strategic alliances, such as our strategic alliance with Enthone, joint development programs and collaborative marketing efforts
with key customers and other industry leaders. For example, we have agreements with local partners to expand our capability to
manufacture certain specialty chemical and deposition products locally and shorten our supply chain for our customers in
China.
OUR SEGMENTS
Our business is organized and operated in three segments which align with the key elements of the advanced semiconductor
manufacturing ecosystem: Specialty Chemicals and Engineered Materials, or SCEM; Microcontamination Control, or MC; and
Advanced Materials Handling, or AMH. We leverage our expertise from these three segments to create new and increasingly
integrated solutions for our customers. The following is a detailed description of our three segments.
SPECIALTY CHEMICALS AND ENGINEERED MATERIALS SEGMENT
The SCEM segment provides high-performance and high-purity process chemistries, gases and materials that enhance our
customers’ product performance. These materials are utilized in critical semiconductor manufacturing processes such as
deposition, cleaning and integration of complex process materials. Advanced materials, delivered at high purity, are critical to
enabling the performance of leading-edge logic and memory applications. We believe the growing demand in the advanced
logic and memory market, challenges with metallization schemes and the need for specialized cleaning solutions will drive
demand in our SCEM segment. In conjunction with products from our MC and AMH segments, the materials that our SCEM
segment produces provide unique solutions to safely and efficiently deliver critical materials to support semiconductor and
other advanced manufacturing processes. In addition, certain of the materials that our SCEM segment provides allow for
enhanced product performance for our customers in aerospace, medical, pharmaceuticals and other high-technology intensive
material segments.
Specialty Gas Products. Our specialty gas solutions provide advanced safety and process capabilities to semiconductor,
display and solar panel manufacturers. Our SDS cylinders store and deliver hazardous gases, such as arsine, phosphine,
germanium tetrafluoride and boron trifluoride, at sub-atmospheric pressure through the use of our proprietary carbon-based
adsorbent materials. These products minimize potential leaks during transportation and use and allow more gas to be stored in
the cylinder, features which provide significant safety, environmental and productivity benefits over traditional high-pressure
cylinders. New generations of SDS products further increase the gas storage capacity, reducing tool down time and thereby
generating significant cost savings for our customers. We also offer VAC, a complementary technology to SDS, where select
implant gases and gas mixtures are stored under high pressure but are delivered sub-atmospherically.
Specialty Materials Products. Our specialty materials include specialized graphite, silicon carbide and a variety of unique,
high purity coatings for dry or plasma etch, chemical vapor deposition and ion implant applications. Our POCO® premium
graphite is used to make precision consumable electrodes for electrical discharge machining, hot glass contact materials for
glass product manufacturing and forming and other consumable products for various industrial applications, including
aerospace, optical, medical devices, air bearings and printing. Our high-performance specialty coatings, such as our Pegasus™
and Cearus™ coatings, provide erosion resistance, minimize particle generation and prevent contamination on critical
components in semiconductor environments and other high-technology manufacturing operations. Our specialty materials
provide customized solutions for applications challenged with unique temperature, corrosive, chemical or process
8
environments, such as electrostatic chucks used to hold wafers during processing, plasma etch chamber components, aircraft
bearings and ultrasonic transducers.
Advanced Deposition Materials Products. Our advanced deposition materials include advanced liquid, gaseous and solid
precursors that are incorporated in CVD and ALD processes by the semiconductor industry, including organometallic
precursors for the deposition of tungsten, titanium, cobalt and aluminum containing films and organosilane precursors for the
deposition of silicon oxide and silicon nitride films. These precursors are designed in close collaboration with OEM process
tool manufacturers and device makers to produce application specific solutions that are compatible with complex integrations of
material solutions used to build the semiconductor device. We offer delivery systems and containers that allow for reliable
storage and delivery of low volatility solid and liquid precursors required in ALD processes. When combined with our
proprietary corrosion-resistant coatings and filtration solutions from our MC segment, our advanced deposition materials enable
the industry’s highest purity levels, resulting in improved device performance.
Surface Preparation and Integration Products. We offer a range of materials used to prepare the surface of a semiconductor
wafer during the manufacturing process and to integrate with materials being used on the wafer. We offer a broad range of
cleaning solutions for applications such as semiconductor post-etch residue removal, wafer etching, organics removal, negative
resist removal, edge bead removal and corrosion prevention. Our wet chemistry solutions, combined with filtration solutions
from our MC segment and fluid handling solutions from our AMH segment, provide enhanced purity, which results in
improvements in our customers’ processes. Our consumable polyvinyl alcohol roller brush products are used to clean the wafer
following the CMP process, and our pad conditioners, based on our silicon carbide capabilities, lengthen CMP pad life.
Through the acquisitions of BASF’s precision microchemicals business and Sinmat, we now offer slurry products used for
polishing ultra-hard surface materials, including SiC and GaN substrates, which are utilized in the power electronics and
advanced communications end-markets. We also provide advanced plating solutions, such as our Viaform® product (a
trademark of and exclusively licensed from Element Solutions, Inc.), which includes inorganic and proprietary organic
molecules that provide the wiring for copper interconnects.
Specialty Chemicals. Our specialty chemicals include advanced liquid and solid materials, which are used in a range of high-
performance material applications ranging from medical devices to materials used in semiconductor applications. Our product
solutions include organometallic and organosilane materials used in semiconductor device manufacturing, monomers and
polymers used in the manufacture of medical devices, polyolefin catalysts used in the manufacture of polyethene and
polypropylene, chromic materials used in security dyes and inks, isotopic ally labeled materials used in clinical diagnostics and
a range of materials used in the manufacture of pharmaceutical ingredients. In addition, our specialty chemicals business
provides materials to a number of our other businesses to enable advanced performance of final product solutions.
MICROCONTAMINATION CONTROL SEGMENT
The MC segment offers solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing
processes and other high-technology industries. The design and performance of our liquid and gas filtration and purification
products are important to the semiconductor manufacturing process because they remove contamination, directly reduce
defects, improve manufacturing yield and enhance the long-term reliability of the semiconductor device. Our proprietary filters
remove organic and inorganic nanometer-sized contaminants from various fluids and gases used in the manufacturing process,
including photolithography, deposition, planarization and surface etching and cleaning. As our customers leverage leading-edge
lithography tools and multi-patterning technology to enable each subsequent generation of products, our filtration and
purification products are utilized to achieve necessary levels of purity and contamination control. We believe demand for
purification and filtration products is being driven by the continuous node shrink in logic semiconductors and the ramp in the
3D NAND market, as the risk of yield loss grows with the incremental manufacturing steps needed for the production of these
devices. We utilize expertise from the AMH segment in polymer science and from the SCEM segment in formulated cleaning
chemistries to develop differentiated filtration and purification solutions for our customers.
Liquid Microcontamination Control Products. We offer a variety of products that control contaminants in our customers’
wet processes. For example, our Torrento® series of filters is used for the filtration of aggressive acid and base chemistries for
both semiconductor fabs as well as specialty chemical manufacturers, including our SCEM segment. Manufacturers of high
purity chemicals and semiconductor fabs use our Trinzik® and Microgard™ products for the filtration of chemicals and ultra-
pure water. Our Impact® series of filters are used in point-of-use photochemical dispense applications, including those
provided by our AMH segment, where the delivery of superior flow rate performance and reduced microbubble formation is
critical. Our Protego® series of liquid purifier/filter products are used to reduce metallic contamination in chemical
manufacturing and in critical wafer rinsing and drying applications by our customers. In addition, we provide membrane and
liquid filtration offerings serving semiconductor, pharmaceutical and medical applications.
Gas Microcontamination Control Products. We offer a broad portfolio of products designed to remove particulate and
molecular contaminants from controlled environments and gas streams in semiconductor, flat panel display and LED fabs. Our
9
Wafergard® gas filters reduce outgassing and remove particle contamination. Our GateKeeper® gas purifiers and large facility-
wide gas purification systems provide continuous purified gas supply to customer fabs from the point of creation on the gas
pads to the point-of-use at the wafer by chemically reacting and absorbing contaminants, effectively removing gaseous
contaminants down to part-per-trillion levels. Our Chambergard™ gas diffusers provide semiconductor equipment
manufacturers with the capability to rapidly vent their tools to atmosphere to dramatically reduce process cycle times without
adding particles to the wafers. In addition, our Vaporsorb products are used to eliminate airborne molecular contamination from
critical process tool areas or cleanrooms in the fab. These products are used in or alongside critical processing tools to improve
yield and reduce tool downtime.
ADVANCED MATERIALS HANDLING SEGMENT
The AMH segment develops solutions to monitor, protect, transport and deliver critical liquid chemistries, wafers and
substrates for a broad set of applications in the semiconductor and other high-technology industries. These systems and
products improve our customers’ yields by protecting wafers from abrasion, degradation and contamination during
manufacturing and transportation and by assuring the consistent, clean and safe delivery of advanced chemicals from the
chemical manufacturer to the point-of-use in the semiconductor fab. The AMH segment collaborates closely with our SCEM
segment in developing products that are compatible with advanced chemistries to enhance yields and integrates liquid filtration
technology from our MC segment to deliver consistent and pure chemistry.
Microenvironment Solutions. We lead the market with our high-volume line of Ultrapak® and Crystalpak® products for
wafers ranging from 100 to 200 millimeter, which ensure the clean and secure transport of wafers from the wafer manufacturers
to the semiconductor fabs. We also offer a front-opening shipping box, or FOSB, for the transportation and automated interface
of 300 millimeter wafers. We lead the market for 300 millimeter front-opening unified pods, or FOUPs, wafer transport and
process carriers and standard mechanical interface pods, or SMIF pods, for 200 millimeter wafer applications. These
microenvironment products safely and accurately deliver wafers within the semiconductor fab environment to the various
process fabrication steps. We are a leader in reticle protection products for photolithography, including products that protect the
high-value EUV lithography masks during both the mask manufacturing process and their use in the semiconductor fab.
Fluid Management Products. We offer various fluid management products that cover a range of applications, including liquid
packaging, fluid handling and process monitoring products. Our broad portfolio of flexible and rigid polymer packaging and
container products, from low-volume containers to transport high-value photoresist chemistries, such as our NOWPak®
products, to large intermediate bulk containers allow our customers to safely and efficiently transport chemicals in bulk, such as
our FluoroPure® products. Our connection systems provide safe and efficient chemical dispense from the container to the fab.
Chemical companies utilize our packaging products to ensure the purity of chemistries shipped to semiconductor fabs, resulting
in enhanced yields.
In addition, we are a leader in high-purity fluid handling products such as valves, fittings, tubing, pipe, custom fabricated
products and associated connection systems, such as our PrimeLock® connections, for high-purity chemical applications and
our proprietary digital flow control technology improving the uniformity of chemicals applied on wafers. Our IntelliGen®
integrated, high-precision liquid dispense systems enable the uniform application of advanced chemistries during the wafer
fabrication process, integrating our valve control expertise with filter device technologies from our MC segment, in order to
conserve high-value chemistry and reduce defects on wafers. Our comprehensive product lines provide our customers with a
single-source provider for their high-purity chemical management needs throughout the manufacturing process.
Further, we provide market-leading instrumentation solutions to ensure consistency of complex blended chemistries and CMP
slurries. For example, our Single Particle Optical Sizing technology accurately determines particle size and counts. We also
produce on-tool process monitoring systems that perform automated online particle size and/or counts analysis of suspensions
with the Accusizer® system. These applications include real-time monitoring of CMP slurries and other instrumentation
for liquid applications in both semiconductor and life science industries. Our SemiChem® systems and Invue® products
measure chemical concentration in CMP slurries and formulated cleaning chemistries. These process instruments provide our
customers critical process monitoring to enable improved semiconductor device yields.
OUR CUSTOMERS AND MARKETS
Our most significant customers include logic and memory semiconductor device manufacturers, semiconductor equipment
makers, gas and chemical manufacturing companies and wafer grower companies serving the global semiconductor industry.
We also sell our products to flat panel display equipment makers, panel manufacturers, manufacturers of hard disk drive
components and devices and their related ecosystems.
Our other high-technology markets include manufacturers and suppliers in the solar and life science industries, electrical
discharge machining customers, glass and glass container manufacturers, aerospace manufacturers and manufacturers of
biomedical implantation devices.
10
In 2021, 2020 and 2019, net sales to our top ten customers accounted for 43%, 46% and 43%, respectively, of our combined net
sales. In 2021, 2020 and 2019, Taiwan Semiconductor Manufacturing Company Limited, accounted for $272 million, $208
million and $187 million of our net sales, respectively, or approximately 12%, 11% and 12% of our net sales, respectively,
including sales from each of our three reporting segments. In addition, in 2021, 2020 and 2019, Samsung Electronics
Co. accounted for $199 million, $172 million and $128 million of our net sales, respectively, or approximately 9%, 9% and 8%
of our net sales, respectively, including sales from all of the Company’s segments. International net sales represented
approximately 77%, 75% and 76%, respectively, of our total net sales in 2021, 2020 and 2019.
We may enter into supply agreements with our customers. These agreements generally have a term of one to three years, but
typically do not contain any long-term purchase commitments. Instead, we work closely with our customers to develop non-
binding forecasts of the future volume of orders. However, customers may cancel their orders, change production quantities
from forecasted volumes or delay production for reasons beyond our control.
SALES, MARKETING AND SUPPORT
We sell our products worldwide, primarily through our direct sales force and strategic independent distributors located in all
major semiconductor markets. Independent distributors are also used in other market territories and for specific market
segments. As of December 31, 2021, our sales and marketing force consisted of approximately 630 employees worldwide.
Our unique capabilities and long-standing industry relationships have provided us with the opportunity for significant
collaboration with our customers at the product design stage, which has facilitated our ability to introduce new materials and
new solutions that meet our customers’ needs. We are constantly seeking to identify for our customers a variety of materials,
contamination and process control challenges that may be addressed by our product solutions. Our sales representatives provide
our customers with worldwide technical support and information about our products and materials.
We believe that our technical support services are important to our sales and marketing efforts. These services include assisting
in defining a customer’s needs, evaluating alternative products and materials, designing a specific system to perform the desired
operation, training users and assisting customers in compliance with relevant government regulations. Additionally, our field
application engineers, located in all of the major markets we serve, work directly with our customers on product qualification
and process improvements in their facilities. We maintain a network of service centers, applications laboratories and technology
centers located in all key markets internationally and in the United States to support our products and our customers with their
advanced development needs, provide local technical service, application support and ensure fast turnaround time.
COMPETITION
The market for our products is highly competitive. While price is an important factor, we compete primarily on the basis of the
following factors:
technical expertise;
product quality and performance;
advanced manufacturing capabilities;
total cost of ownership;
historical customer relationships;
breadth of product line;
breadth of geographic presence;
customer service and support; and
after-sales service.
We believe that we compete favorably with respect to the factors listed above. We believe that our key competitive strengths
include our broad product line, our strong research and development infrastructure and investment, our manufacturing
excellence, our advanced quality control systems, the low total cost of ownership of our products, our ability to provide our
customers with quick order fulfillment and our applications expertise in semiconductor manufacturing processes. However, our
competitive position varies depending on the market segment and specific product areas within these segments. While we have
longstanding relationships with a number of semiconductor and other electronic device manufacturers, we still face significant
competition from companies that also have longstanding relationships with other semiconductor and electronic device
manufacturers and, as a result, have been able to have their products specified by those customers for use in manufacturers’
fabrication facilities.
The competitive landscape is varied, ranging from large multinational companies to small regional or regionally-focused
companies. While product quality and technology remain critical, overall, industry trends are indicating a shift to localized,
cost-competitive and consolidated supply chains.
Because of the unique breadth of our capabilities, we believe that there are no global competitors that compete with us across
the full range of our product offerings. Many of our competitors are local companies that participate in only a few products or
in specific geographies. While there are other larger, broad-based materials suppliers, many are concentrated in specific product
areas, such as filtration, specialty chemicals or materials handling. Notable competitors with respect to certain specific product
11
areas include Pall Corporation (part of Danaher Corporation), Shin-Etsu Polymer Co., Ltd., Gemu Valves, Inc., Tokyo Keiso
Co., Ltd., Mersen, the EMD Performance Materials division of Merck KGaA, E. I. du Pont de Nemours and Company, Air
Liquide, Praxair, Inc. (a subsidiary of Linde plc.), Donaldson Company, Inc. and Parker Hannifin Corp.
ENGINEERING, RESEARCH AND DEVELOPMENT
We believe that technology is important to the success of our businesses, and we plan to continue to devote significant
resources to engineering, research and development, or ER&D, balancing efforts between shorter-term market needs and
longer-term investments. As of December 31, 2021, we had approximately 1,050 employees in ER&D. We have supplemented
and may continue to supplement our internal research and development efforts by licensing technology from third parties and/or
acquiring rights with respect to products incorporating externally owned technologies. Our R&D expenses consist of personnel
and other direct and indirect costs for internally funded project development, including the use of outside service providers.
We believe we have a rich pipeline of development projects. Our ER&D efforts are directed toward developing and improving
our technology platforms for semiconductor and advanced processing applications and identifying and developing products for
new applications, often working directly with our customers to address their particular needs.
We have ER&D capabilities in the United States, Canada, China, Japan, South Korea, Taiwan, Singapore and Malaysia to meet
the global needs of our customers. We use sophisticated methodologies to research, develop and characterize our materials and
products. Our capabilities to test and characterize our materials and products are focused on continuously reducing risks and
threats to the integrity of the critical materials that our customers use in their manufacturing processes.
In addition, we collaborate with leading universities and industry consortia, such as the University of California, Yale
University, Pennsylvania State University, the Interuniversity Microelectronics Center (imec®) and CEA-LETI. We undertake
this work to extend the reach of our internal R&D and to gain access to leadership ideas and concepts beyond the time horizon
of our internal development activities.
PATENTS AND OTHER INTELLECTUAL PROPERTY RIGHTS
As of December 31, 2021, we owned approximately 2,840 active patents worldwide, of which about 630 were United States
patents. Additionally, we owned about 1,300 pending patent applications globally. In addition, we license certain patents owned
by third parties. We rely on a combination of patent, copyright, trademark and trade secret laws and license agreements to
establish and protect our proprietary rights. We seek to refresh our intellectual property on an ongoing basis through continued
innovation. While we license and expect to continue to license technology used in the manufacture and distribution of products
from third parties, we do not consider any particular patent or license to be material to our business.
We vigorously protect and defend our intellectual property. We require each of our employees, including our executive officers,
to enter into agreements with us pursuant to which the employee agrees to keep our proprietary information confidential and to
assign to us inventions made during the course of employment. We also require outside scientific collaborators, sponsored
researchers and other advisors and consultants who are provided confidential information to execute confidentiality agreements
with us. These agreements generally provide that all confidential information developed or made known to the entity or
individual during the course of the entity’s or individual’s relationship with the Company is to be kept confidential and not
disclosed to third parties except in specific limited circumstances.
MANUFACTURING
Our customers rely on our products and materials to ensure the integrity of the critical materials used in their manufacturing
processes by providing purity, cleanliness, consistent performance, dimensional precision and stability. Our ability to meet our
customers’ expectations, combined with our substantial investments in worldwide manufacturing capacity, position us well to
respond to the increasing demands from our customers for yield-enhancing materials and solutions.
To meet our customers’ needs worldwide, we have established an extensive global manufacturing network with facilities in the
United States, Canada, Japan, Taiwan, Malaysia, South Korea and China. Because we work in an industry where contamination
control is paramount, we maintain Class 100 to Class 10,000 cleanrooms for manufacturing and assembly. We believe that our
12
worldwide advanced manufacturing capabilities are important competitive advantages. These include:
engineered polymer conversion and processing;
advanced membrane modification and cleaning;
chemical distillation, synthesis and purification;
gas delivery systems;
high-purity gas handling and transfilling;
high-purity materials packaging;
membrane casting;
cartridge manufacturing and assembly;
specialty coating capabilities;
solids and powders compounding and handling;
graphite synthesis;
blow molding;
rotational molding;
machining; and
assembly.
We have made significant investments in systems and equipment to create innovative products and tool designs, including
metrology and 3D printing capabilities for rapid analysis and prototype production. In addition, we use contract manufacturers
for certain of our products both in the United States and Asia.
RAW MATERIALS
Our products are made from a wide variety of raw materials that are generally available from multiple sources of supply. While
we seek to have several sources of supply for raw materials, certain materials included in our products, such as certain filtration
membranes in our MC segment, petroleum coke and specialty and commodity chemicals in our SCEM segment and certain
polymer resins in our AMH segment, are obtained from a single source or a limited group of suppliers or from suppliers in a
single country. We have entered into multi-year supply agreements with a number of suppliers for the purchase of raw materials
in the interest of supply assurance and to control costs.
GOVERNMENTAL REGULATION
Our operations are subject to federal, state and local regulatory requirements relating to environmental, waste management and
health and safety matters, including measures relating to the release, use, storage, treatment, transportation, discharge, disposal
and remediation of contaminants, hazardous substances and wastes, as well as practices and procedures applicable to the
construction and operation of our plants. Although some risk of costs and liabilities related to these matters is inherent in our
business, as with many similar businesses, we believe that our business is operated in substantial compliance with applicable
regulations. However, new, modified or more stringent requirements or enforcement policies could be adopted, which could
adversely affect us. While we expect that capital expenditures will be necessary to ensure that any new manufacturing facility is
in compliance with environmental and health and safety laws, we do not expect these expenditures to be material.
HUMAN CAPITAL RESOURCES
We believe that our employees are a critical asset in achieving our mission of helping our customers improve their productivity,
performance and technology by providing enhanced materials and process solutions for the most advanced manufacturing
environments. In order to attract and retain top talent, we are focused on creating a diverse, inclusive and safe workplace and
are committed to providing competitive total rewards and quality development and training opportunities for our employees.
As of December 31, 2021, we had approximately 6,850 employees, of whom approximately 53%, 18%, 9%, 7%, 6%, 5% and
2% are located in North America, Southeast Asia, Japan, China, South Korea, Taiwan and Europe, respectively. Given the
variability of business cycles in the semiconductor industry and the quick response time required by our customers, it is critical
that we be able to quickly adjust the size of our production staff to maximize efficiency. Therefore, we use skilled temporary
labor as required. None of our employees is represented by a labor union or covered by a collective bargaining agreement other
than statutorily mandated programs in certain international jurisdictions.
Culture. Our organization is built around what we call our PACE values: our core values of treating people with respect and
dignity, acting honestly and consistently, encouraging creativity and innovation and a dedication to excellence. We believe that
by continuing to focus on these values, we provide our employees with a positive work environment that encourages them to
continue innovating.
We regularly conduct surveys of our employees to understand their perspectives on a number of topics. During 2021, these
topics included commitment to Entegris’ core values, safety and general employee satisfaction. Management uses the
information gathered from these surveys to inform its decision making with respect to employee matters, aiming to continue to
be an employer of choice in our industries.
13
Diversity and Inclusion. We believe that maintaining a culture of diversity and inclusion helps enable us to innovate more
effectively. To that end, we seek to promote diverse perspectives throughout our organization and are an equal opportunity
employer committed to making employment decisions without regard to race, religion, national or ethnic origin, sex, sexual
orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law.
Our commitment to diversity and inclusion is evidenced by the creation and support of our Employee Networks, which are
networks of our employees who share a common interest and are designed to advance diversity and inclusion and to promote
our workplaces as environments where all individuals are valued for their talents and empowered to reach their fullest potential.
As of December 31, 2021, our Employee Networks included groups focused on gender identity, sexual orientation, age and
veteran status.
Health, Safety and Wellness. Our success depends on the well-being of our employees. We maintain a culture focused on
safety and strive to identify, eliminate and control risk in the workplace in an effort to prevent injury and illness. Our employees
have access to a global safety management system and are encouraged to report incidents, near misses or other observations in
the system. The system has been widely adopted in our manufacturing locations across the globe, and management uses the
information generated by it to set safety-related policies and to set goals for future performance. Further, we provide our
employees with a comprehensive benefits package that includes health insurance and other resources that support their physical
and mental well-being.
In response to the COVID-19 pandemic, we have taken proactive, aggressive actions to protect the health and safety of our
employees, customers, partners and suppliers, consistent with the latest and evolving governmental guidelines. We expect to
continue to implement appropriate measures until the COVID-19 pandemic is adequately contained. We continue to monitor the
rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public
health authorities, and may take additional actions based on their recommendations or as we otherwise see fit to protect the
health and safety of our employees, customers, partners and suppliers.
Total Rewards. We are focused on enhancing our high-performing organization. To achieve this, we seek to attract and retain
talented employees by providing compelling total rewards, encompassing pay, benefits and other programs, that enrich our
employees, both personally and professionally. Our total rewards program is designed to be attractive and competitive and to
enable our employees to reach their highest potential by directly impacting their financial security, career growth opportunities
and the health and well-being of them and their families.
Talent Development and Training. We are committed to the continued development and training of our employees. We
conduct formal evaluations with each of our employees on an annual basis, and managers provide feedback directly to
employees through informal review sessions periodically throughout the year. Our formal evaluation process requires
employees to track whether they met certain development goals that are set at the beginning of the review period. While we
continue to search for new perspectives and insights with external hires, we also seek to provide opportunities for our
employees to grow their careers and regularly fill open vacancies with internal candidates. In addition, management
periodically assesses succession planning for certain key positions and reviews our workforce to identify high potential
employees for future growth and development.
We also provide formal and informal training opportunities for our employees covering a variety of professional, technical and
leadership topics. Our training opportunities are designed to promote learning across all levels of our organization, and in 2021
our formal training offerings included management trainings and the development of both technical and soft skills.
OUR HISTORY
The Company was incorporated in Delaware on March 17, 2005 in connection with a merger between Entegris, Inc., a
Minnesota corporation, and Mykrolis Corporation, a Delaware corporation. On April 30, 2014, the Company acquired ATMI,
based in Danbury, CT. Entegris has been helping its customers solve their critical materials challenges and enhance their
manufacturing yields for over 50 years, tracing its corporate origins back to Fluoroware, Inc., which began operating in 1966.
AVAILABLE INFORMATION
Our Internet address is www.entegris.com. On this website, under the “About Us—Investor Relations—Financial Information”
section, we post the following filings as soon as reasonably practicable after they are electronically filed with, or furnished to,
the U.S. Securities and Exchange Commission, or SEC: our annual, quarterly, and current reports on Forms 10-K, 10-Q, and 8-
K; our proxy statements; any amendments to those reports or statements, and Form SD. All such filings are available on our
website free of charge. The SEC also maintains a website (www.sec.gov) that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC. The content on our website and any
other website as referred to in this Form 10-K is not incorporated by reference into this Form 10-K unless expressly noted.
14
Item 1A. Risk Factors.
In addition to the other information in this Annual Report on Form 10-K, the following risk factors should be carefully
considered in evaluating us and our common stock. Any of the following risks, many of which are beyond our control, could
materially and adversely affect our financial condition, results of operations or cash flows or cause our actual results to differ
materially from those projected in any forward-looking statements. We may also face other risks and uncertainties that are not
presently known, are not currently believed to be material or are not identified below because they are common to all
businesses. Past financial performance may not be a reliable indicator of future performance and historical trends should not
be used to anticipate results or trends in future periods. For more information, see “Cautionary Statement” in Item 7 of this
Annual Report on Form 10-K.
Risk Factor Summary
Risks Related to Our Business and Industry
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
The impact of the COVID-19 pandemic.
The impact of declines in industry or worldwide economic conditions.
Variability of revenues and operating results.
The evolving nature of the industries we serve and the impact of changes in products and technology.
Supply chain risks.
Operation of a global business.
The impact of tariffs, export controls and other trade laws and restrictions, especially with respect to China.
Customer concentration.
Continuing innovation and introduction of new products.
Risks related to competition.
Our ability to successfully acquire other business, form joint ventures or divest businesses.
The impact of disruptions to our operations.
The use of hazardous materials in our operations.
Loss of key employees.
Our ability to obtain, protect and enforce intellectual property rights.
The impact of information technology system failures, network disruptions and breaches in data security.
The impact of climate change.
Risks Related to Government Regulation
•
•
•
The impact of environmental laws and regulations.
Risks related to the regulatory environment.
Changes in taxation or adverse tax rulings.
Risks Related to Our Indebtedness
•
•
The impact of our indebtedness.
Restrictions on our operations as a result of the terms of the Credit Agreement.
Risks Related to Owning our Common Stock
•
•
•
The volatility of the price of our common stock.
Changes in capital allocation strategy.
Provisions in our charter documents and Delaware law may delay or prevent an acquisition of us.
Risks Related to Our Pending Merger with CMC Materials, Inc.
•
•
Failure to complete the merger and termination thereof.
The impact of the merger on the market price of shares of our common stock.
15
•
•
•
•
Restrictions on our operations until the completion of the merger.
Employee-related risks, including retention.
Retention of customers or suppliers.
Risks related to debt of the combined company.
Risks Related to Our Business and Industry
The COVID-19 pandemic and continuing governmental responses could materially adversely affect our financial condition
and results of operations.
The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection
rates vary across the countries in which we operate. As we are currently experiencing with the omicron variant, there may be
additional waves of infection, which could be more contagious than prior waves. We have taken proactive measures to protect
the safety of our employees at all of our global facilities. Governmental authorities continue to implement numerous and
constantly evolving measures to try to contain the virus, such as travel bans and restrictions, masking recommendations and
mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business
shutdowns. Measures providing for business shutdowns have generally excluded certain essential services, including critical
infrastructure and the businesses that support that critical infrastructure. While all of our facilities currently remain operational,
these measures have impacted and may further impact our workforce and operations, as well as those of our customers,
suppliers and other third parties with which we do business. For example, in March 2020 the government of Malaysia issued an
order that significantly reduced the number of employees who could be physically present to operate our Malaysian plant,
which temporarily reduced the productivity of that plant. During 2021, we experienced brief interruptions in operations at
several of our sites across the world.
Constraints and limitations imposed on our operations or modifications on our business practices, or those of our suppliers, may
limit our ability to meet customer demand, cause us to increase our safety stock of certain materials, reduce our productivity,
slow or diminish our research and development activities, make our products less competitive, or cause our customers to seek
alternative suppliers and delay customer qualification activities, any of which could harm our business, reduce our profitability
or have a material adverse effect on our financial condition and results of operations. For example, employees working
remotely may not be able to maintain the same level of productivity and efficiency and employees may face additional demands
on their time, such as increased responsibilities resulting from school closures or the illness of family members. Absenteeism
caused by the COVID-19 pandemic may increase in the future and may harm our productivity. We have incurred and may
continue to incur incremental compensation expense related to the COVID-19 pandemic. Furthermore, restrictions or
disruptions of transportation, such as reduced availability of air transport, port closures and increased border controls or
closures, have in certain instances resulted in higher costs and delays both in obtaining materials and shipping finished goods to
customers. The pandemic and related restrictions have placed considerable strain on us, our suppliers and other third parties
with which we do business. The increased reliance on remote access to information systems by us and our customers, suppliers
and other third parties with which we do business increases the risk of exposure of our information and systems to potential
cybersecurity breaches. There is no certainty that additional measures required by government authorities or as we determine to
be in the best interests of our employees, customers, partners and suppliers will be sufficient to mitigate the risks posed by the
virus and we may be unable to respond to the needs of our global business. Furthermore, we cannot predict with certainty the
impact that future government, restrictions, mandates or related measures may have on our workforce and operations. These
may require significant time and attention from management to implement, increase our operating costs, reduce productivity,
result in attrition of our employees or hinder our ability to recruit and retain our employees.
The degree to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot
be predicted, including, but not limited to, the duration and spread of outbreaks, their severity, potential additional waves of
infection, the emergence of more virulent or more dangerous strains of the virus, the actions to mitigate the virus and its impact,
the development, distribution, efficacy and acceptance of vaccines and how quickly and to what extent normal economic and
operating conditions can resume. The prolonged implementation, or re-implementation, of measures by governments to try to
contain the virus may lead to fatigue in complying with COVID-19 restrictions among the public, which in turn may further
exacerbate its spread. Furthermore, the COVID-19 pandemic makes it more difficult for us to forecast demand and provide
guidance for upcoming periods. Accordingly, any guidance we provide is likely to be less reliable than usual, and actual results
are more likely to differ from any such guidance. In light of the foregoing, investors are urged to put the guidance in context
and not to place undue reliance on it.
Declines in the semiconductor industry or worldwide economic conditions may cause demand for our products to decrease
and may adversely affect our business.
16
Declines in industry or worldwide economic conditions may adversely affect our business. Our revenue is primarily dependent
upon demand from semiconductor manufacturers, which is largely driven by the current and anticipated demand for electronic
products that utilize semiconductors. Despite recent increases in demand for semiconductors in applications such as
smartphones, 5G wireless technology, cloud computing, the Internet of Things, machine learning and artificial intelligence,
autonomous vehicles and virtual reality, the semiconductor industry has historically been, and is likely to continue to be,
cyclical with periodic significant downturns, resulting in significantly decreased demand for products such as ours. While
demand for semiconductors has remained robust, the COVID-19 pandemic has significantly increased economic and demand
uncertainty and contributed to substantial volatility and inflationary pressure in global markets, including those in which we
participate. We anticipate that the pandemic will continue to adversely affect the global economy, and it is possible that it could
cause a global recession, each of which may adversely affect our business. We have previously experienced significant revenue
deterioration and operating losses due to severe downturns in the semiconductor industry, which often occur suddenly. The
semiconductor industry is also affected by seasonal shifts in demand. We are unable to predict the timing, duration or severity
of any future downturns in the semiconductor industry. As a result, we could underperform the market or our peers.
During downturns and periods of soft demand, our revenue is reduced and we typically experience greater pricing pressure and
shifts in product and customer mix, which often adversely affect our gross margin and net income. Furthermore, to remain
competitive, we must maintain a satisfactory level of engineering, research and development activity, invest in our
infrastructure and maintain the ability to respond to any increases in demand and, as a result, a lower volume of sales can have a
large and disproportionate impact on our profitability. Even moderate seasonality can cause our operating results to fluctuate
significantly from one period to the next. Uncertain and volatile economic, political, public health or business conditions in any
of our key sales regions can cause or exacerbate negative trends in business and consumer spending and have historically
impacted customer demand for our products. These conditions can cause material adverse changes in our results of operations
and financial condition, including:
•
•
•
•
•
•
•
a decline in demand for our products would have an immediate impact on our revenues;
an increase in reserves for accounts receivable due to our customers’ inability to pay us;
lower utilization of our manufacturing facilities, which could lead to lower margins;
an increase in write-offs for excess or obsolete inventory that we cannot sell;
potential impairment charges relating to goodwill, intangible assets, manufacturing equipment or other long-lived
assets, to the extent that any downturn indicates that the carrying amount of the asset may not be recoverable;
greater challenges in forecasting operating results, making business decisions and identifying and prioritizing business
risks; and
additional cost reduction efforts, including additional restructuring activities, which may adversely affect our ability to
capitalize on opportunities.
We anticipate that the ongoing COVID-19 pandemic may cause us to experience at least some of these adverse changes, but we
cannot predict the timing or degree to which they will occur, if at all.
Our revenues and operating results are variable.
Our revenues and operating results may fluctuate significantly from quarter-to-quarter or year-to-year due to a number of
factors, many of which are outside our control. We manage our expenses based in part on our expectations of future revenues.
Because some of our expenses are relatively fixed in the short term, a change in the timing of revenue or the amount of profit
we generate from a small number of transactions can unfavorably affect operating results in a particular period. Factors that
may cause our financial results to fluctuate unpredictably include:
•
•
•
•
•
•
economic conditions in the semiconductor industry or in the other industries we serve;
the impact of the COVID-19 pandemic on the global economy, the semiconductor industry, the other industries we
serve, our manufacturing capabilities or our supply chain;
the size and timing of customer orders;
consolidation of our customers, which could impact their purchasing decisions and negatively affect our revenues;
procurement shortages;
the failure of our suppliers or outsource providers to perform their obligations;
• manufacturing difficulties;
17
•
•
•
•
•
•
•
•
•
•
•
•
•
additional expenses we would expect to incur in our efforts to respond promptly to any supply shortages,
manufacturing difficulties or other supplier problems;
decisions to increase or accelerate our purchasing of raw materials, components or other supplies in an effort to
mitigate supply risk;
customer decisions to decelerate orders in order to draw down their inventory;
customer cancellations of or delays in shipments, installations or customer acceptances or, alternatively, acceleration
of orders from customers to increase their inventory;
our customers’ rate of replacement of our consumable products;
changes in average selling prices, customer mix and product mix;
our ability to develop, introduce and market new, enhanced and competitive products in a timely manner;
our competitors’ introduction of new products;
legal or technical challenges to our products or technologies;
disruptions in transportation, communication, demand, information technology or supply, including strikes, acts of
God, wars, terrorist activities and natural or man-made disasters;
legal, tax, accounting or regulatory changes (including changes in import/export regulations and tariffs) or changes in
the interpretation or enforcement of existing requirements;
changes in our estimated tax rate; and
foreign currency exchange rate fluctuations.
The COVID-19 pandemic is likely to exacerbate the adverse impact of many of these factors on our revenues and results of
operations, at least in the short term.
The industries we serve are constantly evolving, and any failure to manage our business effectively during periods of rapid
change may adversely affect our business performance and results of operations.
Intense competition in the semiconductor industry often leads to rapid changes in products and technology. These changes can
significantly alter demand for our products and the amount and mix of customers’ spending on our products and solutions can
significantly impact our results of operations. Changes in demand may arise from factors such as advances in fabrication
processes, new and emerging technologies, end-user demand, customers’ production capacity and customers’ capacity
utilization. We must accurately forecast demand for each of our products and effectively manage our resources and production
capacity across our various businesses. Although we regularly reassess our allocation of resources in response to the changing
business environment, we may incur unexpected or additional costs to align our operations with demand, If we do not
adequately anticipate changes in our business environment, we may lack the infrastructure, manufacturing capacity and
resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we
may expand our capacity too rapidly, resulting in excess fixed costs. Even with effective allocation of resources and
management of costs, during periods of decreasing demand, our gross margins and earnings will usually be adversely impacted.
Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance,
particularly if we have not accurately anticipated the correct mix of industry changes. Our success will depend, to a significant
extent, on our management’s ability to identify and respond to these challenges effectively.
Our ability to increase sales of our products, particularly our capital equipment products, depends in part upon our ability in a
very short timeframe to ramp up our manufacturing capacity and to mobilize our supply chain. If we are unable to expand our
manufacturing capacity on a timely basis, manage the expansion effectively and obtain larger quantities of raw materials, our
customers could obtain products from our competitors, which would reduce our market share, harm our reputation as a trusted
partner and impact our results of operations. These challenges have been exacerbated by the COVID-19 pandemic. In 2021, we
faced several instances where our manufacturing capacity was constrained and the lead time to manufacture and deliver our
customers’ products was extended. If we are unable to meet our customers’ demand for our products or deliver our products
within their required lead times, our customers may seek to replace us with alternative suppliers. Additionally, although we
have been increasing inventory levels to support strong demand in a challenging supply chain environment, historically we have
operated our business on a just-in-time shipment basis with a modest level of inventory, ordering supplies and planning
production based on internal demand forecasts. The failure to accurately forecast demand for our products, in terms of both
volume and product type, has in the past led to, and may in the future lead to, delays in product shipments and disappointment
of customer expectations, as well as an increased risk of excess and obsolete inventory.
18
We depend on single and limited source suppliers, and an interruption in our ordinary sources of supply could affect our
ability to manufacture our products and have an adverse effect on our results of operations.
We rely on single or limited source suppliers for certain raw materials that are critical to the manufacturing of our products,
such as plastic polymers, filtration membranes, petroleum coke and other materials. If we were to lose any one of these sources,
it could be difficult for us to find an alternative supplier and we would need to qualify this new source through our customers’
rigorous qualification processes. Although we seek to reduce our dependence on single and limited source suppliers, the partial
or complete loss of any of these sources could interrupt our manufacturing operations and result in a material adverse effect on
our results of operations.
At times, we have experienced a limited supply of certain raw materials, which has resulted in delays, lost revenue, increased
costs and risks associated with qualifying products that are manufactured using such new raw materials with our customers.
Events such as an industry-wide increase in demand for, or the discontinuation of, raw materials used in our products could
harm our ability to acquire sufficient quantities of such raw materials, and our manufacturing operations may be interrupted.
For example, in 2021 we experienced a disruption in the supply of certain ceramic material for use in our coatings business in
our SCEM division when the supplier was unable to produce these materials at the required specifications. When these events
occur, we work collaboratively with the supplier to determine the root cause and to solve the manufacturing issue in order to
reestablish the supply of these materials. We may be unable to successfully reestablish our raw material supply in the future, in
which case shortages may adversely affect our operations. Additionally, our suppliers may not have the capacity to meet
increases in our demand for raw materials, in turn, making us unable to meet demand from our customers. Prices for our raw
materials can vary widely. While we have long-term arrangements with certain key suppliers that fix our price for the purchase
of certain raw materials, if the cost of our raw materials increases, as we have seen recently due to inflationary pressure, and we
are unable to correspondingly increase the sales price of our products or find other cost savings, our profit margins will decline.
The COVID-19 pandemic has caused a difficult and dynamic supply chain and global logistics environment, and we have
experienced instances of raw material constraints and shortages, higher freight costs and delivery delays in both inbound
shipments of raw materials and outgoing shipments of finished products to customers. If our suppliers or sub-suppliers are
unable to maintain their operations or COVID-19 related restrictions become more severe, we may encounter difficulties
obtaining raw materials, which may cause us to fail to meet customer demand or require us to pay higher prices for these
materials, either of which could harm our business and profitability. To mitigate the risk of potential supply interruptions from
the COVID-19 pandemic, during 2021, we chose to increase certain inventory levels, causing us to hold more inventory than
we might have otherwise maintained. Additionally, an economic slowdown caused by the COVID-19 pandemic or otherwise
could harm the financial health of our suppliers and sub-suppliers. Although we regularly monitor the financial health of
companies in our supply chain, financial hardship on our suppliers or sub-suppliers could cause a disruption in our ability to
obtain raw materials or components or adversely affect our operations. We may increase our safety stocks of raw materials or
components or alter our payment terms with certain suppliers, including prepaying for raw materials, any of which could put
downward pressure on our cash flow.
We are exposed to the risks of operating a global business as a significant amount of our sales and manufacturing activity
occur outside the United States.
Sales to customers outside the United States accounted for approximately 77%, 75% and 76% of our net sales in 2021, 2020
and 2019, respectively. We anticipate that international sales will continue to account for a majority of our net sales. In
addition, a number of our key domestic customers derive a significant portion of their revenues from sales in international
markets. We also manufacture a significant portion of our products outside the United States and depend on international
suppliers for many of our parts and raw materials. We intend to continue to pursue opportunities in both sales and
manufacturing internationally. Our international operations are subject to a number of risks and potential costs that could
adversely affect our revenue and profitability, including:
•
•
•
border closures, travel bans, entry limitations or inspections and other restrictions on the international movement of
goods, including actions to limit the export of goods in order to secure a domestic supply in light of actual or
anticipated global shortages, as well as the potential exercise of governmental power to requisition or prioritize the
production of specified goods or to commandeer facilities in the public interest, such as in the effort to combat the
COVID-19 pandemic, any of which could adversely affect our ability to obtain supplies and deliver our products to
customers;
the implementation of laws, rules, regulations, policies and other government actions, such as “trade wars,” tariffs,
sanctions or other changes in international trade requirements that affect our business and that of our customers and
suppliers, any of which could impose additional costs on our operations and limit our ability to operate our business;
challenges in hiring and integrating workers in different countries;
19
•
•
•
•
•
•
•
•
•
•
•
challenges in managing a diverse workforce with different experience levels, languages, cultures, customs, business
practices and worker expectations, along with differing employment practices and labor issues;
challenges of maintaining appropriate business processes, procedures and internal controls and complying with legal,
environmental, health and safety, anti-bribery, anti-corruption and other regulatory requirements that vary by
jurisdiction, including new and evolving requirements for social distancing and other measures to minimize the spread
of COVID-19;
challenges in developing relationships with local customers, suppliers and governments;
fluctuating pricing and availability of raw materials and supply chain interruptions or slowdowns, including as a result
of difficulties, financial or otherwise, faced by segments of the transportation industry;
public health crises, such as the COVID-19 pandemic;
expense and complexity of complying with U.S. and foreign import and export regulations, including the ability to
obtain required import and export licenses;
fluctuations in interest rates and currency exchange rates, including the relative strength or weakness of the U.S. dollar
against foreign currencies that are important to our business, including the Japanese yen, euro, Taiwanese dollar,
Korean won, Chinese renminbi, Singapore dollar, Malaysian ringgit, Canadian dollar or Israeli shekel, which could
cause our sales and profitability to decline;
liability for foreign taxes assessed at rates higher than those applicable to our domestic operations;
challenges and costs associated with the protection of our intellectual property throughout the world;
customer or government efforts to encourage operations and sourcing in a particular country, such as Korea or China,
including efforts to develop and grow local competitors, require local manufacturing, and provide special incentives to
government-backed local customers to buy from local competitors; and
political and economic instability and uncertainty, which may result in severely diminished liquidity and credit
availability, rating downgrades of sovereign debt, declining valuation of certain investments, declines in consumer
confidence, declines in economic growth, volatility in unemployment rates and uncertainty about economic stability.
In the past, these factors have disrupted our operations and increased our costs, and we expect that these factors will continue to
do so in the future.
Tariffs, export controls and other trade laws and restrictions resulting from international trade disputes, strained
international relations and changes to foreign and national security policy, especially as they relate to China, could have an
adverse impact on our operations.
Tariffs, additional taxes, trade barriers and other measures, particularly those arising out of relations between the United States
and China, may increase costs of raw materials and our manufacturing costs, decrease margins, reduce the competitiveness of
our products or inhibit our ability to sell products or purchase necessary equipment and supplies, any of which could have a
material adverse effect on our business, results of operations or financial condition. For example, both the United States and
China have implemented several rounds of tariffs and retaliations with respect to certain products imported from the other
country, some of which have impacted certain raw materials we use. We have made operational changes in an effort to mitigate
the impact of these tariffs on our products, but our efforts may not be successful.
In addition, we are subject to export control and economic sanctions laws and regulations that restrict the delivery of some of
our products and services to certain end users, countries and nationals of certain countries. In certain circumstances, these
restrictions may prohibit the transfer of certain of our products, services and technologies, and in other circumstances they may
require us to obtain a license from the U.S. government before delivering the controlled item or service. We must also comply
with export control and economic sanctions laws and regulations imposed by other countries. Although we maintain an export
and trade control compliance program, it may be ineffective or circumvented, exposing us to legal liabilities. Compliance with
these laws could significantly limit our sales in the future. Changes in, and responses to, U.S. trade controls could reduce the
competitiveness of our products and cause our sales to drop, which could have a material adverse effect on our business,
financial condition and results of operations.
In addition to the tariffs mentioned above, over the last several years, the U.S. government has significantly expanded export
controls on certain technologies and commodities to certain markets, particularly with respect to semiconductor and other high
technology exports to China. For example, effective June 29, 2020, the U.S. Department of Commerce imposed new export
controls on the transfer of many U.S. products and technologies, including many commercial-grade electronics, to “military end
users” in China, a term which may include many Chinese commercial companies that sell products to or do business with the
20
military. Likewise, beginning in May 2019, the U.S. Department of Commerce imposed significant restrictions on the transfer
of any products from the United States, as well as many products produced overseas that incorporate U.S. content or rely on
U.S. software or technology, to Huawei Technologies Co., Ltd. and several of its overseas affiliates, including HiSilicon, and
took similar action against Semiconductor Manufacturing International Corporation in December 2020. The U.S. Department of
Commerce continues to impose similar export-related restrictions against other Chinese companies for their support of the
military, for business activities, including supply chain activities, related to the Xinjiang region of China, and for other actions
found to be contrary to U.S. national security or foreign policy. The U.S. government also continuously assesses which
“emerging and foundational technologies” warrant new or additional controls, which could subject additional U.S.-origin
products and services to more stringent export restrictions. It is possible that these modified regulations, and any future
regulations, could reduce demand for our products. As a result of these restrictive measures, certain of our customers have made
efforts to source products domestically in order to mitigate perceived risks to their supply chain. If these efforts are successful,
are widespread amongst our customers and expand to our products and solutions broadly, overall global demand for our
customers’ products or for other products produced or manufactured in the United States or based on U.S. technology may be
reduced, in turn reducing demand for our products, which could have a material adverse effect on our business, financial
condition and results of operations. Such risks may be especially exacerbated as they relate to China, a market that is important
to our business, representing approximately 16% of our sales in 2021.
A significant portion of our sales is concentrated on a limited number of key customers, and our net sales and profitability
may materially decline if we were to lose one or more of these customers.
Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows,
collections and profitability. Our top ten customers accounted for 43%, 46% and 43% of our net sales in 2021, 2020 and 2019,
respectively. Our customers could stop using our products in their manufacturing processes with limited advance notice to us,
and we would have limited or no contractual recourse. The cancellation, reduction or deferral of purchases of our products by
any one of these customers could significantly reduce our revenues in any particular quarter. If we were to lose any of our
significant customers, if our products are not specified for our significant customers’ products or if we suffer a material
reduction in their purchase orders, our revenue could decline and our business, financial condition and results of operations
could be materially and adversely affected. Due to the long design and development cycle and lengthy customer product
qualification periods required for most of our products, we may be unable to replace these customers quickly, if at all.
Furthermore, the semiconductor industry has been undergoing, and is expected to continue to undergo, consolidation. If any of
our customers merge or are acquired, we may experience lower overall sales from the merged or combined companies. In
addition, our principal customers also hold considerable purchasing power and may be able to negotiate sales terms that result
in decreased pricing, increased costs, and/or lower margins for us, and limitations on our ability to share jointly developed
technology with others.
If we are unable to anticipate and respond to rapid technological change and customer requirements by continuing to
innovate and introduce new and enhanced products and solutions, our business could be seriously harmed.
The semiconductor industry is subject to rapid technological change, changing customer requirements and frequent new product
introductions. In our industry, the first company to introduce an innovative product that addresses an identified market need will
often have a significant advantage over competing products. For this reason, we make significant expenditures to research,
develop, engineer and market new products and make significant capital investments in technology and manufacturing capacity
in anticipation of future business and without any purchase commitment from our customers. We incurred $167.6 million,
$136.1 million and $121.1 million for engineering, research and development expense in 2021, 2020 and 2019, respectively, to
support new product and technology development. Following development, it may take several years for sales of a new product
to reach a substantial level, if ever. If a product concept does not progress beyond the development stage or only achieves
limited acceptance in the marketplace, we may not receive a direct return on our expenditures, we may lose market share and
our revenue and our profitability may decline. For example, in the past, we incurred significant impairment charges for capital
expenditures related to developing the capability to manufacture shippers and FOUPs for 450 mm wafers, which major
semiconductor manufacturers announced that they would not initiate manufacturing for in the foreseeable future.
We believe that our future success will depend upon our ability to continue to develop mission-critical solutions to maximize
our customers’ manufacturing yields and enable higher performance semiconductor devices. A failure to successfully anticipate
and respond to technological changes by developing, marketing and manufacturing new products or enhancements to our
existing products could harm our business prospects and significantly reduce our sales. For example, as 3D NAND technology
advances to higher densities, the conventional process used to etch critical features no longer works. Recognizing the need for a
new chemistry, we developed a series of prototype formulations for highly selective nitride etch and developed a specialized
liquid filter that removes contaminants while simultaneously maintaining the critical components that make the chemistry
function. While we have achieved process-of-record for these specific etch processes with certain customers and we are
preparing for rapid, high-volume ramp, we may not generate significant revenue from these solutions. We cannot assure you
21
that the new products and technology we choose to develop and market will be successful. In addition, if new products have
reliability or quality problems, we may experience reduced orders, higher manufacturing costs, delays in acceptance and
payment, additional service and warranty expense and damage to our reputation.
Competition from new or existing companies could harm our financial condition, results of operations and cash flow.
We operate in a highly competitive industry. We face many competitors, some of which have substantially greater
manufacturing, financial, research and development and marketing resources than we do. In addition, some of our competitors
may have better-established customer relationships than we do, which may enable them to have their products specified for use
more frequently and more quickly by these customers. We also face competition from smaller, regional companies that focus on
serving customers in their regions. Further, customers continually evaluate the benefits of internal manufacturing versus
outsourcing, and a customer’s decision to internally manufacture products that we provide may negatively impact us. If we are
unable to maintain our competitive position, we could experience downward pressure on prices, fewer customer orders, reduced
margins, the inability to take advantage of new business opportunities and a loss of market share, any of which could have a
material adverse effect on our results of operations. Further, we expect that existing and new competitors will improve their
products and introduce new products with enhanced performance characteristics. The introduction of new products or more
efficient production of existing products by competitors could diminish our market share and increase pricing pressure on our
products.
We may acquire other businesses, form joint ventures or divest businesses, which could negatively affect our financial
performance.
We intend to continue to engage in business combinations, acquisitions, joint ventures, investments or other types of
collaborations to address gaps in our product offerings, adjust our business and product portfolio to meet our ongoing strategic
objectives, diversify into complementary markets, increase our scale or accomplish other strategic objectives. These
transactions involve numerous risks to our business, financial condition and operating results, including but not limited to:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
experiencing difficulty in identifying suitable acquisition candidates and completing transactions at appropriate
valuations, in a timely manner, on a cost-effective basis or at all, due to substantial competition for acquisition targets;
inability to successfully integrate any acquired businesses into our business operations;
failure to realize the anticipated synergies or other benefits of any such transaction;
entering into markets in which we have limited or no prior experience;
finding acquirors and obtaining adequate value for businesses that no longer meet our objectives;
inability to complete proposed transactions due to the failure to obtain regulatory or other approvals;
requirements imposed by government regulators in connection with their review of a transaction, which may include,
among other things, divestitures and restrictions on the conduct of our existing business or the acquired business;
undertaking multiple transactions at the same time in order to take advantage of acquisition opportunities that do arise,
which could strain our ability to effectively execute and integrate such transactions;
diversion of management’s attention from our day-to-day business due to dedication of significant management
resources to such transactions;
employee uncertainty and lack of focus during the integration process that may also disrupt our business;
the risk of litigation or claims associated with a proposed or completed transaction;
challenges associated with managing new, more diverse and more widespread operations, projects and people,
potentially located in regions where we have not historically conducted or operated our business;
dependence on unfamiliar or less secure supply chains and inefficient scale of the acquired entity;
increasing costs of performing due diligence to meet the expectations of investors and government regulators;
despite our due diligence, we could assume unknown, underestimated or contingent liabilities, such as potential
environmental, health and safety liabilities, any of which could lead to costly litigation or mitigation actions;
an acquired technology or product may have inadequate or invalid intellectual property protection or may be subject to
claims of infringement by a third party, which may result in claims for damages and lower than anticipated revenue;
we could experience negative effects on our reported results of operations from dilutive results from operations and/or
from future potential impairment of acquired assets, including goodwill, related to acquisitions;
22
•
•
•
an acquired company may have inadequate or ineffective internal controls over financial reporting, disclosure controls
and procedures, cybersecurity, privacy, environmental, health and safety, anti-bribery, anti-corruption, human resource
or other policies or practices, which may require unexpected or additional integration, mitigation and remediation
costs;
reductions in cash or increases in debt to finance transactions, which reduce the cash flow available for general
corporate or other purposes, including share repurchases and dividends; and
difficulties in retaining key employees or customers of an acquired business.
Manufacturing interruptions or delays, or other disruptions to our operations, could adversely affect our business, financial
condition and results of operations.
Our manufacturing processes are complex and require the use of expensive and technologically sophisticated equipment and
materials. These processes are frequently modified to improve manufacturing yields, process stability and product quality. We
have, on occasion, experienced manufacturing difficulties, such as critical equipment breakdowns or the introduction of
impurities in the manufacturing process. Any future difficulties could cause lower yields, make our products unmarketable and/
or delay deliveries to customers. In addition, any modification to the manufacturing process of a product could require that the
product be re-qualified by customers, which can increase our costs and delay our ability to sell this product to our customers.
These and other manufacturing difficulties may result in the loss of sales and exposure to warranty and product liability claims.
Some of our products are manufactured at only one or two facilities in different countries, many of which are subject to severe
weather events and natural catastrophes, such as typhoons in Taiwan, Malaysia and China, earthquakes in Japan and Taiwan,
hurricanes in east Texas and Florida, severe winter weather in Texas, wildfires in California and Colorado and flooding in
Arkansas. Our suppliers and customers face similar dangers. Although we have continuity plans designed to mitigate the impact
of natural disasters on our operations, those plans may be insufficient, and any catastrophe may disrupt our ability to
manufacture and deliver products to our customers, resulting in an adverse impact on our business and results of operations. A
disruption at our manufacturing facilities could impact sales of the products manufactured at those facilities until another
facility could commence or expand production of those products, and disruptions at our other facilities may similarly adversely
affect our operations. In addition to natural disasters, disruptions may be caused by other factors, including civil unrest,
outbreaks of disease, terrorist actions or other events outside our control. We have moved, and we may again move, the
manufacture of certain products from one plant to another. If we fail to transfer and re-establish the manufacturing processes in
the destination plant efficiently and effectively, we may not be able to meet customer demand, we may lose credibility with our
customers and our business may be harmed. Even if we successfully move our manufacturing processes, we may not achieve
the anticipated levels of cost savings or efficiencies, if any.
Our operations use hazardous materials that expose us to various risks, including potential liability for personal injury and
potential remediation obligations.
Our operations involve, and we are exposed to the risks associated with, the use and manufacture of hazardous materials. In
particular, we manufacture specialty chemicals, which is an inherently hazardous process that may result in accidents, and store
and transport hazardous raw materials, products and waste in, to and from various facilities. Potential risks that may disrupt our
operations or expose us to significant losses and liabilities include explosions and fires, chemical spills and other discharges,
releases of toxic or hazardous substances or gases, and pipeline and storage tank leaks and ruptures. These and other hazards
may result in liability for personal injury, death, damage to property and contamination of the environment; suspension of
operations; the imposition of civil or criminal fines, penalties and other sanctions; cleanup costs; claims by governmental
entities or third parties; reputational harm; increases in our insurance costs; and other adverse impacts on our results of
operations. Moreover, a failure of one of our products at a customer site could interrupt the business operations of the customer.
For example, while we believe that our SDS and VAC delivery systems are safe to transport, store and deliver toxic gases, any
leakage could cause serious damage, including injury or death, to any person exposed to those toxic gases, potentially creating
significant product liability exposure for us. Our insurance coverage may be inadequate to satisfy any such liabilities, and our
financial results or financial condition could be adversely affected.
Loss of any of our key personnel could harm our business, and our inability to attract and retain new qualified personnel
could inhibit our ability to operate and grow our business successfully.
Many of our key personnel have significant experience in the semiconductor industry and deep technical expertise. The loss of
the services of any of our key employees or an inability to attract, train and retain qualified and skilled employees, particularly
research and development and engineering personnel, could inhibit our ability to operate and grow our business. As the
semiconductor industry has grown in recent years, competition for qualified talent, particularly those with significant industry
experience, has intensified. During 2021 we experienced, and may in the future continue to experience, an increasingly
competitive and constrained labor market, which may limit our ability to add headcount required to meet our customers’
demand, decrease our productivity due to an influx of inexperienced workers and cause our labor costs to increase and our
23
profitability to decline. As a result, the difficulty and costs associated with attracting and retaining employees has risen and may
continue to rise.
If we fail to obtain, protect and enforce intellectual property rights, our business and prospects could be harmed.
Our future success and competitive position depend in part upon our ability to obtain, maintain and enforce intellectual property
rights. We rely on patent, trade secret and trademark laws to protect many of our major product platforms. Although we often
file applications for additional patents, our pending applications may not be approved. Moreover, any patents that we own or
obtain may not provide us with any competitive advantage, and these patents may expire or be challenged, invalidated,
circumvented, rendered unenforceable or otherwise compromised by third parties. We may not develop additional proprietary
technology. In addition, any failure to obtain intellectual property protection in the international jurisdictions we serve could
expose us to increased competition, which could limit our growth and future revenue. Although we enter into confidentiality
agreements with our employees and certain third parties to protect our proprietary information and technology, these
agreements may be inadequate to protect our interests, and the remedies available to us for any breach may not adequately
mitigate any breach. Furthermore, third parties may be able to replicate or obtain our confidential and proprietary information
and technology through lawful means, and they may also be able to design around our patents. Additionally, we may lose trade
secret protection as a result of the actions or omissions of us, our employees or third parties. Any weakness in our ability to
protect our intellectual property could adversely affect our business, financial condition and results of operations.
Third parties may misappropriate our intellectual property rights, and disputes regarding intellectual property rights may arise.
We may bring litigation in order to enforce our patents, copyrights or other intellectual property rights, to protect our trade
secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement. Such
litigation could result in substantial costs and diversion of resources and could negatively affect our sales, profitability and
prospects regardless of whether our efforts are successful. For example, from 2015 until 2020, we were party to litigation to
enforce our intellectual property rights against Gudeng Precision Industrial Co., Ltd. for their patent infringement. We settled
this dispute in 2020 by licensing certain of our intellectual property rights to Gudeng. In 2021, Gudeng filed a patent lawsuit
against us and the lawsuit is pending. We continue to vigorously defend our patents and rights, which will cause us to incur
costs. We may initiate other costly litigation against our competitors or other third parties in order to protect our intellectual
property rights. We cannot predict how any existing or future litigation will be resolved or what impact it may have on us.
Our commercial success also depends, in part, on our ability to avoid infringing or misappropriating any patents or other
proprietary rights of third parties. If we infringe or misappropriate a third party’s patent or other proprietary rights, we could be
required to pay damages, alter our products or processes, obtain a license to continue use of a proprietary right or cease utilizing
such proprietary rights, including making or selling products utilizing such proprietary rights. If we are required to obtain a
license, we may be unable to do so on commercially acceptable terms, or at all.
We may be subject to information technology system failures, network disruptions and breaches in data security, which
could damage our reputation and adversely affect our financial condition, results of operations and cash flows, and new
laws and regulations regarding data privacy may increase our costs.
We collect and store sensitive data, including our financial information, intellectual property, confidential information,
proprietary business information and personally identifiable information of our employees and others, as well as similar
information of our customers, suppliers and business partners. We maintain this information in our data centers, on our
networks and on information technology, or IT, systems owned and maintained by third parties. The secure processing,
maintenance and transmission of this information is critical to our operations. All IT systems are subject to disruption, breach or
failure. Data breaches, including those sponsored by state actors, have become increasingly common in recent years. For
example, during 2020 the United States government was hacked via third-party software applications by hackers suspected of
being sponsored by a foreign intelligence agency. While we and our third-party providers have implemented network security
procedures, virus protection software, intrusion prevention systems, access control, emergency recovery processes and internal
control measures, we and they have experienced, and expect to continue to be subject to, cybersecurity threats and incidents
ranging from employee error or misuse, to individual attempts to gain unauthorized access to systems, to sophisticated and
targeted measures known as advanced persistent threats. Despite the precautions undertaken by us and our third-party providers,
IT system failures, network disruptions and breaches of data security could cause disruption in our operations, issues with
customer communication and order management, the unauthorized or unintentional disclosure of sensitive information,
disruptions in our transaction processing or undermine the integrity of our disclosure controls and procedures and our internal
control over financial reporting, which could affect our reputation, result in significant liabilities and expenses, adversely affect
our ability to report our financial results in a timely manner and could have a material adverse effect on our financial condition,
results of operations and cash flows. These risks may be further amplified by the increased reliance on remote access to IT
systems by us and our customers, suppliers and other third parties with which we do business as a result of employees working
remotely in response to the COVID-19 pandemic.
24
Moreover, new laws and regulations, such as the European Union’s General Data Protection Regulation, the California
Consumer Privacy Act and China’s Personal Information Protection Law, add to the complexity of our compliance obligations,
which increases our compliance costs. Although we have established internal controls and procedures intended to achieve
compliance with such laws and regulations, a failure to fully comply could result in significant penalties.
Climate change may have a long-term impact on our business.
There are inherent climate-related risks wherever our business is conducted. Changes in market dynamics, stakeholder
expectations, local, national and international climate change policies, and the frequency and intensity of extreme weather
events on critical infrastructure in the United States and abroad, all have the potential to disrupt our business and operations.
Such events could result in a significant increase in our costs and expenses and harm our future revenue, cash flows and
financial performance. Global climate change is resulting in, and may continue to result, in certain natural disasters and adverse
weather events, such as drought, wildfires, storms, sea-level rise and flooding, occurring more frequently or with greater
intensity, which could cause business disruptions and impact employees’ abilities to commute or to work from home
effectively. Government failure to address climate change in line with the Paris Agreement could result in greater exposure to
economic and other risks from climate change and impact our ability to achieve climate goals.
Risks Related to Government Regulation
We are subject to a variety of environmental laws and regulations that could cause us to incur significant liabilities and
expenses.
Failure to comply with the wide variety of federal, state, local and non-U.S. regulatory requirements relating to the release, use,
storage, treatment, transportation, discharge, disposal and remediation of, and human exposure to, hazardous chemicals could
result in future liabilities or the suspension of production or shipment. These requirements have become stricter over time.
These laws and regulations, among others, increase the complexity and costs of transporting our products from the country in
which they are manufactured to our customers. Further changes to these and similar regulations could restrict our ability to
expand, build or acquire new facilities, require us to acquire costly control equipment, cause us to incur expenses associated
with remediation of contamination, cause us to modify our manufacturing or shipping processes or otherwise increase our cost
of doing business and have a negative impact on our financial condition, results of operations and cash flows. In addition, the
potential adoption of new laws, rules or regulations related to climate change poses risks that could harm our results of
operations or affect the way we conduct our businesses. For example, new or modified regulations could require us to make
substantial expenditures to enhance our environmental compliance efforts.
We are exposed to various risks from our regulatory environment.
We are subject to risks related to new, different, inconsistent, or even conflicting laws, rules, and regulations that may be
enacted by legislative or executive bodies and/or regulatory agencies in the countries where we operate; disagreements or
disputes related to international trade; and the interpretation and application of laws, rules, and regulations. As a public
company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various
governing bodies, including those related to health and safety, export controls, financial and other disclosures, corporate
governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt
payments to governmental officials or customers, conflict minerals or other social responsibility legislation, employment
practices, immigration or travel regulations and antitrust regulations, among others. Each of these laws, rules and regulations
imposes costs on our business, including financial costs and potential diversion of our management’s attention, and may present
risks to our business, including potential fines, restrictions on our actions and reputational damage if we do not fully comply.
The volume of changes to such laws, rules and regulations may increase in the United States over the next several quarters as
the Biden administration continues to implement its policies.
To maintain high standards of corporate governance and public disclosure, we intend to invest in appropriate resources to
comply with evolving standards. Changes in or ambiguous interpretations of laws, regulations and standards may create
uncertainty regarding compliance matters. Efforts to comply with new and changing regulations have resulted in, and are likely
to continue to result in, increased administrative expenses and diversion of management’s time and attention from revenue-
generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with laws
and regulations, our reputation, business, financial condition and/or results of operations could be adversely affected, we may
be disqualified or barred from participating in certain activities and we may be forced to modify our operations to achieve full
compliance.
Changes in taxation or adverse tax rulings could adversely affect our results of operations.
We operate in many foreign countries and are subject to taxation at various rates and audit by multiple taxing authorities. Our
results of operations could be affected by tax audits, changes in tax rates, changes in laws and regulations governing the
calculation, location and taxation of earned profit, changes in laws and regulations affecting our ability to realize deferred tax
25
assets on our balance sheet and changes in laws and regulations relating to the repatriation of cash into the United States. Each
quarter we forecast our tax liability based on our forecast of our performance for the year in each tax jurisdiction. If our
performance forecast changes, our forecasted tax liability would also likely change, perhaps materially.
We have undertaken and expect to continue to undertake a number of complex internal reorganizations of our foreign
subsidiaries in order to rationalize and streamline our foreign operations, focus our management efforts on certain local
opportunities and take advantage of favorable business conditions in certain localities. These or any future reorganizations
could result in adverse tax consequences in one or more jurisdictions, which could adversely impact our profitability from
foreign operations and result in a material reduction in our results of operations.
Various other jurisdictions, including members of the Organization for Economic Cooperation and Development, are
considering changes to their tax laws, including provisions intended to address base erosion and profit shifting by taxpayers.
Any tax reform adopted in these or other countries may exacerbate the risks described above.
Risks Related to Our Indebtedness
We have a substantial amount of indebtedness and may in the future incur substantially more debt, each of which could
adversely affect our ability to obtain financing in the future and react to changes in our business.
As of December 31, 2021, we had an aggregate principal amount of $945.0 million of indebtedness outstanding, including our
4.375% senior unsecured notes due April 15, 2028 and our 3.625% senior unsecured notes due May 1, 2029, or collectively the
Notes, and our senior secured term loan facility due 2025, or the Term Loan Facility. In addition, we have approximately $400
million of unutilized capacity under our senior secured revolving credit facility due 2026, or the Revolving Facility. We refer to
the Term Loan Facility and the Revolving Facility as the Credit Facilities, and the credit agreement that governs the Credit
Facilities as the Credit Agreement.
Further, we may incur significant additional secured and unsecured indebtedness in the future. For example, in connection with
our proposed merger with CMC, we have entered into an amended and restated commitment letter with Morgan Stanley Senior
Funding, Inc. and certain other financial institutions providing for a senior secured first lien term loan B facility in an aggregate
principal amount of up to $4 billion and a senior unsecured bridge term loan facility in an aggregate principal amount of up to
$895 million. Commitments under the bridge facility will be reduced by, among other things, the aggregate gross cash proceeds
in excess of $300 million resulting from any issuance or sale by Entegris of certain securities, including senior unsecured notes
or other debt securities or other indebtedness for borrowed money, equity securities and equity-linked securities.
Although the indentures governing the Notes, or the Indentures, and the Credit Agreement restrict our ability to incur additional
indebtedness, the restrictions have a number of significant qualifications and exceptions. For example, the Credit Agreement
provides that we can request additional loans and commitments up to the greater of $400 million or 100% of our EBITDA, as
well as additional amounts if our secured net leverage ratio is less than a specified ratio. Further, these restrictions do not
prevent us from incurring monetary obligations that do not constitute indebtedness. If we add new indebtedness and other
monetary obligations to our current debt levels, the related risks that we now face would intensify.
Our debt could have important consequences, including:
•
•
•
•
•
limiting our ability to obtain additional financing to fund future working capital, capital expenditures, acquisitions or
other general corporate purposes;
requiring a substantial portion of our cash flow to be dedicated to debt service payments instead of other purposes;
increasing our vulnerability to adverse changes in general economic, industry and competitive conditions;
exposing us to increased interest expense for borrowings with variable interest rates, including borrowings under the
Credit Facilities; and
placing us at a disadvantage compared to other, less leveraged competitors or competitors with comparable debt
having more favorable terms.
We may be unable to generate sufficient cash to service our indebtedness and may be forced to take other actions, which
may not be successful, to satisfy our obligations under our indebtedness.
We may be unable to maintain sufficient cash flow from operating activities to permit us to pay the principal of, premium, if
any, and interest on our indebtedness. Our ability to make scheduled payments on or to refinance our debt obligations depends
on our financial condition and operating performance and the condition of the capital markets, which are subject to prevailing
economic, industry and competitive conditions, as well as many financial, business, legislative, political, regulatory and other
factors beyond our control. If our cash flow and capital resources are insufficient to fund our debt service obligations, we could
face substantial liquidity problems, be forced to reduce or delay investments and capital expenditures, dispose of material assets
26
or operations, seek additional debt or equity capital or restructure or refinance our indebtedness, any of which could have a
material adverse effect on our business, financial position and results of operations.
Any refinancing of our debt could be at higher interest rates and may require us to comply with more onerous covenants, which
could further restrict our business operations. We may not be able to implement any refinancing on commercially reasonable
terms or at all and, even if successful, a refinancing may not allow us to meet our scheduled debt service obligations. The
agreements governing our indebtedness restrict our ability to dispose of assets and use the proceeds of such dispositions, and we
may be unable to consummate any dispositions or generate proceeds sufficient to meet our debt service obligations.
If we cannot make scheduled payments on our debt, holders of the Notes and lenders under the Credit Facilities could declare
all outstanding principal and interest to be due and payable, the lenders under the Revolving Facility could terminate their
commitments to advance further loans, our secured lenders could foreclose against the assets securing their borrowings and we
could be forced into bankruptcy or liquidation.
The terms of the Credit Agreement may restrict our operations, particularly our ability to respond to changes or raise
additional funds.
The Credit Agreement contains restrictive covenants that impose significant operating and financial restrictions that may limit
our ability to take actions that may be in our long-term best interest, including restrictions on our ability to:
•
•
•
incur additional indebtedness and guarantee indebtedness;
pay dividends or make other distributions in respect of, or repurchase or redeem, capital stock;
prepay, redeem or repurchase certain debt;
• make investments, loans, advances and acquisitions;
•
•
•
sell or otherwise dispose of assets, including capital stock of our subsidiaries;
enter into transactions with affiliates;
alter the businesses we conduct; and
• merge or sell all or substantially all of our assets or incur a change of control in our capital stock ownership.
In addition, the restrictive covenants may, depending on the amount of revolving borrowings, unreimbursed letter of credit
drawings and undrawn letters of credit, require us to maintain a secured net leverage ratio, which we may be unable to meet.
Also, the Indentures contain limited covenants, such as a covenant restricting our ability and certain of our subsidiaries’ ability
to incur certain debt secured by liens. Our failure to comply with these covenants could result in the acceleration of some or all
of our indebtedness, which could lead to bankruptcy, reorganization or insolvency.
Risks Related to Owning our Common Stock
The price of our common stock has been and may remain volatile.
The price of our common stock has been volatile. In 2021, the closing price of our stock on The Nasdaq Global Select Market,
or Nasdaq, ranged from a low of $93.99 to a high of $154.75, and, as in past years, the price of our common stock may show
even greater volatility in the future. The trading price of our common stock is subject to significant volatility in response to
numerous factors, many of which are beyond our control or may be unrelated to our operating results, including the following:
•
•
•
•
•
•
•
•
•
•
the significant increase in volatility in the stock market in general as a result of the COVID-19 pandemic;
any changes to our financial guidance, as well as potential decreased confidence in any guidance we do provide;
changes in global economic conditions, including those resulting from trade tensions or the COVID-19 pandemic;
the failure to meet the expectations of securities analysts, which may vary significantly from our actual results;
changes in financial estimates by securities analysts;
press releases or announcements by, or changes in market values of, comparable companies;
high volatility in price and volume in the markets for high-technology stocks;
the public perception of equity values of publicly traded companies;
fluctuations in our results of operations; and
the other risks and uncertainties described in this Annual Report on Form 10-K and in our other filings with the SEC.
27
Fluctuations in our results of operations could cause our stock price to decline significantly. We believe that period-to-period
comparisons of our results of operations may not be meaningful, and you should not rely upon them as indicators of our future
performance. Future decreases in our stock price may adversely impact our ability to raise sufficient additional capital in the
future, if needed.
There can be no assurance that we will continue to declare cash dividends or that we will recommence the repurchase of our
shares in any particular amounts or at all.
In connection with our proposed acquisition of CMC, we have suspended our previously announced share repurchase program.
Future payments of quarterly dividends and any future repurchases of shares of our common stock are subject to capital
availability and periodic determinations by our board of directors that they are in the best interest of our stockholders and
comply with all laws and applicable agreements. Future dividends and any future share repurchases may be affected by, among
other factors, potential capital requirements for acquisitions and the funding of our research and development activities; legal
risks; changes in federal and state income tax laws or corporate laws; contractual restrictions, such as financial or operating
covenants in our debt arrangements; availability of domestic cash flow; and changes to our business model. The amounts of our
dividend payments may change from time to time, and we may decide at any time to reduce, suspend or discontinue the
payment of dividends or the repurchase of shares. A reduction, suspension or discontinuation of our dividend payments or the
cessation of our share repurchase program could have a negative effect on the price of our common stock and may harm our
reputation.
Provisions in our charter documents and Delaware law may delay or prevent an acquisition of us, which could decrease the
value of our shares.
Our certificate of incorporation, our by-laws and Delaware law contain provisions that could make it harder for a third party to
acquire us without the consent of our board of directors. These provisions include limitations on actions by written consent of
our stockholders.
Our certificate of incorporation makes us subject to the anti-takeover provisions of Section 203 of the Delaware General
Corporation Law. In general, Section 203 prohibits publicly held Delaware corporations from engaging in a “business
combination” with an “interested stockholder” for a period of three years after the date of the transaction in which the person
became an interested stockholder, unless the business combination is approved in a prescribed manner. This provision could
discourage parties from bidding for our shares of common stock and could, as a result, reduce the likelihood of an increase in
the price of our common stock that would otherwise occur if a bidder sought to buy our common stock.
Our certificate of incorporation authorizes our board of directors to issue, without further stockholder approval, up to 5,000,000
shares of preferred stock in one or more series and to fix and designate the rights, preferences, privileges and restrictions of the
preferred stock, including dividend rights, conversion rights, voting rights, redemption rights and liquidation preferences. The
holders of any shares of preferred stock could have preferences over the holders of our common stock with respect to dividends
and liquidation rights. Any issuance of preferred stock may have the effect of delaying, deterring or preventing a change in
control. Any issuance of preferred stock could decrease the amount of earnings and assets available for distribution to the
holders of common stock and could adversely affect the rights and powers, including voting rights, of the holders of common
stock. The issuance of preferred stock could have the effect of decreasing the market price of our common stock.
Risks Related to Our Pending Merger with CMC Materials, Inc.
Failure to complete our pending merger with CMC Materials, Inc. could have a materially adverse effect on our financial
condition and results of operations and could negatively impact our stock price.
On December 14, 2021, we entered into an agreement and plan of merger with merger sub and CMC, pursuant to which merger
sub will merge with and into CMC, with CMC surviving the merger as a wholly-owned subsidiary of Entegris. We will incur
significant transaction costs relating to the merger, including legal, accounting, financial advisory, regulatory and other
expenses. In general, these expenses are payable by us whether or not the merger is completed. The payment of such transaction
costs could have an adverse effect on our financial condition, results of operations or cash flows. In addition, we could be
subject to litigation in the event the merger is not consummated, which could subject us to significant liability for damages and
result in the incurrence of substantial legal fees. The current market price of our stock may reflect an assumption that the
pending merger will occur and failure to complete the merger could result in a decline in our stock price.
The merger may not be completed and the merger agreement may be terminated in accordance with its terms.
The merger is subject to a number of conditions that must be satisfied, including the approval by CMC stockholders of the
merger agreement proposal, or waived (to the extent permissible), in each case before the completion of the merger. These
conditions to the completion of the merger, some of which are beyond our control and that of CMC, may not be satisfied or
waived in a timely manner or at all, and, accordingly, the merger may be delayed or not completed.
28
Additionally, either we or CMC may terminate the merger agreement under certain circumstances, including, among other
reasons, if the merger is not completed by December 14, 2022 (which date may be extended to March 14, 2023, under certain
circumstances. In addition, if the merger agreement is terminated under certain circumstances specified in the merger
agreement, CMC may be required to pay us a termination fee of $187 million, including certain circumstances in which the
CMC board of directors effects an adverse recommendation change or CMC enters into an agreement with respect to a superior
proposal following the termination of the merger agreement.
The announcement and pendency of the merger agreement and any subsequent termination of the merger agreement could
negatively impact us or CMC.
Whether or not the merger is completed, the announcement and pendency of the merger could cause disruptions in our
businesses. If the merger is not completed for any reason, including as a result of a failure to obtain the required CMC
stockholder vote or the failure to obtain the requisite regulatory approvals, our ongoing businesses may be adversely affected.
We may be subject to a number of risks, including the following:
•
•
•
•
we may experience negative reactions from the financial markets, including negative impacts on our stock price;
we may experience negative reactions from our suppliers and customers;
our current and prospective employees and those of CMC may experience uncertainty about their future roles with the
combined company, which might adversely affect our or CMC’s abilities to retain key managers and other employees;
the merger agreement places certain restrictions on the conduct of each company’s business prior to completion of the
merger and such restrictions, the waiver of which is subject to the consent of the other company (not to be
unreasonably withheld, conditioned or delayed), which may prevent us or CMC from taking certain other specified
actions during the pendency of the merger; and
• matters relating to the merger (including integration planning) will require substantial commitments of time and
resources by our management and CMC management, which could otherwise have been devoted to day-to-day
operations or to other opportunities that may have been beneficial to us or CMC, as applicable, as an independent
company.
The market price for shares of our common stock following the completion of the merger may be affected by factors
different from, or in addition to, those that historically have affected or currently affect the market price of shares of our
common stock.
Upon consummation of the merger, our stockholders and CMC stockholders will both hold shares of common stock in Entegris.
Our businesses differ from those of CMC, and CMC’s businesses differ from those of our business, and, accordingly, the results
of operations of the combined company will be affected by some factors that are different from those currently or historically
affecting our results of operations and those currently or historically affecting the results of operations of CMC. The results of
operations of the combined company may also be affected by factors different from those that currently affect or have
historically affected either us or CMC.
Until the completion of the merger or the termination of the merger agreement in accordance with its terms, we and CMC
are each prohibited from entering into certain transactions and taking certain actions that might otherwise be beneficial to
us or CMC and our or their respective shareholders.
From and after the date of the merger agreement and before completion of the merger, the merger agreement restricts us and
CMC from taking specified actions without the consent of the other party (with CMC being restricted from taking a broader set
of specified actions than us) and requires that the business of each company and its respective subsidiaries be conducted in all
material respects in the ordinary course of business consistent with past practice. These restrictions may prevent us or CMC
from making appropriate changes to our or their respective businesses or organizational structures or from pursuing attractive
business opportunities that may arise before the completion of the merger, and could have the effect of delaying or preventing
other strategic transactions. Adverse effects arising from the pendency of the merger could be exacerbated by any delays in
consummation of the merger or termination of the merger agreement.
Failure to attract, motivate and retain executives and other key employees could diminish the anticipated benefits of the
merger.
The success of the merger will depend in part on the retention of personnel critical to the business and operations of the
combined company due to, for example, their technical skills or management expertise. Competition for qualified personnel can
be intense.
Our current and prospective employees and those of CMC may experience uncertainty about their future role with us and the
combined company until strategies with regard to these employees are announced or executed, which may impair our and
29
CMC’s ability to attract, retain and motivate key management, sales, marketing, technical and other personnel before and
following the merger. Employee retention may be particularly challenging during the pendency of the merger, as employees
may experience uncertainty about their future roles with the combined company. If we or CMC are unable to retain personnel,
including our and CMC’s key management, who are critical to the successful integration and future operations of the
companies, we and the combined company could face disruptions in our operations, loss of existing customers or loss of sales
to existing customers, loss of key information, expertise or know-how, and unanticipated additional recruitment and training
costs. In addition, the loss of key personnel could diminish the anticipated benefits of the merger.
If our key employees or CMC’s key employees depart, the integration of the companies may be more difficult and the
combined company’s business following the merger may be harmed. Furthermore, the combined company may have to incur
significant costs in identifying, hiring and retaining replacements for departing employees and may lose significant expertise
and talent relating to our business or CMC’s business, and the combined company’s ability to realize the anticipated benefits of
the merger may be adversely affected. In addition, there could be disruptions to or distractions for the workforce and
management associated with activities of labor unions or integrating employees into the combined company. No assurance can
be given that the combined company will be able to attract or retain our key employees and those of CMC to the same extent
that the separate companies have been able to attract or retain their respective employees in the past.
The failure to successfully combine our and CMC’s businesses may adversely affect our future results.
The success of the merger will depend, in part, on our ability to realize anticipated benefits from integrating CMC into the
Company. To realize these anticipated benefits, our business and CMC must be successfully combined. If we are not able to
achieve these objectives, the anticipated benefits of the merger may not be realized fully or at all, or may take longer to realize
than expected.
We may not be able to retain customers or suppliers, or customers or suppliers may seek to modify contractual obligations
with us, which could have an adverse effect on our business and operations. Third parties may terminate or alter existing
contracts or relationships with us or CMC.
As a result of the merger, we may experience impacts on relationships with customers or suppliers that may harm our business
and results of operations. Certain customers or suppliers may seek to terminate or modify contractual obligations following the
merger whether or not contractual rights are triggered as a result of the merger. There can be no guarantee that customers or
suppliers will remain with or continue to have a relationship with us or do so on the same or similar contractual terms following
the merger. If any customers or suppliers seek to terminate or modify contractual obligations or discontinue the relationship
with us, then our business and results of operations may be harmed. If certain of our suppliers were to seek to terminate or
modify an arrangement with us, then we may be unable to procure necessary supplies from other suppliers in a timely and
efficient manner and on acceptable terms, or at all.
We and CMC also have contracts with vendors, landlords, licensors and other business partners which may require us or CMC,
as applicable, to obtain consent from these other parties in connection with the merger. If these consents cannot be obtained, we
may suffer a loss of potential future revenue, incur costs, and lose rights that may be material to its business. In addition, third
parties with whom we or CMC currently have relationships may terminate or otherwise reduce the scope of their relationship
with either party in anticipation of the merger. Any such disruptions could limit our ability to achieve the anticipated benefits of
the merger. The adverse effect of any such disruptions could also be exacerbated by a delay in the completion of the merger or
by a termination of the merger agreement.
The combined company’s debt may limit our financial flexibility following the merger.
We expect to incur a substantial amount of debt in connection with the merger and have entered into an amended and restated
commitment letter with Morgan Stanley Senior Funding, Inc. and certain other financial institutions providing for a senior
secured first lien term loan B facility in an aggregate principal amount of up to $4 billion and a senior unsecured bridge term
loan facility in an aggregate principal amount of up to $895 million. We expect to use a portion of the proceeds from such
facilities to repay and terminate both our and CMC’s existing credit facilities (or, amend or otherwise refinance, our Revolving
Facility) substantially concurrently with the completion of the merger. Accordingly, as of September 30, 2021, the combined
company would have had approximately $5.6 billion of total debt, after giving pro forma effect to the merger, the refinancing of
our and CMC’s existing credit facilities and certain other adjustments.
Following the merger, the combined company’s substantial indebtedness could have adverse effects on the combined
company’s financial condition and results of operations, including:
•
•
increasing its vulnerability to changing economic, regulatory and industry conditions;
limiting its ability to compete and its flexibility in planning for, or reacting to, changes in its business and the industry;
30
•
•
•
limiting its ability to pay dividends to its stockholders;
limiting its ability to borrow additional funds; and
increasing its interest expense and requiring it to dedicate a substantial portion of its cash flow from operations to
payments on its debt, thereby reducing funds available for working capital, capital expenditures, acquisitions, share
repurchases, dividends and other purposes.
The combined company’s ability to make scheduled payments of the principal of, and to pay interest on or to refinance its
indebtedness following the merger will depend on, among other factors, the combined company’s respective financial positions
and performance, as well as prevailing market conditions and other factors beyond its control. Our combined business may not
continue to generate cash flow from operations in the future sufficient to service the combined company’s debt and make
necessary capital expenditures and meet its other liquidity needs. If the combined company is unable to generate such cash
flow, it may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional
equity capital or debt refinancing on terms that may be onerous. The combined company may not be able to engage in any of
these activities or engage in these activities on desirable terms, which could result in a default on its debt obligations which, if
not cured or waived, could accelerate the combined company’s repayment obligations under all of its outstanding debt which
could have a material adverse effect on the combined company’s business, results of operations or financial condition.
In addition, the level and quality of the combined company’s earnings, operations, business and management, among other
things, will impact the determination of the combined company’s credit ratings. A decrease in the ratings assigned to the
combined company by the ratings agencies may negatively impact the combined company’s access to the debt capital markets
and increase the combined company’s cost of borrowing. There can be no assurance that the combined company will be able to
obtain any future required financing on acceptable terms or at all. In addition, there can be no assurance that the combined
company will be able to maintain the current credit worthiness or prospective credit rating of the Company. Any actual or
anticipated changes or downgrades in such credit rating may have a negative impact on the liquidity, capital position or access
to capital markets of the combined company.
The covenants contained in the agreements governing the combined company’s indebtedness following the merger will
impose restrictions on the combined company and certain of its subsidiaries that may affect their ability to operate their
businesses.
The agreements that will govern the indebtedness of the combined company following the merger, including the indebtedness
to be incurred pursuant to the commitment letter (or any indebtedness that may refinance or replace the bridge facility as set
forth in the commitment letter) will contain various affirmative and negative covenants. Such covenants may, subject to certain
significant exceptions, restrict the ability of the combined company and certain of its subsidiaries after the merger to, among
other things, incur liens, incur debt, engage in mergers, consolidations and acquisitions, transfer assets outside the ordinary
course of business, make loans or other investments, pay dividends, repurchase equity interests, make other payments with
respect to equity interests, repay or repurchase subordinated debt and engage in affiliate transactions. In addition, such
agreements may also contain financial covenants that would require the combined company to maintain certain financial ratios
under certain circumstances. The ability of the combined company and its subsidiaries to comply with these provisions after the
merger may be affected by events beyond their control. Failure to comply with these covenants could result in an event of
default, which, if not cured or waived, could accelerate the combined company’s repayment obligations under all of its
outstanding debt which could have a material adverse effect on the combined company’s business, results of operations or
financial condition.
Item 1B. Unresolved Staff Comments.
Not Applicable.
31
Item 2. Properties.
Our principal executive offices are located in Billerica, Massachusetts. Information about our principal and certain other
facilities is set forth below:
Location
Bedford, Massachusetts
Principal Function
Research & Manufacturing
Billerica, Massachusetts(1)
Burnet, Texas
Chaska, Minnesota
Colorado Springs, Colorado
Danbury, Connecticut
Decatur, Texas
Hsin-chu, Taiwan
JangAn, South Korea
Kulim, Malaysia
San Luis Obispo, California
San Luis Obispo, California
Suwon, South Korea
Yonezawa, Japan
Executive Offices, Research & Manufacturing
Research & Manufacturing
Executive Offices, Research & Manufacturing
Manufacturing
Research & Manufacturing
Manufacturing
Executive Offices, Sales Research &
Manufacturing
Manufacturing
Manufacturing
Manufacturing
Manufacturing
Executive Offices & Research
Manufacturing
Approximate
Square Feet
80,000
175,000
86,000
186,000
82,000
73,000
359,000
146,330
127,000
195,000
37,000
34,000
42,000
185,000
Reporting Segment
Leased/
Owned
Owned MC & SCEM
MC, SCEM &
Leased
AMH
Owned SCEM
Owned AMH
Owned AMH
Leased
SCEM
Owned SCEM
Leased
MC, SCEM &
AMH
MC, SCEM &
Owned
AMH
Owned SCEM & AMH
Owned MC
Leased MC
Leased MC & SCEM
Owned MC & AMH
(1) This lease has been extended through September 30, 2026 and is subject to one five-year renewal option.
In addition, we own and lease space for manufacturing, distribution, technical support, sales, service, repair, and general
administrative purposes in the United States, Canada, China, Germany, France, Israel, Japan, Malaysia, Singapore, South Korea
and Taiwan. Leases for our facilities expire through December 2031. We currently expect to be able to extend the terms of
expiring leases or to find suitable replacement facilities on reasonable terms. We believe that our facilities are well-maintained
and suitable for their respective operations. We regularly assess the size, capability and location of our global infrastructure and
periodically make adjustments based on these assessments.
Item 3. Legal Proceedings.
As of December 31, 2021, we were not involved in any legal proceedings that we believe will have a material impact on our
consolidated financial position, results of operations or cash flows. From time to time the Company may be a party to litigation
involving claims against the Company arising in the ordinary course of our business. We are not aware of any material potential
litigation or claims against us which would have a material adverse effect upon our financial statements.
For purposes of this disclosure, we have determined that legal proceedings that involve governmental authorities and that relate
to environmental matters are not material to our business or financial condition in circumstances where we reasonably believe
that such proceedings will result in either no monetary sanctions or potential monetary sanctions of less than $1.0 million,
exclusive of interest and costs.
Item 4. Mine Safety Disclosures.
Not applicable.
32
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
Market Information and Holders
Entegris’ common stock, $0.01 par value per share, trades on the Nasdaq Global Select Market under the symbol “ENTG”. As
of January 31, 2022, there were 861 shareholders of record.
Dividend Policy
Holders of the Company’s common stock are entitled to receive dividends when and if they are declared by the Company’s
board of directors. The Company’s board of directors declared cash dividends of $0.08 per share during each of the first,
second, third and fourth quarters of 2021, which totaled $43.6 million.
On January 19, 2022, the Company’s board of directors declared a quarterly cash dividend of $0.10 per share to be paid on
February 23, 2022 to shareholders of record as of February 2, 2022.
Future dividend declarations, if any, as well as the record and payment dates for such dividends, are subject to the final
determination of our board of directors. Furthermore, the credit agreement governing the Credit Facilities contains restrictions
that may limit our ability to pay dividends.
Issuer Sales of Unregistered Securities During the Past Three Years
None.
Comparative Stock Performance
The following graph compares the cumulative total shareholder return on the common stock of Entegris, Inc. from
December 31, 2016 through December 31, 2021 with the cumulative total return of (1) The Nasdaq Composite Index, and
(2) The Philadelphia Semiconductor Index, assuming $100 was invested at the close of trading on December 31, 2016 in
Entegris, Inc. common stock, the Nasdaq Composite Index and the Philadelphia Semiconductor Index and that all dividends are
reinvested.
Prepared by Zacks Investment Research, Inc. Used with permission. All rights reserved. Copyright 1980-2022.
Index Data: Copyright NASDAQ OMX, Inc. Used with permission. All rights reserved.
33
Period EndedIndex ValueComparison of Five-Year Cumulative Total ReturnAssumes Initial Investment of $100December 31, 2021Entegris, Inc.NASDAQ Composite - Total ReturnsPhiladelphia Semiconductor Index12/31/1612/31/1712/31/1812/31/1912/31/2012/31/2102004006008001,000 Entegris, Inc.
Nasdaq Composite
Philadelphia Semiconductor
Index
December 31,
2016
December 31,
2017
December 31,
2018
December 31,
2019
December 31,
2020
December 31,
2021
$100.00
100.00
$170.48
129.64
$157.56
125.96
$284.98
172.18
$549.59
249.52
$794.70
304.85
100.00
140.55
132.05
215.58
331.27
473.22
Issuer Purchases of Equity Securities
On December 14, 2020, the Company’s board of directors authorized a repurchase program, effective February 16, 2021,
covering the repurchase of up to an aggregate of $125 million of the Company’s common stock during a period of twelve
months, in open market transactions and in accordance with one or more pre-arranged stock trading plans to be established in
accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act. This repurchase
program will expire pursuant to its terms on February 15, 2022. In connection with its proposed acquisition of CMC, the
Company suspended its previously announced share repurchase program and does not anticipate authorizing a new repurchase
program in 2022.
The following table provides information concerning shares of the Company’s common stock, $0.01 par value per share,
purchased by the Company during the three months ended December 31, 2021:
(a)
Total Number of
Shares Purchased
(b)
Average Price Paid
per Share
(c)
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
(d)
Maximum Number
(or Approximate
Dollar Value) of
Shares that May Yet
Be Purchased Under
the Plans or Programs
62,500
$131.64
62,500
$73,559,663
41,800
$150.9
41,800
$67,252,095
17,600
121,900
$146.24
$140.35
17,600
121,900
$64,678,249
$64,678,249
Period
October 3, 2021 - November
6, 2021
November 7, 2021 -
December 4, 2021
December 5, 2021 -
December 31, 2021
Total
The Company issues common stock awards under its equity incentive plans. In the consolidated financial statements, the
Company treats shares of common stock withheld for tax purposes on behalf of its employees in connection with the vesting or
exercise of the awards as common stock repurchases because they reduce the number of shares that would have been issued
upon vesting or exercise. These withheld shares of common stock are not considered common stock repurchases under the
Company’s authorized common stock repurchase plan and accordingly are not included in the common stock repurchase totals
in the preceding table.
Item 6. Reserved.
34
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the Company’s consolidated financial condition and results of operations should be
read along with the consolidated financial statements and the accompanying notes thereto included elsewhere in this Annual
Report on Form 10-K. This discussion contains forward-looking statements that involve numerous risks and uncertainties,
including, but not limited to, those described in Item 1A, “Risk Factors” and the “Cautionary Statements” section of this Item 7
below. You should review Item 1A “Risk Factors” of this Annual Report on Form 10-K for a discussion of important factors
that could cause actual results to differ materially from the results described in or implied by the forward-looking statements
contained in the following discussion and analysis. The Company has elected to omit discussion of the earliest of the three
years covered by the consolidated financial statements presented. Information pertaining to fiscal year 2019 results of
operations and the year-over-year comparison of changes in our Financial Condition and Results of Operations as of and for
the year ended December 31, 2020 and 2019 can be found in Part II, Item 7, “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2020,
filed on February 4, 2021.
Cautionary Statements
This Annual Report on Form 10-K and the portions of the Company’s Definitive Proxy Statement incorporated by reference in
this Annual Report on Form 10-K contain “forward-looking statements.” The words “believe,” “expect,” “anticipate,” “intend,”
“estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended
to identify such forward-looking statements. These forward-looking statements may include statements about the impact of the
Company’s pending merger with CMC; the COVID-19 pandemic on the Company’s operations and markets, including supply
chain issues related thereto; future period guidance or projections; the Company’s performance relative to its markets, including
the drivers of such performance; market and technology trends, including the duration and drivers of any growth trends and the
impact of the COVID-19 pandemic on such trends; the development of new products or new applications for existing products
and the success of their introductions; the focus of the Company’s engineering, research and development projects and levels of
spending related thereto; the Company’s ability to execute on its business strategies, including with respect to the Company’s
expansion of its manufacturing presence in Taiwan; the Company’s capital allocation strategy, which may be modified at any
time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the impact of the
acquisitions the Company has made and commercial partnerships the Company has established; future capital and other
expenditures, including estimates thereof; the Company’s expected tax rate; the impact, financial or otherwise, of any
organizational changes; the impact of accounting pronouncements; quantitative and qualitative disclosures about market risk;
and other matters. These forward-looking statements are based on current management expectations and assumptions only as of
the date of this Annual Report on Form 10-K, are not guarantees of future performance and involve substantial risks and
uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or
implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, the risk factors and
additional information described in this Annual Report on Form 10-K under the caption “Risk Factors,” elsewhere in this
Annual Report on Form 10-K and in the Company’s other periodic filings. Except as required under the federal securities laws
and the rules and regulations of the SEC, the Company undertakes no obligation to update publicly any forward-looking
statements or information contained herein, which speak as of their respective dates.
Overview
This overview is not a complete discussion of the Company’s financial condition, changes in financial condition and results of
operations; it is intended merely to facilitate an understanding of the most salient aspects of its financial condition and
operating performance and to provide a context for the detailed discussion and analysis that follows, and must be read in its
entirety in order to fully understand the Company’s financial condition and results of operations.
The Company is a leading supplier of advanced materials and process solutions for the semiconductor and other high-
technology industries. Our mission is to help our customers improve their productivity, performance and technology by
providing enhanced materials and process solutions for the most advanced manufacturing environments. We leverage our
unique breadth of capabilities to create mission-critical microcontamination control products, specialty chemicals and advanced
materials handling solutions that maximize manufacturing yields, reduce manufacturing costs and enable higher device
performance for our customers.
Our customized materials solutions enable the highest levels of performance essential to the manufacture of semiconductors. As
our customers introduce more complex architectures and search for new materials with better electrical and structural properties
to improve the performance of their devices, they rely on Entegris as a trusted partner to address these challenges. We
understand these challenges and have solutions to address them, such as our advanced deposition materials, implant gases,
formulated cleaning chemistries and selective etch chemistries. Our customers also require greater end-to-end materials purity
and integrity in their manufacturing process that, when combined with smaller dimensions and more complex architectures, can
be challenging to achieve. To enable the use of new metals and the further miniaturization of chips, and to maximize yield and
35
increase long-term device reliability, we provide products such as our advanced liquid and gas filtration and purification
products that help to selectively remove new classes of contaminants throughout the semiconductor supply chain. In addition, to
ensure purity levels are maintained across the entire supply chain, from bulk manufacturing, to transportation to and delivery
through a fab, to application onto the wafer, we provide high-purity packaging and materials handling products.
Our business is organized and operated in three operating segments, which align with the key elements of the advanced
semiconductor manufacturing ecosystem. The Specialty Chemicals and Engineered Materials, or SCEM, segment provides
high-performance and high-purity process chemistries, gases, and materials, and safe and efficient delivery systems to support
semiconductor and other advanced manufacturing processes. The Microcontamination Control, or MC, segment offers solutions
to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-
technology industries. The Advanced Materials Handling, or AMH, segment develops solutions to monitor, protect, transport,
and deliver critical liquid chemistries, wafers and other substrates for a broad set of applications in the semiconductor industry,
life sciences and other high-technology industries. While these segments have separate products and technical know-how, they
share common business systems and processes, technology centers, and strategic and technology roadmaps. With the
technology, capabilities and complementary product portfolios from these three segments, we are uniquely positioned to
collaborate across divisions to create new, co-optimized and increasingly integrated solutions for our customers. For example,
our SCEM segment offers a highly selective nitride etch chemistry, our MC segment provides a liquid filter that is specifically
matched to that formulation and our AMH segment ensures the integrity of the product as it is moved to and through the fab
environment.
Key operating factors Key factors which management believes have the largest impact on the overall results of operations of
the Company include:
•
•
•
Level of sales Since a significant portion of the Company’s product costs (except for raw materials, purchased
components and direct labor) are largely fixed in the short-to-medium term, an increase or decrease in sales affects
gross profits and overall profitability significantly. Also, increases or decreases in sales and operating profitability
affect certain costs such as incentive compensation and commissions, which are highly variable in nature. The
Company’s sales are subject to the effects of industry cyclicality, technological change, substantial competition,
pricing pressures and foreign currency fluctuation.
Variable margin on sales The Company’s variable margin on sales is determined by selling prices and the costs of
manufacturing and raw materials. This is affected by a number of factors, which include the Company’s sales mix,
purchase prices of raw material (especially polymers, membranes, stainless steel and purchased components), domestic
and international competition, direct labor costs, and the efficiency of the Company’s production operations, among
others.
Fixed cost structure The Company’s operations include a number of large fixed or semi-fixed cost components, which
include salaries, indirect labor and benefits, facility costs, lease expenses, and depreciation and amortization. It is not
possible to vary these costs easily in the short term as volumes fluctuate. Accordingly, increases or decreases in sales
volume can have a large effect on the usage and productivity of these cost components, resulting in a large impact on
the Company’s profitability.
Impact of COVID-19 on our Business
The COVID-19 pandemic continues to impact the global economy and cause significant macroeconomic uncertainty. Infection
rates vary across the countries in which we operate. Governmental authorities have continued to implement numerous and
constantly evolving measures to try to contain the virus, such as travel bans and restrictions, masking recommendations and
mandates, vaccine recommendations and mandates, limits on gatherings, quarantines, shelter-in-place orders and business
shutdowns. We have taken proactive, aggressive action to protect the health and safety of our employees, customers, partners
and suppliers, consistent with the latest and evolving governmental guidelines. We expect to continue to implement appropriate
measures until the COVID-19 pandemic is adequately contained. We continue to monitor the rapidly evolving situation and
guidance from international and domestic authorities, including federal, state and local public health authorities, and may take
additional actions based on their recommendations and requirements or as we otherwise see fit to protect the health and safety
of our employees, customers, partners and suppliers.
While certain of our operations have from time-to-time been temporarily affected by government-mandated restrictions, to date
we have not experienced significant adverse impacts to our global operations as a result of the COVID-19 pandemic. Broader
impacts of the pandemic have included a more dynamic supply chain and global logistics environment, and we have
experienced instances of raw material constraints, higher freight costs and delivery delays in both inbound shipments of raw
materials and outgoing shipments of finished products to customers. While we continue to focus on mitigating risks to our
operations and supply chain in the current industry environment, we expect some of the foregoing challenges to linger. From a
36
demand perspective, during 2021 we continued to see strong demand for our leading-edge products, largely driven by
accelerated digitalization, 5G applications and high-performance computing.
In the current circumstances, given the dynamic nature of the situation, any impact on our financial condition, results of
operations or cash flows in the future continues to be difficult to estimate and predict, as it depends on future events that are
highly uncertain and cannot be predicted with accuracy, including, but not limited to, the duration and continued spread of the
outbreak, its severity, potential additional waves of infection, the emergence of more virulent or more dangerous strains of the
virus, the actions taken to mitigate the virus or its impact, the development, distribution, efficacy and acceptance of vaccines
worldwide, how quickly and to what extent normal economic and operating conditions can resume, the broader impact that the
pandemic is having on the economy and our industry and specific implications the pandemic may have on our suppliers and on
global logistics. See Item 1A, “Risk Factors,” for additional information regarding risks associated with the COVID-19
pandemic, including under the caption “The COVID-19 pandemic and continuing governmental responses could materially
adversely affect our financial condition and results of operations.”
Overall Summary of Financial Results for the Year Ended December 31, 2021
Total net sales for 2021 were $2,298.9 million, up $439.6 million, or 24%, from sales of $1,859.3 million for 2020.
Total net sales increased primarily as a result of an increase in overall demand for the Company’s products from semiconductor
industry customers, particularly in the sale of liquid filtration, advanced deposition materials, selective etch and other areas of
increasing importance to our customers. Total net sales also reflected net sales associated with acquisitions of $8.6 million and
favorable foreign currency translation effects of $2.7 million.
The Company’s gross profit increased by $209.9 million for 2021 to $1,059.7 million, up from $849.7 million for 2020.
Accordingly, the Company reported a 46.1% gross margin rate compared to 45.7% in 2020. The increases in gross profit and
gross margin primarily reflect higher factory utilization associated with stronger sales levels.
The Company’s selling, general and administrative, or SG&A, expenses increased in 2021 by $27.3 million, mainly reflecting
higher employee costs.
The Company’s engineering, research and development, or ER&D, expenses increased in 2021 by $31.6 million, mainly
reflecting higher employee costs of $17.3 million and project related costs of $10.8 million.
As a result of the aforementioned and other factors discussed below, net income for 2021 was $409.1 million, or $3.00 per
diluted share, compared to net income of $295.0 million, or $2.16 per diluted share, in 2020.
In 2021, the Company acquired BASF’s Precision Microchemicals business for $89.7 million in cash, net of cash acquired. The
transaction is described in further detail in note 3 to the Company’s consolidated financial statements.
On December 14, 2021, the Company entered into the merger agreement with merger sub and CMC. Pursuant and subject to
the terms and conditions of the merger agreement, upon completion of the transaction, merger sub will merge with and into
CMC, with CMC surviving and continuing as a wholly-owned subsidiary of the Company. At the effective time of the proposed
merger, each outstanding share of common stock of CMC (with certain exceptions set forth in the merger agreement) will be
converted into the right to receive $133.00 in cash and 0.4506 shares of common stock of Entegris, plus cash in lieu of any
fractional shares. The transaction is subject to certain conditions, including the affirmative vote of holders of a majority of the
outstanding shares of common stock of CMC approving the adoption of the merger agreement and the receipt of approvals
under United States and certain foreign antitrust and competition laws. The Company has agreed to operate its business in the
ordinary course during the period between the execution of the merger agreement and the effective time of the proposed
merger, subject to specific exceptions set forth in the merger agreement, and has agreed to certain other customary restrictions
on operations, as set forth in the merger agreement. The Company has obtained fully committed debt financing from Morgan
Stanley Senior Funding, Inc. and certain other financial institutions.
During 2021, the Company’s operating activities provided cash flow of $400.5 million. Cash and cash equivalents were $402.6
million at December 31, 2021 compared with $580.9 million at December 31, 2020. The Company had long-term borrowings,
including current maturities, of $937.0 million at December 31, 2021 compared with $1,085.8 million at December 31, 2020.
Critical Accounting Policies and Estimates
Management’s discussion and analysis of financial condition and results of operations are based upon the Company’s
consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the
United States, or GAAP. The preparation of these consolidated financial statements requires the Company to make estimates,
assumptions and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure
of contingent assets and liabilities. At each balance sheet date, management evaluates its estimates, including, but not limited to,
those related to long-lived assets (property, plant and equipment, and identified intangible assets), goodwill and income taxes.
The Company bases its estimates on historical experience and various other assumptions that management believes to be
37
reasonable under the circumstances. Management’s utilization of different judgments or estimates could result in material
differences in the amount and timing of the Company’s results of operations for any period. In addition, actual results could be
different from the Company’s current estimates, possibly resulting in increased future charges to earnings.
Our critical accounting policies that are most significantly affected by estimates, assumptions and judgments used in the
preparation of the Company's consolidated financial statements relate to business acquisitions and are discussed below. See
note 1 to the Company’s consolidated financial statements for additional information about the Company’s other significant
accounting policies.
Business Acquisitions
The Company accounts for acquired businesses using the acquisition method of accounting which requires that the assets
acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values. The judgments made in
determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can
materially impact net income. Accordingly, for significant items the Company typically obtains assistance from a third-party
valuation firm.
There are several methods that can be used to determine the fair value of assets acquired and liabilities assumed in a business
combination. For intangible assets, the Company normally utilizes the “income method,” which starts with a forecast of all of
the expected future net cash flows attributable to the subject intangible asset. These cash flows are then adjusted to present
value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Depending on
the asset valued, the key assumptions included one or more of the following: (1) future revenue growth rates, (2) future gross
margin, (3) future selling, general and administrative expenses, (4) royalty rates, and (5) discount rates.
Estimating the useful life of an intangible asset also requires judgment. For example, different types of intangible assets will
have different useful lives, influenced by the nature of the asset, competitive environment, and rate of change in the industry.
Certain assets may even be considered to have indefinite useful lives. All of these judgments and estimates can significantly
impact the determination of the amortization period of the intangible asset, and thus net income.
38
Results of Operations
Year ended December 31, 2021 compared to year ended December 31, 2020
The following table sets forth the results of operations and the relationship between various components of operations, stated as
a percent of net sales, for 2021 and 2020.
(Dollars in thousands)
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Engineering, research and development expenses
Amortization of intangible assets
Operating income
Interest expense
Interest income
Other expense (income), net
Income before income taxes
Income tax expense
Net income
2021
2020
% of net sales
% of net sales
$ 2,298,893
100.0 % $ 1,859,313
100.0 %
1,239,229
1,059,664
292,408
167,632
47,856
551,768
41,240
(243)
31,695
479,076
69,950
$
409,126
53.9
46.1
12.7
7.3
2.1
24.0
1.8
—
1.4
20.8
3.0
17.8
1,009,591
849,722
265,128
136,057
53,092
395,445
48,600
(786)
(6,656)
354,287
59,318
$
294,969
54.3
45.7
14.3
7.3
2.9
21.3
2.6
—
(0.4)
19.1
3.2
15.9
Net sales For 2021, net sales were $2,298.9 million, up $439.6 million, or 24%, from 2020. An analysis of the factors
underlying the increase in net sales is presented in the following table:
(In thousands)
Net sales in 2020
Increase mainly associated with customer demand
Increase associated with acquired businesses
Increase associated with effect of foreign currency translation
Net sales in 2021
$
1,859,313
428,258
8,591
2,731
$
2,298,893
The Company’s net sales reflected an increase in overall demand for the Company’s products from semiconductor industry
customers, particularly in the sale of liquid filtration, advanced deposition materials, selective etch and other areas of increasing
importance to our customers. Total net sales also reflected net sales associated with acquisitions of $8.6 million and favorable
foreign currency translation effects of $2.7 million.
In addition to our semiconductor focused products, during 2021 we reached over $50 million of sales of Aramus “high purity
bags”, used for COVID-19 vaccines. We will seek to expand the use of these solutions into non-COVID biologics.
Sales percentage on a geographic basis for 2021 and 2020 and the percentage increase in sales for 2021 compared to sales for
2020 were as follows:
North America
Taiwan
China
South Korea
Japan
Europe
Southeast Asia
Year ended
December 31, 2021
December 31, 2020
Percentage increase in
sales
23 %
20 %
16 %
14 %
13 %
9 %
5 %
25 %
20 %
13 %
15 %
13 %
8 %
5 %
13 %
22 %
47 %
16 %
25 %
36 %
23 %
The increase in sales for all geographic areas was primarily driven by a general increase in demand for products in all three of
the Company’s segments.
39
Gross margin
The following table sets forth gross margin as a percentage of net revenues:
Gross margin as a percentage of net revenues:
2021
2020
Percentage point change
46.1 %
45.7 %
0.4
Gross margin increased by 0.4 percentage points for 2021 compared to 2020, primarily due to higher factory utilization
associated with stronger sales levels.
Selling, general and administrative expenses
Selling, general and administrative expenses consist primarily of payroll and related expenses for the sales and administrative
staff, professional fees (including accounting, legal and technology costs and expenses), and sales and marketing costs. SG&A
expenses for 2021 increased $27.3 million, or 10%, to $292.4 million from $265.1 million in 2020. SG&A expenses, as a
percent of net sales, decreased to 12.7% from 14.3% a year earlier, primarily reflecting the increase in sales.
An analysis of the factors underlying the increase in SG&A expenses is presented in the following table:
(In thousands)
Selling, general and administrative expenses in 2020
Employee costs
Other decreases, net
Selling, general and administrative expenses in 2021
Engineering, research and development expenses
$
$
265,128
30,858
(3,578)
292,408
Engineering, research and development expenses consist of expenses for the support of current product lines and the
development of new products and manufacturing technologies. These expenses were $167.6 million in 2021 and $136.1 million
in 2020. ER&D expenses as a percent of net sales remained flat at 7.3% compared to a year earlier.
An analysis of the factors underlying the increase in ER&D expenses is presented in the following table:
(In thousands)
Engineering, research and development expense in 2020
Employee costs
Project related costs
Professional fees
Other increases, net
$
136,057
17,324
10,811
1,240
2,200
Engineering, research and development expense in 2021
$
167,632
The Company’s overall ER&D efforts will continue to focus on developing and improving its technology platforms for
semiconductor and advanced processing applications and identifying and developing products for new applications, and the
Company often works directly with its customers to address their particular needs. As a percentage of revenue, the Company
expects to increase ER&D expenses in the coming years.
Amortization of intangible assets Amortization of intangible assets was $47.9 million in 2021 compared to $53.1 million for
2020. The decrease primarily reflects the elimination of amortization expense of $6.8 million for identifiable intangible assets
acquired in acquisitions that became fully amortized in previous periods, partially offset by additional amortization expense of
$1.7 million associated with recent acquisitions as discussed in note 3 to the consolidated financial statements.
Interest expense Interest expense was $41.2 million in 2021 and $48.6 million in 2020. Interest expense includes interest
associated with debt outstanding and the amortization of debt issuance costs associated with such borrowings. The decrease
primarily reflects lower average debt levels and interest rates in 2021.
Interest income Interest income was $0.2 million in 2021 and $0.8 million in 2020. The decrease reflects lower average
interest rates and cash balances.
Other expense (income), net Other expense, net, was $31.7 million in 2021 compared to other income, net, of $6.7 million in
2020.
40
In 2021, other expense, net consisted mainly of a loss on extinguishment of debt of $23.1 million associated with the
redemption of the Company’s $550 million aggregate principal amount of senior unsecured notes due 2026, or the 2026 Notes
(see note 8 to the Company’s consolidated financial statements), and foreign currency transaction losses of $7.9 million.
In 2020, other income, net consisted mainly of foreign currency transaction gains of $9.8 million, partially offset by loss on
debt extinguishment costs of $2.4 million associated with payments on the Term Loan Facility.
Income tax expense The Company recorded income tax expense of $70.0 million in 2021 compared to income tax expense of
$59.3 million in 2020. The Company’s effective tax rate was 14.6% in 2021 compared to an effective tax rate of 16.7% in 2020.
The decrease in the effective tax rate from 2020 to 2021 is primarily due to a benefit related to the reversal of a valuation
allowance on federal foreign credits generated in 2020 of $6.2 million. Additionally, the Company recognized a net capital loss
tax benefit of $5.1 million during the tax year ended December 31, 2021. These benefits were partially offset by tax recorded on
the sale of intangible property of $3.5 million in 2021. The 2020 tax rate included a benefit of $1.5 million related to additional
R&D tax credits, an increase in discrete benefits related to share-based compensation of $8.8 million, and lower accrued
withholding taxes on foreign earnings. These decreases were partially offset by a valuation allowance on federal foreign tax
credits generated during the year of $6.2 million.
Net income Net income was $409.1 million, or $3.00 per diluted share, in 2021 compared to net income of $295.0 million, or
$2.16 per diluted share, in 2020. The increase reflects the Company’s aforementioned operating results described in greater
detail above.
Non-GAAP Financial Measures Information The Company’s consolidated financial statements are prepared in conformity
with accounting principles generally accepted in the United States. The Company also utilizes certain non-GAAP financial
measures as a complement to financial measures provided in accordance with GAAP in order to better assess and reflect trends
affecting the Company’s business and results of operations. See “Non-GAAP Information” included below in this section for
additional detail, including the reconciliation of the Company’s non-GAAP measures to the most directly comparable GAAP
measures.
The Company’s non-GAAP financial measures include adjusted EBITDA and adjusted operating income, together with related
percentage changes, and non-GAAP earnings per share, or EPS.
Adjusted EBITDA increased to $699.4 million in 2021, compared to $542.5 million in 2020. Adjusted EBITDA as a percent of
net sales was 30.4% in 2021 compared to 29.2% in 2020. Adjusted operating income increased 32.7% to $609.1 million in
2021, compared to $459.0 million in 2020. Adjusted operating income as a percent of net sales was 26.5% in 2021 compared to
24.7% in 2020. Non-GAAP EPS increased 35.4% to $3.44 in 2021, compared to $2.54 in 2020. The increases in adjusted
EBITDA and adjusted operating income as a percentage of net sales reflect the increases in sales and gross profit.
Segment Analysis
The Company reports its financial performance based on three reporting segments. See note 16 to the consolidated financial
statements for additional information on the Company’s three segments.
The following table and discussion concern the results of operations of the Company’s three reportable segments for the years
ended December 31, 2021 and 2020.
(In thousands)
Specialty Chemicals and Engineered Materials
Net sales
Segment profit
Microcontamination Control
Net sales
Segment profit
Advanced Materials Handling
Net sales
Segment profit
Unallocated general and administrative expenses
Specialty Chemicals and Engineered Materials (SCEM)
2021
2020
711,291 $
167,807
919,363 $
321,300
704,946 $
159,995
609,532
127,969
742,186
248,910
538,682
111,028
49,478 $
39,370
$
$
$
$
For 2021, SCEM net sales increased to $711.3 million, up 17% from $609.5 million in 2020. The sales increase was mainly due
to increased sales of specialty gases and advanced deposition materials, formulated cleaning chemistries and advanced coatings,
41
as well as additional sales of $1.2 million attributable to the acquisition of BASF’s Precision Microchemicals business in the
fourth quarter of 2021.
SCEM reported a segment profit of $167.8 million for 2021, up 31% compared to $128.0 million in 2020. The increase in
SCEM’s profit in 2021 was primarily due to higher sales levels and a gain on a sale of non-core intangibles, partially offset by
higher operating expenses of 11% mainly due to higher compensation costs.
Microcontamination Control (MC)
For 2021, MC net sales increased to $919.4 million, up 24% from $742.2 million in 2020. The sales increase was due to
improved performance across substantially all platforms, with growth especially strong in liquid filtration and gas filtration
products.
MC reported a segment profit of $321.3 million for 2021, up 29% compared to $248.9 million in 2020. The increase in MC’s
profit in 2021 was primarily due to higher gross profit related to the increased sales volume, partially offset by higher operating
expenses of 13%, primarily due to higher compensation costs.
Advanced Materials Handling (AMH)
For 2021, AMH net sales increased 31% to $704.9 million from $538.7 million in 2020. The sales increase was mainly due to
improved sales from wafer handling, fluid handling and measurement products and sales of our Aramus high purity bags, as
well as additional sales of $6.8 million attributable to the acquisition of Global Measurement Technologies, Inc. and its
manufacturing partner Clean Room Plastics, Inc., which are referred to collectively herein as GMTI.
AMH reported a segment profit of $160.0 million for 2021, up 44% compared to $111.0 million in 2020. The increase in
AMH’s profit in 2021 was primarily due to higher sales volume, favorable product mix, partially offset by a 16% increase in
operating expenses, primarily due to higher compensation costs.
Unallocated general and administrative expenses
Unallocated general and administrative expenses for 2021 totaled $49.5 million compared to $39.4 million for 2020. The $10.1
million increase mainly reflects the increase in compensation costs of $8.2 million and deal and integration costs of $2.1
million.
Liquidity and Capital Resources
We consider the following when assessing our liquidity and capital resources:
In thousands
Cash and cash equivalents
Working capital
Total debt
December 31, 2021
December 31, 2020
$
402,565 $
934,369
937,027
580,893
931,631
1,085,783
The Company has historically financed its operations and capital requirements through cash flow from its operating activities,
long-term loans, lease financing and borrowings under domestic and international short-term lines of credit. On April 30, 2021,
the Company issued $400.0 million aggregate principal amount of 3.625% senior unsecured notes due May 1, 2029, or the 2029
Notes. The Company used the net proceeds of the offering, together with cash on hand and borrowings under the Revolving
Facility, to redeem all of the 2026 Notes. The redemption of the 2026 Notes resulted in a loss on extinguishment of debt of
$23.1 million. In connection with our issuance of the 2029 Notes, we amended the Revolving Facility to provide for, among
other things, lending commitments in an aggregate principal amount of up to $400.0 million (up from $300.0 million) and to
extend the maturity date to April 30, 2026.
Based on our analysis, we believe our existing balances of domestic cash and cash equivalents and our currently anticipated
operating cash flows will be sufficient to meet our cash needs arising in the ordinary course of business for the next twelve
months and for the longer term.
We may seek to take advantage of opportunities to raise additional capital through additional debt financing or through public
or private sales of securities. If in the future our available liquidity is not sufficient to meet the Company’s operating and debt
service obligations as they come due, management would need to pursue alternative arrangements through additional equity or
debt financing in order to meet the Company’s cash requirements. There can be no assurance that any such financing would be
available on commercially acceptable terms, or at all. In 2021, we did not experience difficulty accessing the capital and credit
markets, but future volatility in the capital and credit markets may increase costs associated with issuing debt instruments or
affect our ability to access those markets. In addition, it is possible that our ability to access the capital and credit markets could
42
be limited at a time when we would like, or need, to do so, which could have an adverse impact on our ability to refinance
maturing debt and/or react to changing economic and business conditions.
In summary, our cash flows for each period were as follows:
(in thousands)
Net cash provided by operating activities
Net cash used in investing activities
Net cash (used in) provided by financing activities
(Decrease) increase in cash and cash equivalents
Operating activities
Year ended
December 31, 2021
$
400,454 $
(298,118)
Year ended
December 31, 2020
446,674
(243,326)
(276,497)
(178,328)
22,149
228,982
Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities.
Compared to 2020, the $46.2 million decrease in cash provided by operating activities in 2021 was primarily due to changes in
working capital, partially offset by higher net income. Changes in working capital for 2021 were driven by higher trade
accounts receivables and notes receivables, inventory and lower income taxes payable. The change for trade accounts
receivables and notes receivables was primarily due to increased sales activity compared to the prior year. The change for
inventory is due to an increase in raw material purchases to mitigate potential supply chain issues related to COVID-19 and
increased business activity. The change for taxes was primarily driven by higher tax payments compared to the prior year.
Investing activities
Investing cash flows consist primarily of capital expenditures, cash used for acquisitions and proceeds from sales of property
and equipment.
The increase in cash used in investing activities in 2021 compared to 2020 was primarily due to higher cash paid for
acquisitions of property, plant and equipment. This was partially offset by decreased cash paid for acquisitions.
Acquisition of property and equipment totaled $210.6 million in 2021, which primarily reflected investments in facilities,
equipment and tooling, compared to $131.8 million in 2020, which primarily reflected investments in equipment and tooling.
Capital expenditures in 2021 generally reflected more spending related to growth capacity investments and the investment in
our previously announced investment in our new facility in Taiwan.
In 2021, the Company acquired BASF’s Precision Microchemicals business and certain assets of another company in an
immaterial transaction. The cash used to acquire these assets was $91.9 million, net of cash acquired. The transactions are
described in further detail in note 3 to the Company’s consolidated financial statements.
In 2020, the Company acquired Sinmat and GMTI. The cash used to acquire Sinmat and GMTI was $111.9 million, net of cash
acquired. The transactions are described in further detail in note 3 to the Company’s consolidated financial statements.
Financing activities
Financing cash flows consist primarily of repurchases of common stock, payment of dividends to stockholders, issuance and
repayment of short-term and long-term debt, and proceeds from the sale of shares of common stock through employee equity
incentive plans.
In 2021, there was $276.5 million of cash used in financing activities compared to $22.1 million cash provided by financing
activities in 2020. The change was primarily due to a $318.1 million increase in payments on long-term debt and debt
extinguishment and a $22.5 million increase in repurchase and retirement of common stock. The Company made a payment of
$569.1 million related to the redemption of the $550.0 million aggregate principal amount of 2026 Notes during 2021,
compared to a payment of $251.0 million of outstanding borrowings under the Term Loan Facility in 2020. The increase in cash
flows used in financing activities was offset in part by the absence of a $16.1 million deferred acquisition payment related to
our acquisition of Digital Specialty Chemicals in 2020, a $16.0 million increase in proceeds from the issuance of common stock
from employee stock plans and a $8.7 million decrease in taxes paid related to net share settlement of equity awards.
The Company’s total dividend payments were $43.5 million in 2021 compared to $43.2 million in 2020. The Company has paid
a cash dividend in each of the past 17 quarters. On January 19, 2022, the Company’s board of directors declared a quarterly
cash dividend of $0.10 per share to be paid on February 23, 2022 to shareholders of record as of February 2, 2022.
Other Liquidity and Capital Resources Considerations
Debt
43
(In thousands)
Total debt (par value)
December 31, 2021
December 31, 2020
$
945,000 $
1,095,000
In connection with the proposed merger, on December 31, 2021, Entegris entered into an amended and restated commitment
letter, which amended and restated the commitment letter with Morgan Stanley Senior Funding, Inc. and certain other financial
institutions, which are referred to collectively herein as the financing sources, dated as of December 14, 2021, among Entegris
and the financing sources. Such commitment letter as amended and restated is referred to herein as the commitment letter.
Pursuant to the commitment letter, the financing sources (a) committed to provide to Entegris (i) a senior secured first lien term
loan B facility in an aggregate principal amount of up to $4.0 billion, which is referred to herein as the term loan B facility and
(ii) a senior unsecured bridge term loan facility in an aggregate principal amount of up to $895.0 million, which is referred to as
the bridge facility and, together with the term loan B facility, the facilities and (b) to the extent that such financing sources are
revolving lenders under Entegris’ existing credit agreement, (i) consented to the merger and certain amendments to the terms
the Revolving Facility and (ii) committed to provide to Entegris, additional revolving credit commitments in an aggregate
principal amount of $175.0 million. See note 8 to the Company’s consolidated financial statements for additional discussion.
On April 30, 2021, the Company issued $400.0 million aggregate principal amount of the 2029 Notes. The Company used the
net proceeds of the offering, together with cash on hand and borrowings under the Revolving Facility, to redeem all of the 2026
Notes. We capitalized $4.1 million of third-party expenses related to the issuance of the 2029 Notes as debt issuance costs. At
December 31, 2021, we had $400.0 million aggregate principal amount of 3.625% senior unsecured notes outstanding on the
2029 Notes.
The Company voluntarily redeemed its $550.0 million aggregate principal amount of 2026 Notes at a redemption price of
103.469% (expressed as percentage of principal amount), plus accrued and unpaid interest of $5.6 million. The redemption of
the 2026 Notes resulted in a loss on extinguishment of debt of $23.1 million.
In connection with our issuance of the 2029 Notes, we amended the Revolving Facility to provide for, among other things,
lending commitments in an aggregate principal amount of up to $400.0 million (up from $300.0 million) and to extend the
maturity date to April 30, 2026. The Revolving Facility bears interest at a rate per annum equal to, at the Company’s option,
either a base rate (such as prime rate) or LIBOR, plus, in each case, an applicable margin. At December 31, 2021, there was no
balance outstanding under the Revolving Facility and we had undrawn outstanding letters of credit of $0.2 million.
The Company’s Term Loan Facility matures on November 6, 2025 and bears an interest rate of 2.10% at December 31, 2021.
As of December 31, 2021, the aggregate principal amount outstanding under the Term Loan Facility was $145.0 million.
As of December 31, 2021, we had $400 million aggregate principal amount of 4.375% senior unsecured notes due April 15,
2028 outstanding.
Through December 31, 2021, the Company was in compliance with all applicable financial covenants included in the terms of
its credit facilities.
The Company also has lines of credit with one bank that provide for borrowings of Japanese yen for the Company’s Japanese
subsidiary equivalent to an aggregate of approximately $8.7 million. There were no outstanding borrowings under these lines of
credit at December 31, 2021.
Cash and cash requirements
(In thousands)
Cash and cash equivalents
U.S.
Non-U.S.
December 31, 2021 December 31, 2020
$
402,565 $
107,814
294,751
580,893
268,135
312,758
Our cash and cash equivalents include cash on hand and highly liquid debt securities with original maturities of three months or
less, which are valued at cost and approximate fair value. We utilize a variety of funding strategies in an effort to ensure that
our worldwide cash is available in the locations in which it is needed. We have accrued taxes on any earnings that are not
indefinitely reinvested. We estimate that no material withholding taxes would be incurred if any indefinitely reinvested earnings
were distributed.
Cash requirements
We have cash requirements to support working capital needs, capital expenditures, business acquisitions, contractual
obligations, commitments, principal and interest payments on debt and other liquidity requirements associated with our
operations. We generally intend to use available cash and funds generated from our operations to meet these cash requirements,
but in the event that additional liquidity is required we may also borrow under our revolving credit facility.
44
The following table summarizes our short and long-term cash requirements as of December 31, 2021:
(In thousands)
Long-term debt
Interest payments on long-term debt
Capital purchase obligations
Supply purchase obligations
Operating leases
Other liabilities reflected on our consolidated balance sheet
Total
Total
Due within one year of
December 31, 2021
Due later than one year from
December 31, 2021
$
945,000 $
— $
229,059
307,685
18,600
86,449
464,276
35,051
274,144
9,300
13,340
362,290
945,000
194,008
33,541
9,300
73,109
101,986
$ 2,051,069 $
694,125 $
1,356,944
Long-term debt and interest payments on long-term debt. We have contractual obligations for principal and interest payments
on our long-term debt. See note 8 of the consolidated financials for additional information. Debt obligations are classified based
on their stated maturity date, regardless of their classification on the Company’s consolidated balance sheets. Interest
projections on both variable and fixed rate long-term debt are based on interest rates effective as of December 31, 2021 and do
not include $8.0 million for net unamortized discounts and debt issuance costs.
Capital purchase obligations. We have capital purchase obligations that represent commitments for the construction or
purchase of property, plant and equipment. They were not recorded as liabilities on the Company’s consolidated balance sheet
as of December 31, 2021, as the Company had not yet received the related goods or taken title to the property.
We expect capital expenditure spending to be approximately $500.0 million in 2022 for growth capacity investments and the
construction of our new manufacturing and enhanced technology facility in Taiwan. Of this amount, approximately $225
million will be spent for the new facility in Taiwan. This new facility will ultimately support all three of our divisions.
Supply purchase obligations. We have commitments, including take-or-pay contracts, that are not presented as capital purchase
commitments above. They were not recorded as liabilities on the Company’s consolidated balance sheet as of December 31,
2021, as the Company had not yet received the related goods or taken title to the property.
Operating lease commitments. Commitments under operating leases primarily relate to leasehold properties. See note 10 of the
consolidated financials for additional information.
Other liabilities. Other liabilities primarily includes employee compensation and benefits, contract liabilities, pension liabilities,
net tax liabilities, and other accrued liabilities. The timing of cash flows associated with these obligations is based upon
management’s estimates over the terms of these arrangements and is largely based upon historical experience. Included in our
other liabilities due within one year is our employee incentive payout of $86.5 million, which will be paid in the first quarter of
2022.
Of the tax liabilities included in the table above, $23.8 million relates to uncertain tax positions. We are unable to accurately
predict when these amounts will be realized or released. However, it is reasonably possible that there could be significant
changes to our unrecognized tax benefits in the next twelve months due to a tax audit settlement or some other unforeseeable
event. See note 12 of the consolidated financials for additional information.
Other Planned Uses of Capital. On December 14, 2021, we entered into the merger agreement, with merger sub and CMC.
Pursuant and subject to the terms and conditions of the merger agreement, upon completion of the transaction, merger sub will
merge with and into CMC, with CMC surviving and continuing as a wholly-owned subsidiary of Entegris. At the effective time
of the proposed merger, each outstanding share of common stock of CMC (with certain exceptions set forth in the merger
agreement) will be converted into the right to receive $133.00 in cash and 0.4506 shares of common stock of Entegris, plus cash
in lieu of any fractional shares. The transaction is subject to certain conditions, including the affirmative vote of holders of a
majority of the outstanding shares of common stock of CMC approving the adoption of the merger agreement and the receipt of
approvals under United States and certain foreign antitrust and competition laws. We have agreed to operate our business in the
ordinary course during the period between the execution of the merger agreement and the effective time of the proposed
merger, subject to specific exceptions set forth in the merger agreement, and have agreed to certain other customary restrictions
on operations, as set forth in the merger agreement. Entegris has obtained fully committed debt financing from Morgan Stanley
Senior Funding, Inc. and certain other financial institutions.
As of December 31, 2021, we believe our cash and cash equivalents, cash generated from operations, and our ability to access
capital markets will satisfy our cash needs for the foreseeable future both globally and domestically.
45
New Accounting Pronouncements
Recently adopted accounting pronouncements Refer to note 1 to the Company’s consolidated financial statements for a
discussion of accounting pronouncements implemented in 2021. Other than the adoption of ASU No. 2019-12, “Simplifying the
Accounting for Income Taxes”, there were no recently issued accounting pronouncements adopted in 2021.
Recently issued accounting pronouncements Refer to note 1 of the Company’s consolidated financial statements for a
discussion of accounting pronouncements recently issued but not yet adopted.
Non-GAAP Information The Company’s consolidated financial statements are prepared in conformity with GAAP.
The Company also utilizes certain non-GAAP financial measures as a complement to financial measures provided in
accordance with GAAP in order to better assess and reflect trends affecting the Company’s business and results of operations.
These non-GAAP financial measures include adjusted EBITDA and adjusted operating income, together with related measures
thereof, and non-GAAP earnings per share, as well as certain other supplemental non-GAAP financial measures included in the
discussion of the Company’s financial results.
Adjusted EBITDA is defined by the Company as net income before (1) income tax expense, (2) interest expense, (3) interest
income, (4) other expense (income), net, (5) charge for fair value write-up of acquired inventory sold, (6) deal and transaction
costs, (7) integration costs, (8) severance and restructuring costs, (9) amortization of intangible assets and (10) depreciation.
Adjusted operating income is defined by the Company as adjusted EBITDA exclusive of the depreciation addback noted above.
The Company also utilizes non-GAAP financial measures whereby adjusted EBITDA and adjusted operating income are each
divided by the Company’s net sales to derive adjusted EBITDA margin and adjusted operating margin, respectively.
Non-GAAP EPS is defined by the Company as net income before, as applicable, (1) charge for fair value write-up of acquired
inventory sold, (2) deal and transaction costs, (3) integration costs, (4) severance and restructuring costs, (5) loss on
extinguishment of debt and modification, (6) amortization of intangible assets and (7) the tax effect of the foregoing
adjustments to net income, stated on a per share basis, divided by diluted weighted average shares outstanding.
The Company provides supplemental non-GAAP financial measures to help management and investors to better understand its
business and believes these measures provide investors and analysts additional and meaningful information for the assessment
of the Company’s ongoing results. Management also uses these non-GAAP measures to assist in the evaluation of the
performance of its business segments and to make operating decisions.
Management believes the Company’s non-GAAP measures help indicate the Company’s baseline performance before certain
gains, losses or other charges that may not be indicative of the Company’s business or future outlook and offer a useful view of
business performance in that the measures provide a more consistent means of comparing performance. The Company believes
the non-GAAP measures aid investors’ overall understanding of the Company’s results by providing a higher degree of
transparency for such items and providing a level of disclosure that will help investors understand how management plans,
measures and evaluates the Company’s business performance. Management believes that the inclusion of non-GAAP measures
provides greater consistency in its financial reporting and facilitates investors’ understanding of the Company’s historical
operating trends by providing an additional basis for comparisons to prior periods.
Management uses adjusted EBITDA and adjusted operating income to assist it in evaluations of the Company’s operating
performance by excluding items that management does not consider as relevant in the results of its ongoing operations.
Internally, these non-GAAP measures are used by management for planning and forecasting purposes, including the preparation
of internal budgets; for allocating resources to enhance financial performance; for evaluating the effectiveness of operational
strategies; and for evaluating the Company’s capacity to fund capital expenditures, secure financing and expand its business.
In addition, and as a consequence of the importance of these non-GAAP financial measures in managing its business, the
Company’s board of directors uses non-GAAP financial measures in the evaluation process to determine management
compensation.
The Company believes that certain analysts and investors use adjusted EBITDA, adjusted operating income and non-GAAP
EPS as supplemental measures to evaluate the overall operating performance of firms in the Company’s industry. Additionally,
lenders or potential lenders use adjusted EBITDA measures to evaluate the Company’s creditworthiness.
The presentation of non-GAAP financial measures is not meant to be considered in isolation, as a substitute for, or superior to,
financial measures or information provided in accordance with GAAP. Management strongly encourages investors to review
the Company’s consolidated financial statements in their entirety and to not rely on any single financial measure.
Management notes that the use of non-GAAP measures has limitations, including but not limited to:
First, non-GAAP financial measures are not standardized. Accordingly, the methodology used to produce the Company’s non-
GAAP financial measures is not computed under GAAP and may differ notably from the methodology used by other
46
companies. For example, the Company’s non-GAAP measure of adjusted EBITDA may not be directly comparable to EBITDA
or an adjusted EBITDA measure reported by other companies.
Second, the Company’s non-GAAP financial measures exclude items such as amortization and depreciation that are recurring.
Amortization of intangibles and depreciation have been, and will continue to be for the foreseeable future, significant recurring
expenses with an impact upon the Company’s results of operations, notwithstanding the lack of immediate impact upon cash
flows.
Third, there is no assurance that the Company will not have future charges for fair value write-up of acquired inventory,
restructuring activities, deal and transaction costs, integration costs or similar items and, therefore, may need to record
additional charges (or credits) associated with such items, including the tax effects thereon. The exclusion of these items in the
Company’s non-GAAP measures should not be construed as an implication that these costs are unusual, infrequent or non-
recurring.
Management considers these limitations by providing specific information regarding the GAAP amounts excluded from these
non-GAAP financial measures and evaluating these non-GAAP financial measures together with their most directly comparable
financial measures calculated in accordance with GAAP. The calculations of adjusted EBITDA, adjusted operating income, and
non-GAAP EPS, and reconciliations between these financial measures and their most directly comparable GAAP equivalents,
are presented below in the accompanying tables.
47
The reconciliation of GAAP measures to adjusted operating income and adjusted EBITDA for the years ended December 31,
2021 and 2020 are presented below:
In thousands
Net sales
Net income
Net income - as a % of net sales
Adjustments to net income
Income tax expense
Interest expense
Interest income
Other expense (income), net
GAAP – Operating income
Operating margin - as a % of net sales
Charge for fair value write-up of acquired inventory sold
Deal and transaction costs
Integration costs
Severance and restructuring costs
Amortization of intangible assets
Adjusted operating income
Adjusted operating margin
Depreciation
Adjusted EBITDA
Adjusted EBITDA – as a % of net sales
2021
2020
$ 2,298,893
$ 1,859,313
$ 409,126
$ 294,969
17.8%
15.9%
69,950
41,240
(243)
31,695
551,768
24.0%
428
4,744
3,780
529
47,856
609,105
59,318
48,600
(786)
(6,656)
395,445
21.3%
590
2,576
2,963
4,364
53,092
459,030
26.5%
24.7%
90,311
83,430
$ 699,416
$ 542,460
30.4%
29.2%
The reconciliation of GAAP measures to non-GAAP earnings per share for the years ended December 31, 2021 and 2020 are
presented below:
In thousands, except per share data
Net income
Adjustments to net income:
Charge for fair value write-up of acquired inventory sold
Deal and transaction costs
Integration costs
Severance and restructuring costs
Loss on debt extinguishment and modification
Amortization of intangible assets
Tax effect of adjustments to net income and discrete tax items(1)
Non-GAAP net income
Diluted earnings per common share
Effect of adjustments to net income
Diluted non-GAAP earnings per common share
2021
2020
$
409,126 $
294,969
428
4,744
3,780
529
23,338
47,856
590
2,576
2,963
4,364
2,378
53,092
(20,411)
(15,197)
469,390 $
345,735
3.00 $
0.44 $
3.44 $
2.16
0.37
2.54
$
$
$
$
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate for each respective
year.
Item 7A. Quantitative and Qualitative Disclosure About Market Risks.
Entegris’ principal financial market risks are sensitivities to interest rates and foreign currency exchange rates. The Company’s
interest-bearing cash and cash equivalents and variable rate debt are subject to interest rate fluctuations. The Company’s cash
and cash equivalents include cash on hand and highly liquid debt securities with original maturities of three months or less are
instruments with maturities of three months or less. A 100-basis point change in interest rates would potentially increase or
48
decrease annual net income by approximately $2.6 million and $3.4 million annually for the years ended December 31, 2021
and 2020, respectively.
The cash flows and results of operations of the Company’s foreign-based operations are subject to fluctuations in foreign
currency exchange rates. Approximately 23.5% and 23.6% of the Company’s sales during 2021 and 2020 were collectively
denominated in the South Korean Won, New Taiwan Dollar, Chinese Renmibi, Canadian Dollar, Malaysian Ringgit, Singapore
Dollar, Euro, Israeli Shekel and the Japanese Yen. Financial results therefore will be affected by changes in currency exchange
rates. If all foreign currencies were to see a 10% reduction versus the U.S. dollar during the years ended December 31,
2021 and 2020, revenue would be negatively impacted by approximately $52.4 million and $43.8 million, respectively.
The Company occasionally uses derivative financial instruments to manage the foreign currency exchange rate risks associated
with its foreign-based operations. At December 31, 2021 and 2020, the Company had no net exposure to any foreign currency
forward contracts.
Item 8. Financial Statements and Supplementary Data.
The information called for by this item is set forth in the Consolidated Financial Statements covered by the Report of
Independent Registered Public Accounting Firm at the end of this report.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
This item is not applicable.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Based on management’s evaluation (with the participation of our principal executive officer and principal financial officer), as
of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded
that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), are effective
to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the
Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and
is accumulated and communicated to management, including our principal executive officer and principal financial officer, as
appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) that occurred during the quarter ended December 31, 2021 that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.
Management Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined
in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability of our
financial reporting and the preparation of consolidated financial statements for external purposes in accordance with GAAP.
Management assessed our internal control over financial reporting as of December 31, 2021. Management based its assessment
on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the
Treadway Commission (2013 framework). Management’s assessment included evaluation of elements such as the design and
operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control
environment.
The Company completed its acquisition of BASF’s Precision Microchemicals business on November 30, 2021. The Company
is continuing to integrate Precision Microchemicals into its internal control over financial reporting, and management’s
evaluation of the effectiveness of the Company’s internal control over financial reporting excluded Precision Microchemicals.
Precision Microchemicals had total assets of approximately $92 million at December 31, 2021 and net sales of $1 million in
2021.
Based on its assessment, management has concluded that our internal control over financial reporting was effective as of the
end of the fiscal year to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
49
consolidated financial statements for external reporting purposes in accordance with GAAP. We reviewed the results of
management’s assessment with the Audit Committee of our board of directors.
KPMG LLP, the independent registered public accounting firm which audited the consolidated financial statements included in
this annual report, has issued an attestation report on our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure
controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control
system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control
system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the
benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems,
no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all
control issues and instances of fraud, if any, have been detected.
50
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
Entegris, Inc.:
Opinion on Internal Control Over Financial Reporting
We have audited Entegris Inc. and subsidiaries' (the Company) internal control over financial reporting as of December 31,
2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal
control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated
Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated
statements of operations, comprehensive income, equity, and cash flows for each of the years in the three-year period ended
December 31, 2021, and the related notes (collectively, the consolidated financial statements), and our report dated February 4,
2022 expressed an unqualified opinion on those consolidated financial statements.
The Company acquired Precision Microchemicals during 2021, and management excluded from its assessment of the
effectiveness of the Company’s internal control over financial reporting as of December 31, 2021, Precision Microchemicals’s
internal control over financial reporting associated with total assets of $92 million and total revenues of $1 million included in
the consolidated financial statements of the Company as of and for the year ended December 31, 2021. Our audit of internal
control over financial reporting of the Company also excluded an evaluation of the internal control over financial reporting of
Precision Microchemicals.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management Report
on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control
over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all
material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control
over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating
effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we
considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
51
/s/ KPMG LLP
Minneapolis, Minnesota
February 4, 2022
Item 9B. Other Information.
None.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not Applicable.
Item 10. Directors, Executive Officers and Corporate Governance.
PART III
Except as set forth below, the information required by this Item 10 has been omitted from this report, and is incorporated by
reference to our Definitive Proxy Statement for the Entegris, Inc. Annual Meeting of Stockholders, which is currently scheduled
to be held on April 27, 2022, and to be filed with the Securities and Exchange Commission pursuant to Regulation 14A within
120 days after the end of our 2021 fiscal year.
In 2005, our board of directors adopted a code of business ethics, The Entegris, Inc. Code of Business Ethics, applicable to all
of our executives, directors and employees, as well as a set of corporate governance guidelines, which have been updated from
time to time. The Entegris, Inc. Code of Business Ethics, the Corporate Governance Guidelines and the charters for our Audit &
Finance Committee, Governance & Nominating Committee and our Management Development & Compensation Committee all
appear on our website at http://www.Entegris.com under “Investor Relations - Corporate Governance”. The Entegris, Inc. Code
of Business Ethics, Corporate Governance Guidelines and committee charters are also available in print to any shareholder that
requests a copy. Copies may be obtained by contacting our Secretary through our corporate headquarters. The Company intends
to comply with the requirements of Item 5.05 of Form 8-K with respect to any amendment to or waiver of the provisions of the
Entegris, Inc. Code of Business Ethics applicable to the registrant’s Chief Executive Officer, Chief Financial Officer, Chief
Accounting Officer or Controller by posting notice of any such amendment or waiver at the same location on our website.
INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The following is a list of our Executive Officers, their ages and their offices, as of the date of this Annual Report on Form 10-K.
Name
Bertrand Loy
Gregory B. Graves
Todd Edlund
Sue Rice
Joe Colella
Jim O’Neill
Corey Rucci
Olivier Blachier
Bruce W. Beckman
Stuart Tison
Clint Haris
William Shaner
Michael D. Sauer
Office
Age
56 President & Chief Executive Officer
61 Executive Vice President, Chief Financial Officer & Treasurer
59 Executive Vice President & Chief Operating Officer
63 Senior Vice President, Global Human Resources
40 Senior Vice President, General Counsel & Secretary
57 Senior Vice President, Chief Technology Officer
62 Senior Vice President, Business Development
48 Senior Vice President, Business and New Markets Development
54 Senior Vice President, Finance
58 Senior Vice President & General Manager, Specialty Chemicals and Engineered Materials
49 Senior Vice President & General Manager, Microcontamination Control
54 Senior Vice President & General Manager, Advanced Materials Handling
56 Vice President, Controller & Chief Accounting Officer
Bertrand Loy has been our Chief Executive Officer, President and a director since November 2012. From July 2008 to
November 2012, he served as our Executive Vice President and Chief Operating Officer. From August 2005 until July 2008, he
served as our Executive Vice President in charge of our information technology, global supply chain and manufacturing
operations. He served as the Vice President and Chief Financial Officer of Mykrolis, a company spun out of Millipore
Corporation, a life science products company, from January 2001 until August 2005. Prior to that, Mr. Loy served as the Chief
Information Officer of Millipore Corporation during 1999 and 2000, and previously served in various strategic planning, global
supply chain and financial roles with Millipore and Sandoz Pharmaceuticals (now Novartis), a pharmaceutical company. He has
52
served on the board of directors of Harvard Bioscience, Inc. (scientific equipment) since November 2014 and is now its lead
independent director. Since July 2013, Mr. Loy has also been on the board of directors of SEMI, the global industry association
representing the electronics manufacturing supply chain, and currently acts as the chairman of the association.
Gregory B. Graves has served as our Executive Vice President and Chief Financial Officer since July 2008. Prior to that, he
served as Senior Vice President and Chief Financial Officer since April 2007. Prior to April 2007, he served as Senior Vice
President, Strategic Planning & Business Development since the effectiveness of the merger with Mykrolis in August 2005. Mr.
Graves served as the Chief Business Development Officer of Entegris Minnesota starting in September 2002 and from
September 2003 until August 2004 he also served as Senior Vice President of Finance. Prior to joining Entegris Minnesota in
September 2002, Mr. Graves held positions in investment banking and corporate development, including at U.S. Bancorp Piper
Jaffray from June 1998 to August 2002 and at Dain Rauscher from October 1996 to May 1998. Mr. Graves has served as a
director of Laird Superfood, Inc. (a plant-based food company) since September 2018, and was a member of the board of
directors of Plug Power Inc. (an energy solutions provider) from May 2017 to June 2019.
Todd Edlund has been our Executive Vice President and Chief Operating Officer since July 2016. Prior to that, he was our
Senior Vice President and Chief Operating Officer since November 2014. After the merger with ATMI in April 2014, Mr.
Edlund served as Senior Vice President and General Manager of our Critical Materials Handling business and prior to that
merger, he was the Vice President and General Manager of our Contamination Control Solutions division since December
2007. He served as the Vice President and General Manager of our Liquid Systems business unit from 2005 to 2007, and prior
to that, as Entegris Minnesota’s Vice President of Sales for semiconductor markets from 2003 to 2005. Prior to 2003,
Mr. Edlund held a variety of positions with our predecessor companies since 1995.
Sue Rice has been our Senior Vice President of Global Human Resources since September 2017. Prior to that, Ms. Rice served
as Senior Vice President and Chief Human Resources Officer for Thermo Fisher Scientific, a scientific equipment company,
from 2013 to 2017, Region Vice President HR Asia Pacific & Emerging Markets from 2009 to 2013 and Group Vice President,
HR Analytical Technologies Group from 2006 to 2009. Prior to that, Ms. Rice held senior human resource positions with
Fidelity Human Resources Services Company and Sherbrooke Associates.
Joe Colella has been our Senior Vice President, General Counsel and Secretary since April 2020. Previously, Mr. Colella
served as our Vice President, Deputy General Counsel from December 2018 until April 2020, Assistant General Counsel from
April 2018 until December 2018 and Senior Corporate Counsel from December 2013 until April 2018. Prior to joining Entegris,
Mr. Colella served as an associate at an international law firm from 2007 until 2013.
Jim O’Neill has been our Senior Vice President, Chief Technology Officer since September 2019, having previously served as
our Vice President, Chief Technology Officer since April 2014 when he joined Entegris as part of our acquisition of ATMI. At
ATMI, Dr. O’Neill was Senior Vice President of Electronic Materials from January 2012 to April 2014. Prior to that, he held
numerous technical and leadership roles in semiconductor research and development with over 23 years at IBM.
Corey Rucci has served as our Senior Vice President, Business Development since January 2018, having served as Vice
President, Business Development since February 2014. Prior to that, he served as Vice President and General Manager of our
Specialty Materials Division since 2011 and as General Manager of Poco Graphite, Inc. (POCO) since 2008 when we acquired
POCO. Prior to joining Entegris, Mr. Rucci served POCO as the President and Chief Operating Officer since 2007, Chief
Operating Officer since 2005, Chief Financial Officer since 2001 and Vice President of Business Development since 1998.
Prior to that, he worked at UNOCAL Corp. for 17 years in a variety of accounting, marketing and business development roles.
Olivier Blachier has been our Senior Vice President, Business and New Markets Development since November 2021 and is
responsible for the company’s merger and acquisition activities and for the commercialization of emerging businesses. Before
joining Entegris, Mr. Blachier held various senior leadership positions between 2007 and 2021 at Air Liquide Group, a global
leader in gases, technologies, and services for the industrial and healthcare sectors. Since 2018, he has been based in Taiwan
and most recently served as APAC vice president for the Hydrogen and Energy Transition business and also led the
implementation of capital projects. Previously, he was president of Air Liquide Far Eastern (ALFE) and vice president of
Electronics where he led the growth of the company’s electronics business in Greater China as well as the hydrogen energy
business across Asia. He also served as group vice president for Air Liquide Industrial Merchant in prior years. From 1997 to
2007, Mr. Blachier worked for Edwards, Ltd., a global vacuum and abatement process leader and subsidiary of BOC Group,
where he held multiple roles in the U.S. and U.K., including leading multiple acquisitions and joint ventures. Mr. Blachier holds
a Master of Sciences in Fluid and Chemical Engineering from Grenoble Poly-technique National Institute in France and
obtained a certificate in Strategy & Organization from Stanford University Graduate School of Business.
Bruce W. Beckman has been our Senior Vice President, Finance since February 2018. Prior to that, Mr. Beckman served as
Vice President, Finance since joining Entegris in April 2015. From 1990 to 2015, Mr. Beckman worked in numerous capacities
for General Mills, Inc., including Vice President, Finance, Meals Division from July 2012 to January 2015, Director of
Corporate Planning & Analysis from July 2008 to July 2012 and Director of Internal Controls from 2003 to 2005.
53
Stuart Tison has been our Senior Vice President, Specialty Chemicals and Engineered Materials since July 2016. Prior to that,
Mr. Tison served as Vice President, Specialty Gas Solutions since February 2015, as Vice President, Business Development
since January 2010 and as Vice President, Corporate Development since July 2007. Prior to that, he served Celerity, Inc. as
Vice President, Engineering and served Entegris predecessor companies Mykrolis and Millipore in a variety of sales,
marketing, business development and engineering roles.
Clint Haris has been our Senior Vice President, Microcontamination Control since July 2016. Prior to that, Mr. Haris served as
our Vice President, Liquid Microcontamination Control since August 2014. Prior to joining Entegris, Mr. Haris served in a
variety of executive roles at Brooks Automation Inc. including Senior Vice President, Life Science Systems from 2010 to 2014
and Senior Vice President and General Manager, Systems Solutions from 2009 to 2010.
William Shaner has been our Senior Vice President, Advanced Materials Handling since July 2016. Prior to that, Mr. Shaner
served as our Senior Vice President, Global Operations since February 2014 and, prior to that, as our Vice President and
General Manager, Microenvironments division since 2007. He has served in a variety of sales, marketing, business
development and engineering roles since joining Entegris in 1995.
Michael D. Sauer has been our Vice President, Controller and Chief Accounting Officer since June 2012. Prior to that, he
served as the Corporate Controller since 2008. From the time of the merger with Mykrolis in August 2005 until April 2008,
Mr. Sauer served as Director of Treasury and Risk Management. Mr. Sauer joined Fluoroware, Inc., a predecessor to Entegris
Minnesota in 1988 and held a variety of finance and accounting positions until 2001 when he became the Director of Business
Development for Entegris Minnesota, the successor to Fluoroware, serving in that position until the merger with Mykrolis.
Item 11. Executive Compensation.
The information required by this Item 11 has been omitted from this report, and is incorporated by reference to our Definitive
Proxy Statement for the Entegris, Inc. Annual Meeting of Stockholders to be held on April 27, 2022, and to be filed with the
Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of our 2021 fiscal year.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Securities Authorized for Issuance Under Equity Compensation Plans:
As of December 31, 2021, our equity compensation plan information is as follows:
Equity Compensation Plan Information
Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights
Weighted-average
exercise price of
outstanding options,
warrants and rights(1)
Number of securities remaining
available for future issuance
under equity compensation
plans (excluding securities
reflected in column (a))(2) (3)
Plan category
(a)
(b)
(c)
Equity compensation plans approved by security
holders
Equity compensation plans not approved by security
holders
Total
1,893,199 $
—
1,893,199 $
55.32
—
55.32
10,112,129
—
10,112,129
(1) The weighted average exercise price does not take into account the shares issuable upon vesting of outstanding
restricted stock units, which have no exercise price.
(2) These shares are available for future issuance under the 2020 Stock Plan in the form of stock options, restricted stock
units, performance shares and other stock awards in accordance with the terms of the 2020 Stock Plan.
(3) Includes 1,450,664 shares remaining available for future issuance under the Company’s Employee Stock Purchase Plan
as of December 31, 2021.
The other information required by this Item 12 has been omitted from this report, and is incorporated by reference to our
Definitive Proxy Statement for the Entegris, Inc. Annual Meeting of Stockholders to be held on April 27, 2022, and to be filed
with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of our 2021 fiscal
year.
54
Item 13. Certain Relationships and Related Transactions, and Director Independence.
The information required by this Item 13 has been omitted from this report, and is incorporated by reference to our Definitive
Proxy Statement for the Entegris, Inc. Annual Meeting of Stockholders to be held on April 27, 2022, and to be filed with the
Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of our 2021 fiscal year.
Item 14. Principal Accountant Fees and Services.
The information required by this Item 14 has been omitted from this report, and is incorporated by reference to our Definitive
Proxy Statement for the Entegris, Inc. Annual Meeting of Stockholders to be held on April 27, 2022, and to be filed with the
Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the end of our 2021 fiscal year.
55
Item 15. Exhibits and Financial Statement Schedules.
(a) The following Financial Statements are included in Item 8 herein:
PART IV
1. Financial Statements:
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets at December 31, 2021 and 2020
Consolidated Statements of Operations for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Equity for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Cash Flows for the Years Ended December 31, 2021, 2020 and 2019
Notes to Consolidated Financial Statements
2. Financial Statement Schedule - All financial statement schedules have been omitted since the information is either not
applicable or is included in the consolidated financial statements notes thereof.
3. Exhibits - The following exhibits are incorporated by reference into this Annual Report on Form 10-K:
Document Incorporated
Referenced Document on file with the Commission
Agreement and Plan of Merger, dated as of December 14, 2021,
by and among Entegris, Inc., CMC Materials, Inc. and Yosemite
Merger Sub, Inc.
Exhibit 2.1 to Entegris, Inc. Current Report on
Form 8-K filed with the Securities and
Exchange Commission on December 16, 2021
Reg. S-K
Item 601(b)
Reference
(2)
(3)
(3)
(4)
(4)
(4)
Amended and Restated Certificate of Incorporation of Entegris,
Inc., as amended
By-Laws of Entegris, Inc., as amended December 17, 2008
Form of certificate representing shares of Common Stock, $.01
par value per share
Indenture, dated as of April 30, 2020, by and among the
Company, certain subsidiaries of the Company and Wells Fargo
Bank, National Association, as trustee, including the form of
note representing the 2028 Notes
Indenture, dated as of April 30, 2021, by and among the
Company, certain subsidiaries of the Company and Wells Fargo
Bank, National Association, as trustee, including the form of
note representing the 2029 Notes
(4)
Description of Capital Stock
(10)
(10)
Credit and Guaranty Agreement dated as of November 6, 2018,
among Entegris, Inc., as borrower, certain subsidiaries of
Entegris, Inc., as guarantors, the lenders party thereto and
Goldman Sachs Bank USA, as administrative agent and
collateral agent
Amendment No. 1 to Credit and Guaranty Agreement, dated as
of February 8, 2019, among Entegris, Inc., as borrower, each
lender party thereto, and Goldman Sachs Bank USA, as
administrative agent and collateral agent
56
Exhibit 3.1 to Entegris, Inc. Annual Report on
Form 10-K for the fiscal year ended
December 31, 2011
Exhibit 3 to Entegris, Inc. Annual Report on
Form 10-K for the fiscal year ended
December 31, 2008
Exhibit 4.1 to Form S-4 Registration
Statement of Entegris, Inc. and Eagle DE, Inc.
(No. 333-124719)
Exhibit 4.1 to Entegris, Inc. Current Report on
Form 8-K filed with the Securities and
Exchange Commission on April 30, 2020
Exhibit 4.1 to Entegris, Inc. Current Report on
Form 8-K filed with the Securities and
Exchange Commission on April 30, 2021
Exhibit 4.1 to Entegris, Inc. Annual Report on
Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on November 6, 2018
Exhibit 10.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on February 8, 2019
(10)
(10)
(10)
(10)
(10)
(10)
Amendment No. 2 to Credit and Guaranty Agreement, dated as
of October 31, 2019, among Entegris, Inc., as borrower, the other
credit parties party thereto, the lenders party thereto, the issuing
banks party thereto, Goldman Sachs Bank USA, as the
predecessor agent, and Morgan Stanley Senior Funding, Inc., as
the successor agent.
Amendment No. 3 to Credit and Guaranty Agreement, dated as
of May 20, 2020, among Entegris, Inc., as borrower, the lenders
party thereto and Morgan Stanley Senior Funding, Inc., as
administrative agent
Amendment No. 4 to Credit and Guaranty Agreement, dated as
of April 30, 2021, among Entegris, Inc., as borrower, the other
credit parties thereto, the lenders party thereto, the issuing banks
party thereto and Morgan Stanley Senior Funding, Inc., as
administrative agent
Pledge and Security Agreement dated as of November 6, 2018,
among Entegris, Inc., as borrower, the guarantors party thereto
and Goldman Sachs Bank USA, as collateral agent
Amendment No. 1 to Pledge and Security Agreement, dated as of
October 31, 2019, among Entegris, Inc., as borrower, the other
credit parties party thereto, Goldman Sachs Bank USA, as the
predecessor agent, and Morgan Stanley Senior Funding, Inc., as
the successor agent
Entegris, Inc. – 2010 Stock Plan, as amended*
(10)
Entegris, Inc. 2020 Stock Plan*
(10)
(10)
(10)
Entegris, Inc. Outside Directors’ Stock Option Plan*
Entegris, Inc. Amended and Restated Employee Stock Purchase
Plan*
Second Amended and Restated Entegris Incentive Plan*
(10)
Entegris, Inc. 2007 Deferred Compensation Plan*
(10)
Amended and Restated Supplemental Executive Retirement Plan
for Key Salaried Employees*
(10)
Amendment to Amended and Restated SERP*
Lease Agreement, dated April 1, 2002 between Nortel Networks
HPOCS Inc. and Mykrolis Corporation, relating to Executive
office, R&D and manufacturing facility located at 129 Concord
Road Billerica, MA
Amendment of Lease between Entegris, Inc. and KBS Rivertech,
LLC dated April 1, 2012
Second Amendment of Lease, dated March 8, 2016, between
Entegris, Inc. and KBS Rivertech, LLC
(10)
(10)
(10)
(10)
Exhibit 10.5 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended June 27,
2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended July 3,
2021
Exhibit 10.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on November 6, 2018
Exhibit 10.6 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended July 3,
2010
Annex 1 to the Entegris, Inc. Schedule 14A
proxy statement for its 2020 Annual Meeting
of Stockholders (No. 001-32598), as filed
with the Securities and Exchange Commission
on March 18, 2020
Exhibit 10.2 to Entegris, Inc. Registration
Statement on Form S-1 (No. 333-33668)
Exhibit 4.1 to Entegris, Inc. Registration
Statement on Form S-8 (No. 333-211444)
Exhibit 10.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on May 24, 2017
Exhibit 10.2 to Entegris, Inc. Quarterly Report
on Form 10-Q for the fiscal period ended June
30, 2007
Exhibit 10.2 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2008
Exhibit 10.15 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2009
Exhibit 10.1.3 to Mykrolis Corporation’s
Quarterly Report on Form 10-Q for the
quarter ended March 31, 2002
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended June 30,
2012
Exhibit 10.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on March 11, 2016
Fluoropolymer Purchase and Sale Agreement, by and between
E.I. Du Pont De Nemours and Company and the Registrant,
dated January 1, 2011, as amended
Exhibit 10.2 to Entegris, Inc. Quarterly Report
on Form 10-Q for the quarter ended April 2,
2011
57
(10)
(10)
(10)
(10)
Form of Indemnification Agreement between Entegris, Inc. and
each of its executive officers and Directors
Form of Executive Change of Control Termination Agreement
between Entegris, Inc. and certain of its executive officers*
Form of Revised Executive Change of Control Termination
Agreement between Entegris, Inc. and certain of its executive
officers executed in 2015 (other than those executive officers
who executed the form previously filed)*
Entegris, Inc. 2015 Stock Option Grant Agreement*
(10)
Entegris, Inc. 2016 Stock Option Grant Agreement*
(10)
Entegris, Inc. 2017 Stock Option Grant Agreement*
(10)
Entegris, Inc. 2018 Performance Share Award Agreement*
(10)
Entegris, Inc. 2018 RSU Award Agreement*
(10)
Entegris, Inc. 2018 Stock Option Grant Agreement*
(10)
Entegris, Inc. 2019 Performance Share Award Agreement*
(10)
Entegris, Inc. 2019 RSU Award Agreement*
(10)
Entegris, Inc. 2019 Stock Option Grant Agreement*
(10)
(10)
(10)
(10)
Entegris, Inc. 2020 Performance Share Award Agreement (under
2010 Stock Plan)*
Entegris, Inc. 2020 RSU Award Agreement (under 2010 Stock
Plan)*
Entegris, Inc. 2020 Stock Option Grant Agreement (under 2010
Stock Plan)*
Entegris, Inc. 2020 RSU Award Agreement (under 2020 Stock
Plan)*
(10)
Entegris, Inc. 2021 Performance Share Award Agreement*
(10)
Entegris, Inc. 2021 RSU Award Agreement*
(10)
Entegris, Inc. 2021 Stock Option Grant Agreement*
Exhibit 10.30 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
August 27, 2005
Exhibit 10.31 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
August 27, 2005
Exhibit 10.1 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 29, 2016
Exhibit 10.4 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 29, 2016
Exhibit 10.4 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 17, 2017
Exhibit 10.3 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 15, 2018
Exhibit 10.1 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 11, 2019
Exhibit 10.2 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 11, 2019
Exhibit 10.3 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 11, 2019
Exhibit 10.1 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.2 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.3 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended March 28,
2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended March 28,
2020
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended March 28,
2020
Exhibit 10.1 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2020
Exhibit 10.2 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2020
Exhibit 10.3 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2020
Exhibit 10.4 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2020
58
(10)
(10)
(10)
(10)
(10)
(10)
Executive Employment Agreement, effective November 28,
2012, between the Registrant and Bertrand Loy*
Exhibit 10.1 to Entegris, Inc. Annual Report
on Form 10-K for the fiscal year ended
December 31, 2012
Amendment No. 1, dated April 26, 2013, to Executive Change in
Control Termination Agreement, between Entegris, Inc. and
Bertrand Loy*
Exhibit 99.1 to Entegris, Inc. Current Report
on Form 8-K filed with the Securities and
Exchange Commission on April 26, 2013
Amendment No. 2, dated February 5, 2020, to Executive Change
in Control Termination Agreement, between Entegris, Inc. and
Bertrand Loy*
Exhibit 10.4 to Entegris, Inc. Annual Report
on Form 10-K filed with the Securities and
Exchange Commission on February 7, 2020
Severance Protection Agreement, dated May 13, 2011 between
Entegris, Inc. and Gregory B. Graves*
Exhibit 10.2 to Entegris, Inc. Quarterly Report
on Form 10-Q for the period ended July 2,
2011
Amendment No. 1, dated as of February 23, 2016, to the
Severance Protection Agreement by and between Entegris, Inc,
and Gregory B. Graves*
Exhibit 10.2 to Entegris, Inc. Quarterly Report
on Form 10-Q filed with the Securities and
Exchange Commission on April 28, 2016
Separation Agreement and Release, dated as of August 27, 2019,
by and between the Company and Gregory Marshall*
Exhibit 10.1 to Entegris, Inc. Quarterly Report
on Form 10-Q filed with the Securities and
Exchange Commission on October 24, 2019
* A “management contract or compensatory plan”
The Company hereby files as exhibits to this Annual Report on Form 10-K the following documents:
Reg. S-K
Item 601(b)
Reference
(10)
(10)
(10)
(10)
(21)
(23)
(24)
(31)
Exhibit No.
10.1
10.2
10.3
10.4
21
23
24
31.1
(31)
31.2
(32)
32.1
(32)
32.2
(101)
101.INS
(101)
(101)
(101)
(101)
(101)
(104)
101.SCH
101.CAL
101.DEF
101.LAB
101.PRE
104
Documents Filed Herewith
Entegris, Inc. 2022 Performance Share Award Agreement*
Entegris, Inc. 2022 RSU Award Agreement*
Entegris, Inc. 2022 Stock Option Grant Agreement*
Third Amendment to Lease Agreement, dated as of October 21, 2021, between Entegris, Inc.
and Rivertech Owner LLC
Subsidiaries of Entegris, Inc.
Consent of Independent Registered Public Accounting Firm
Power of Attorney by the Directors of Entegris, Inc.
Certification required by Rule 13a-14(a) in accordance with Section 302 of the Sarbanes—Oxley
Act of 2002.
Certification required by Rule 13a-14(a) in accordance with Section 302 of the Sarbanes—Oxley
Act of 2002.
Certification required by Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
Certification required by Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
XBRL Instance Document - the instance document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document
XBRL Taxonomy Extension Schema Document
XBRL Taxonomy Extension Calculation Linkbase Document
XBRL Taxonomy Extension Definition Linkbase Document
XBRL Taxonomy Extension Label Linkbase Document
XBRL Taxonomy Extension Presentation Linkbase Document
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* A “management contract or compensatory plan”
Item 16. Form 10-K Summary.
None.
59
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGNATURES
Date: February 4, 2022
ENTEGRIS, INC.
By
/s/ BERTRAND LOY
Bertrand Loy
President & Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the Registrant and in the capacities and on the dates indicated.
TITLE
President, Chief Executive Officer and Director
(Principal executive officer)
Executive Vice President, Chief Financial Officer & Treasurer
(Principal financial officer)
DATE
February 4, 2022
February 4, 2022
Vice President, Controller & Chief Accounting Officer (Principal
accounting officer)
February 4, 2022
Director, Chairman of the Board
February 4, 2022
SIGNATURE
/s/ BERTRAND LOY
Bertrand Loy
/s/ GREGORY B. GRAVES
Gregory B. Graves
/s/ MICHAEL D. SAUER
Michael D. Sauer
PAUL L.H. OLSON*
Paul L.H. Olson
MICHAEL A. BRADLEY*
Michael A. Bradley
RODNEY CLARK*
Rodney Clark
JAMES F. GENTILCORE*
James F. Gentilcore
YVETTE KANOUFF*
Yvette Kanouff
JAMES P. LEDERER*
James P. Lederer
Director
Director
Director
Director
Director
AZITA SALEKI-GERHARDT* Director
Azita Saleki-Gerhardt
*By
Gregory B. Graves, Attorney-in-fact
/s/ Gregory B. Graves
60
February 4, 2022
February 4, 2022
February 4, 2022
February 4, 2022
February 4, 2022
February 4, 2022
ENTEGRIS, INC.
INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets at December 31, 2021 and 2020
Consolidated Statements of Operations for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Equity for the Years Ended December 31, 2021, 2020 and 2019
Consolidated Statements of Cash Flows for the Years Ended December 31, 2021, 2020 and 2019
Notes to Consolidated Financial Statements
F-2
F-4
F-5
F-6
F-7
F-8
F-10
F-1
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
Entegris, Inc.:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Entegris Inc. and subsidiaries (the Company) as of
December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, equity, and cash flows
for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated
financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the
years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express
an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the
PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and
the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement,
whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the
consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such
procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management,
as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a
reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or
disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or
complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Fair value of acquired customer relationships
As discussed in Note 3 to the consolidated financial statements, the Company accounts for acquired businesses using the
acquisition method of accounting by recording assets and liabilities acquired at their respective fair values. During 2021,
the Company acquired BASF’s Precision Microchemical business for a total purchase price of $89.7 million, net of cash
acquired, and the Company recorded intangible assets for customer relationships of $31.8 million.
We identified the assessment of the fair value of certain acquired customer relationships as a critical audit matter. The key
assumptions in the discounted cash flow model used to estimate the acquisition-date fair value of the customer
relationships included future revenue growth rates and the discount rate. Evaluating the key assumptions underlying the
estimate of the fair value of the customer relationships acquired involved a high degree of auditor judgment, as changes in
these key assumptions could have a significant impact on the fair value of the customer relationships.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and
tested the operating effectiveness of certain internal controls related to the Company’s acquisition process. This included
controls related to the development and review of the key assumptions. We evaluated the reasonableness of the Company’s
selected future revenue growth rates by comparing those assumptions to the historical results of BASF’s Precision
Microchemical business and industry outlooks for the end user markets of the acquired business’s products. In addition, we
involved valuation professionals with specialized skills and knowledge, who assisted in evaluating the Company’s discount
F-2
rate by comparing it against a discount rate range that was independently developed using publicly available market data
for comparable entities.
/s/ KPMG LLP
We or our predecessor firms have served as the Company’s auditor since 1966.
Minneapolis, Minnesota
February 4, 2022
F-3
ENTEGRIS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
ASSETS
Current assets:
Cash and cash equivalents
Trade accounts and notes receivable, net
Inventories, net
Deferred tax charges and refundable income taxes
Other current assets
Total current assets
Property, plant and equipment, net
Other assets:
Right-of-use assets
Goodwill
Intangible assets, net
Deferred tax assets and other noncurrent tax assets
Other noncurrent assets
Total assets
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
Accrued payroll and related benefits
Other accrued liabilities
Income taxes payable
Total current liabilities
Long-term debt, excluding current maturities
Pension benefit obligations and other liabilities
Deferred tax liabilities and other noncurrent tax liabilities
Long-term lease liabilities
Commitments and contingent liabilities
Equity:
Preferred stock, par value $.01; 5,000,000 shares authorized; none issued and
outstanding as of December 31, 2021 and December 31, 2020
Common stock, par value $.01; 400,000,000 shares authorized; issued and
outstanding shares as of December 31, 2021: 135,719,366 and 135,516,966,
respectively; issued and outstanding shares as of December 31, 2020: 135,148,774
and 134,946,374, respectively
Treasury stock, common, at cost: 202,400 shares held as of December 31, 2021 and
December 31, 2020
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total equity
Total liabilities and equity
December 31, 2021
December 31, 2020
$
402,565 $
347,413
475,213
35,312
52,867
1,313,370
654,098
66,563
793,702
335,113
17,671
11,379
580,893
264,392
323,944
21,136
43,892
1,234,257
525,367
45,924
748,037
337,632
14,519
11,960
$
3,191,896 $
2,917,696
$
130,734 $
108,818
90,313
49,136
379,001
937,027
37,816
64,170
60,101
—
81,618
94,364
82,648
43,996
302,626
1,085,783
36,457
73,606
39,730
—
—
—
1,357
1,351
(7,112)
879,845
879,776
(40,085)
(7,112)
844,850
577,833
(37,428)
1,713,781
1,379,494
$
3,191,896 $
2,917,696
See the accompanying notes to consolidated financial statements.
F-4
ENTEGRIS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Engineering, research and development expenses
Amortization of intangible assets
Operating income
Interest expense
Interest income
Other expense (income), net
Income before income tax expense
Income tax expense
Net income
Basic net income per common share
Diluted net income per common share
Weighted average shares outstanding
Basic
Diluted
Year ended
December 31,
2021
Year ended
December 31,
2020
Year ended
December 31,
2019
$
2,298,893 $
1,859,313 $
1,591,066
1,239,229
1,059,664
292,408
167,632
47,856
551,768
41,240
1,009,591
849,722
265,128
136,057
53,092
395,445
48,600
(243)
31,695
479,076
69,950
(786)
(6,656)
354,287
59,318
879,413
711,653
284,807
121,140
66,428
239,278
46,962
(4,652)
(121,081)
318,049
63,189
409,126 $
294,969 $
254,860
3.02 $
3.00 $
2.19 $
2.16 $
1.89
1.87
$
$
$
135,411
136,574
134,837
136,266
135,137
136,568
See the accompanying notes to consolidated financial statements.
F-5
ENTEGRIS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Net income
Other comprehensive loss, net of tax
Foreign currency translation adjustments
Pension liability adjustments, net
Other comprehensive loss
Comprehensive income
Year ended
December 31, 2021
Year ended
December 31, 2020
Year ended
December 31, 2019
$
409,126 $
294,969 $
254,860
(2,275)
(382)
(2,657)
406,469 $
(120)
(49)
(169)
294,800 $
(3,692)
69
(3,623)
251,237
$
See the accompanying notes to consolidated financial statements.
F-6
5
2
0
,
2
1
0
,
1
$
)
0
6
8
(
$
)
6
7
7
,
2
3
(
$
3
5
7
,
3
1
2
$
8
5
6
,
7
3
8
$
)
2
1
1
,
7
(
$
2
0
2
2
6
3
,
1
$
9
7
1
,
6
3
1
l
a
t
o
T
d
e
n
i
f
e
D
n
o
i
s
n
e
p
t
i
f
e
n
e
b
s
t
n
e
m
t
s
u
j
d
a
n
g
i
e
r
o
F
y
c
n
e
r
r
u
c
n
o
i
t
a
l
s
n
a
r
t
s
t
n
e
m
t
s
u
j
d
a
d
e
n
i
a
t
e
R
s
g
n
i
n
r
a
e
l
a
n
o
i
t
i
d
d
A
n
i
-
d
i
a
p
l
a
t
i
p
a
c
y
r
u
s
a
e
r
T
k
c
o
t
s
y
r
u
s
a
e
r
T
s
e
r
a
h
s
n
o
m
m
o
C
k
c
o
t
s
n
o
m
m
o
C
s
e
r
a
h
s
g
n
i
d
n
a
t
s
t
u
o
S
E
I
R
A
I
D
I
S
B
U
S
D
N
A
.
C
N
I
,
S
I
R
G
E
T
N
E
Y
T
I
U
Q
E
F
O
S
T
N
E
M
E
T
A
T
S
D
E
T
A
D
I
L
O
S
N
O
C
)
1
3
4
,
1
(
9
2
6
,
9
1
)
7
8
7
,
4
7
(
)
4
8
7
,
0
4
(
9
6
)
2
9
6
,
3
(
0
6
8
,
4
5
2
9
8
8
,
5
6
1
,
1
)
2
6
0
,
6
1
(
0
2
9
,
2
2
)
3
6
5
,
4
4
(
)
0
9
4
,
3
4
(
)
9
4
(
)
0
2
1
(
4
5
6
,
8
4
8
8
,
9
2
)
9
0
1
,
7
6
(
)
1
1
6
,
3
4
(
)
2
8
3
(
)
5
7
2
,
2
(
6
2
1
,
9
0
4
9
6
9
,
4
9
2
4
9
4
,
9
7
3
,
1
—
—
—
9
6
—
—
)
1
9
7
(
—
—
—
)
9
4
(
—
—
)
0
4
8
(
—
—
—
)
2
8
3
(
—
—
—
—
—
—
—
)
2
9
6
,
3
(
)
8
6
4
,
6
3
(
—
—
—
—
—
)
0
2
1
(
—
)
8
8
5
,
6
3
(
—
—
—
—
—
—
)
5
7
2
,
2
(
—
—
)
1
8
6
,
1
6
(
)
5
0
8
,
0
4
(
—
—
0
6
8
,
4
5
2
7
2
1
,
6
6
3
—
—
)
5
3
7
,
9
3
(
)
8
2
5
,
3
4
(
—
—
9
6
9
,
4
9
2
3
3
8
,
7
7
5
—
—
)
7
5
5
,
3
6
(
)
6
2
6
,
3
4
(
—
—
6
2
1
,
9
0
4
1
2
—
—
—
)
0
4
4
,
1
(
9
2
6
,
9
1
)
4
8
0
,
3
1
(
4
8
7
,
2
4
8
)
2
7
0
,
6
1
(
0
2
9
,
2
2
)
0
2
8
,
4
(
8
3
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
—
)
8
(
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
9
—
)
2
2
(
—
—
—
—
7
7
8
—
)
6
2
1
,
2
(
—
—
—
—
)
2
1
1
,
7
(
2
0
2
9
4
3
,
1
0
3
9
,
4
3
1
3
4
6
,
8
4
8
8
,
9
2
)
7
4
5
,
3
(
5
1
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
1
1
—
)
5
(
—
—
—
—
0
5
8
,
4
4
8
)
2
1
1
,
7
(
2
0
2
1
5
3
,
1
7
9
9
—
)
8
7
7
(
—
—
—
—
—
)
3
6
5
(
3
3
1
,
1
9
4
1
,
5
3
1
—
—
—
—
1
8
7
,
3
1
7
,
1
$
)
2
2
2
,
1
(
$
)
3
6
8
,
8
3
(
$
6
7
7
,
9
7
8
$
5
4
8
,
9
7
8
$
)
2
1
1
,
7
(
$
2
0
2
7
5
3
,
1
$
9
1
7
,
5
3
1
.
s
t
n
e
m
e
t
a
t
s
l
a
i
c
n
a
n
i
f
d
e
t
a
d
i
l
o
s
n
o
c
o
t
s
e
t
o
n
g
n
i
y
n
a
p
m
o
c
c
a
e
h
t
e
e
S
k
c
o
t
s
n
o
m
m
o
c
f
o
t
n
e
m
e
r
i
t
e
r
d
n
a
e
s
a
h
c
r
u
p
e
R
)
e
r
a
h
s
r
e
p
0
3
.
0
$
(
d
e
r
a
l
c
e
d
s
d
n
e
d
i
v
i
D
e
s
n
e
p
x
e
n
o
i
t
a
s
n
e
p
m
o
c
d
e
s
a
b
-
e
r
a
h
S
8
1
0
2
,
1
3
r
e
b
m
e
c
e
D
t
a
e
c
n
a
l
a
B
s
n
a
l
p
k
c
o
t
s
r
e
d
n
u
d
e
u
s
s
i
s
e
r
a
h
S
)
s
d
n
a
s
u
o
h
t
n
I
(
e
s
n
e
p
x
e
n
o
i
t
a
s
n
e
p
m
o
c
d
e
s
a
b
-
e
r
a
h
S
9
1
0
2
,
1
3
r
e
b
m
e
c
e
D
t
a
e
c
n
a
l
a
B
s
n
a
l
p
k
c
o
t
s
r
e
d
n
u
d
e
u
s
s
i
s
e
r
a
h
S
t
n
e
m
t
s
u
j
d
a
y
t
i
l
i
b
a
i
l
n
o
i
s
n
e
P
n
o
i
t
a
l
s
n
a
r
t
y
c
n
e
r
r
u
c
n
g
i
e
r
o
F
e
m
o
c
n
i
t
e
N
k
c
o
t
s
n
o
m
m
o
c
f
o
t
n
e
m
e
r
i
t
e
r
d
n
a
e
s
a
h
c
r
u
p
e
R
)
e
r
a
h
s
r
e
p
2
3
.
0
$
(
d
e
r
a
l
c
e
d
s
d
n
e
d
i
v
i
D
k
c
o
t
s
n
o
m
m
o
c
f
o
t
n
e
m
e
r
i
t
e
r
d
n
a
e
s
a
h
c
r
u
p
e
R
)
e
r
a
h
s
r
e
p
2
3
.
0
$
(
d
e
r
a
l
c
e
d
s
d
n
e
d
i
v
i
D
e
s
n
e
p
x
e
n
o
i
t
a
s
n
e
p
m
o
c
d
e
s
a
b
-
e
r
a
h
S
0
2
0
2
,
1
3
r
e
b
m
e
c
e
D
t
a
e
c
n
a
l
a
B
s
n
a
l
p
k
c
o
t
s
r
e
d
n
u
d
e
u
s
s
i
s
e
r
a
h
S
t
n
e
m
t
s
u
j
d
a
y
t
i
l
i
b
a
i
l
n
o
i
s
n
e
P
n
o
i
t
a
l
s
n
a
r
t
y
c
n
e
r
r
u
c
n
g
i
e
r
o
F
e
m
o
c
n
i
t
e
N
1
2
0
2
,
1
3
r
e
b
m
e
c
e
D
t
a
e
c
n
a
l
a
B
t
n
e
m
t
s
u
j
d
a
y
t
i
l
i
b
a
i
l
n
o
i
s
n
e
P
n
o
i
t
a
l
s
n
a
r
t
y
c
n
e
r
r
u
c
n
g
i
e
r
o
F
e
m
o
c
n
i
t
e
N
F-7
ENTEGRIS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating
activities:
Year ended
December 31, 2021
Year ended
December 31, 2020
Year ended
December 31, 2019
$
409,126 $
294,969 $
254,860
Depreciation
Amortization
Share-based compensation expense
Provision for deferred income taxes
Charge for excess and obsolete inventory
Loss on extinguishment of debt
Other
Changes in operating assets and liabilities, net of effects of
acquisitions:
Trade accounts receivable and notes receivable
Inventories
Accounts payable and other accrued liabilities
Other current assets
Income taxes payable, refundable income taxes and noncurrent
taxes payable
Other
Net cash provided by operating activities
Investing activities:
Acquisition of property and equipment
Acquisition of business, net of cash acquired
Other
Net cash used in investing activities
Financing activities:
Proceeds from short-term borrowings
Payments of short-term borrowings
Proceeds from long-term debt
Payments of long-term debt
Payments for debt issuance costs
Payments for debt extinguishment costs
Payments for dividends
Issuance of common stock from employee stock plans
Taxes paid related to net share settlement of equity awards
Repurchase and retirement of common stock
Deferred acquisition payment
Other
Net cash (used in) provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
(Decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
90,311
47,856
29,884
(18,433)
17,103
23,338
(2,000)
(86,766)
(168,372)
53,577
2,870
(3,292)
5,252
400,454
83,430
53,092
22,920
(7,250)
15,387
2,378
1,090
(27,461)
(50,772)
40,162
(11,952)
28,490
2,191
446,674
(210,626)
(91,942)
4,450
(131,752)
(111,912)
338
(298,118)
(243,326)
101,000
(101,000)
400,000
(550,000)
(5,069)
(19,080)
(43,545)
24,744
(16,090)
(67,109)
—
(348)
(276,497)
(4,167)
217,000
(217,000)
400,000
(251,000)
(3,964)
—
(43,245)
8,738
(24,800)
(44,563)
(16,125)
(2,892)
22,149
3,485
74,975
66,428
19,629
(14,008)
11,433
—
12,118
(3,164)
(21,354)
(22,647)
7,784
(3,494)
(262)
382,298
(112,355)
(277,369)
3,884
(385,840)
—
—
—
(4,000)
—
—
(40,566)
7,291
(8,722)
(80,321)
—
(502)
(126,820)
211
(178,328)
228,982
(130,151)
580,893
402,565 $
351,911
580,893 $
482,062
351,911
$
See the accompanying notes to consolidated financial statements
F-8
ENTEGRIS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
Supplemental Cash Flow Information
(In thousands)
Non-cash transactions:
Contingent consideration obligation
Deferred acquisition payments, net
Equipment purchases in accounts payable
Increase in dividends payable
Schedule of interest and income taxes paid:
Interest paid
Income taxes, net of refunds received
Year ended
December 31, 2021
Year ended
December 31, 2020
Year ended
December 31, 2019
$
$
— $
250
29,042
66
— $
1,482
11,921
245
46,791 $
88,059
42,575 $
37,228
686
19,848
11,285
349
41,711
77,970
See the accompanying notes to consolidated financial statements
F-9
ENTEGRIS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2021
(1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations Entegris, Inc. (Entegris or the Company) is a leading supplier of advanced materials and process
solutions for the semiconductor and other high-technology industries.
Principles of Consolidation The consolidated financial statements include the accounts of the Company and its majority-
owned subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation.
Use of Estimates and Basis of Presentation The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States requires management to make judgments, estimates and
assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. On an ongoing
basis, Entegris evaluates its estimates, including those related to receivables, inventories, property, plant and equipment,
goodwill, intangible assets, accrued liabilities, income taxes and share-based compensation, among others. Actual results could
differ from those estimates.
Cash and Cash Equivalents Cash and cash equivalents include cash on hand and highly liquid debt securities with original
maturities of three months or less, which are valued at cost and approximate fair value.
Allowance for Credit Allowances An allowance for uncollectible trade receivables is estimated based on a combination of
write-off history, aging analysis and any specific, known troubled accounts. The Company maintains an allowance for credit
allowances that management believes is adequate to cover expected losses on trade receivables.
Inventories Inventories are stated at the lower of cost and net realizable value. Cost is determined by the first-in, first-out
(FIFO) method.
Leases The Company determines if an arrangement is a lease at inception. Right-of-use (ROU) assets include operating leases.
Lease liabilities for operating leases are classified in “Other accrued liabilities” and “Long-term lease liabilities” in our
consolidated balance sheet. We do not have material financing leases.
Operating assets and liabilities are recognized at commencement date based on the present value of the lease payments over the
lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the
information available at commencement date in determining the present value of lease payments. We use the implicit rate when
readily determinable. The ROU assets include prepaid lease payments and excludes lease incentives. Lease terms may include
options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense
for lease payments is recognized on a straight-line basis over the lease term.
Lease and non-lease components are generally accounted for separately for real estate leases. For non-real estate leases, we
account for the lease and non-lease components as a single lease component.
Property, Plant and Equipment Property, plant and equipment are carried at cost and are depreciated using the straight-line
method over the estimated useful lives of the assets. When assets are retired or disposed of, the cost and related accumulated
depreciation are removed from the accounts, and gains or losses are recognized in the same period. Maintenance and repairs are
expensed as incurred, while significant additions and improvements are capitalized. Long-lived assets, including property, plant
and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset or group of assets may not be recoverable based on estimated future undiscounted cash flows. The amount of
impairment, if any, is measured as the difference between the net book value and the estimated fair value of the asset(s).
Fair Value of Financial Instruments The carrying value of cash equivalents, accounts receivable, accounts payable, accrued
payroll and related benefits, and other accrued liabilities approximates fair value due to the short maturity of those instruments.
The fair value of long-term debt, including current maturities, based upon models utilizing market observable (Level 2) inputs
and credit risk, was $952.5 million at December 31, 2021 compared to the carrying amount of long-term debt, including current
maturities, of $937.0 million at December 31, 2021.
Goodwill and Intangible Assets Goodwill represents the excess of acquisition costs over the fair value of the net assets of
businesses acquired. Goodwill is not subject to amortization, but is tested for impairment annually at August 31, the Company’s
annual testing date, and whenever events or changes in circumstances indicate that impairment may have occurred. The
Company compares the carrying value of its reporting units, including goodwill, to their fair value. For reporting units in which
the assessment indicates that it is more likely than not that the fair value is more than its carrying value, goodwill is not
considered impaired. If the carrying value of the reporting unit exceeds fair value, goodwill is considered impaired.
F-10
Based on its annual analysis, the Company determined there was no indication of impairment of goodwill and the estimated fair
value of each reporting unit exceeded its carrying value.
Amortizable intangible assets include, among other items, patented, unpatented and other developed technology and customer-
based intangibles, and are amortized using the straight-line method over their respective estimated useful lives. The Company
reviews intangible assets and other long-lived assets for impairment if changes in circumstances or the occurrence of events
suggest the remaining value may not be recoverable.
Derivative Financial Instruments The Company records derivatives as assets or liabilities on the balance sheet and measures
such instruments at fair value. Changes in fair value of derivatives are recorded each period in the Company’s consolidated
statements of operations.
The Company periodically enters into forward foreign currency contracts to reduce exposures relating to rate changes in certain
foreign currencies. Certain exposures to credit losses related to counterparty nonperformance exist. However, the Company
does not anticipate nonperformance by the counterparties since they are large, well-established financial institutions. None of
these derivatives is accounted for as a hedge transaction. Accordingly, changes in the fair value of forward foreign currency
contracts are recorded as other expense (income), net, in the Company’s consolidated statements of operations. The fair values
of the Company’s derivative financial instruments are based on prices quoted by financial institutions for these instruments.
Foreign Currency Translation Assets and liabilities of certain foreign subsidiaries are translated from foreign currencies into
U.S. dollars at period-end exchange rates, and the resulting gains and losses arising from translation of net assets located
outside the U.S. are recorded as a cumulative translation adjustment, a component of accumulated other comprehensive loss in
the consolidated balance sheets. Income statement amounts are translated at the weighted average exchange rates for the year.
Translation adjustments are not adjusted for income taxes, as substantially all translation adjustments relate to permanent
investments in non-U.S. subsidiaries. Gains and losses resulting from foreign currency transactions are included in other
expense (income), net, in the Company’s consolidated statements of operations.
Revenue Recognition Revenue is measured based on consideration specified in a contract with a customer, and excludes any
sales incentives and amounts collected on behalf of third parties. The Company recognizes revenue when it satisfies a
performance obligation by transferring control over a product or service to a customer.
Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing
transaction, that are collected by the Company from a customer, are excluded from revenue.
Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are
accounted for as a fulfillment cost and are included in cost of sales.
The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of
the assets that the Company otherwise would have recognized is one year or less.
When the Company receives consideration, or such consideration is unconditionally due, from a customer prior to transferring
goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, which represents a
contract liability. Such deferred revenue typically results from advance payments received on sales of the Company’s products.
The Company makes the required disclosures with respect to deferred revenue below.
The Company does not disclose information about remaining performance obligations that have original expected durations of
one year or less.
The following is a description of principal activities from which the Company generates its revenues. The Company has three
reportable segments. For more detailed information about reportable segments, see note 16 to the consolidated financial
statements. For each of the three reportable segments, the recognition of revenue regarding the nature of goods and services
provided by the segments are similar and described below. The Company recognizes revenue for product sales at a point in time
following the transfer of control of such products to the customer, which generally occurs upon shipment or delivery, depending
on the terms of the underlying contracts. For product sales contracts that contain multiple performance obligations, the
Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone
selling prices, or estimates of such prices, and recognizes the related revenue as control of each individual product is transferred
to the customer in satisfaction of the corresponding performance obligations. All material revenue is being recognized at a point
in time.
The Company generally recognizes revenue for sales of services when the Company has satisfied the performance obligation.
The payment terms and revenue recognized are based on time and materials.
The Company also enters into arrangements to license its intellectual property. These arrangements typically permit the
customer to use a specialized manufacturing process and in return the Company receives a royalty fee. The Company
F-11
recognizes revenue for a sales-based or usage-based royalty promised in exchange for a license of intellectual property when
the subsequent sale or usage occurs.
The Company offers certain customers cash discounts and volume rebates as sales incentives. The discounts and volume rebates
are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and
contractual obligations. The Company periodically reviews the assumptions underlying its estimates of discounts and volume
rebates and adjusts its revenues accordingly.
In addition, the Company offers free product rebates to certain customers. The Company utilizes an adjusted market approach
to estimate the stand-alone selling price of the loyalty program and allocates a portion of the consideration received to the free
product offering. The free product offering is redeemable upon future purchases of the Company’s products. The amount
associated with free product rebates is recorded as deferred revenue on the balance sheet and is recognized as revenue when the
free product is redeemed or when the likelihood of redemption is remote. The Company has deemed that the amount is
immaterial for disclosure.
The Company provides for the estimated costs of fulfilling its obligations under product warranties at the time the related
revenue is recognized. The Company estimates the costs based on historical failure rates, projected repair costs, and knowledge
of specific product failures (if any). The specific warranty terms and conditions vary depending upon the product sold and the
country in which we do business, but generally include parts and labor over a period generally ranging from 90 days to one
year. The Company regularly reevaluates its estimates to assess the adequacy of the recorded warranty liabilities and adjusts the
amounts as necessary.
The Company’s contracts are generally short-term in nature. Most contracts do not exceed twelve months. Payment terms vary
by the type and location of the Company’s customers and the products or services offered. The term between invoicing and
when payment is due is not significant. For certain products or services and customer types, the Company requires payment
before the products or services are delivered to the customer. Those customers that prepay are represented by the contract
liabilities below until the performance obligations are satisfied.
Engineering, Research and Development Expenses Engineering, research and development expenses are expensed as
incurred.
Share-based Compensation The Company measures the cost of employee services received in exchange for the award of
equity instruments based on the fair value of the award at the date of grant. Share-based compensation expense is recognized
using the straight-line attribution method to recognize share-based compensation over the service period of the award, with
adjustments recorded for forfeitures as they occur.
Income Taxes The Company accounts for income taxes under the asset and liability method, which requires the recognition of
deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial
statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the
financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences
are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income tax
expense in the period that includes the enactment date.
The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. A
valuation allowance is recorded to reduce deferred tax assets when it is more likely than not that the Company would not be
able to realize all or part of its deferred tax assets. In making such a determination, the Company considers all available positive
and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax-
planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax
assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset
valuation allowance, which would reduce the provision for income taxes.
The Company’s policy for recording interest and penalties associated with audits and unrecognized tax benefits is to record
such items as a component of income before taxes. Penalties and interest to be paid or received are recorded in other expense
(income), net, in the statement of operations.
Comprehensive Income (Loss) Comprehensive income (loss) represents the change in equity resulting from items other than
shareholder investments and distributions. The Company’s foreign currency translation adjustments, unrealized gains and losses
on available-for-sale investments, and minimum pension liability adjustments are included in accumulated other comprehensive
loss. Comprehensive income (loss) and the components of accumulated other comprehensive loss are presented in the
accompanying consolidated statements of comprehensive income (loss) and consolidated statements of equity.
Recent Accounting Pronouncements Adopted in 2021 In December 2019, the FASB issued ASU No. 2019-12, “Simplifying
the Accounting for Income Taxes” under ASC 740, which simplifies the accounting for income taxes by removing certain
exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application. This
F-12
guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The
Company adopted this new guidance in the first quarter of fiscal 2021. The adoption of ASU 2019-12 did not have a material
impact on the consolidated financial statements.
Recent Accounting Pronouncements Yet to be Adopted
The Company currently has no material recent accounting pronouncements yet to be adopted.
(2) REVENUES
The following table provides information about current contract liabilities from contracts with customers. The contract
liabilities are included in other accrued liabilities balance in the consolidated balance sheet.
(In thousands)
Balance at beginning of year
Revenue recognized that was included in the contract liability balance at the beginning
of the period
Increases due to cash received, excluding amounts recognized as revenue during the
period
Balance at end of year
2021
2020
$
13,852 $
13,022
(13,819)
(11,018)
23,017
23,050 $
11,848
13,852
$
(3) ACQUISITIONS
Pending Acquisition - CMC Materials
On December 14, 2021, Entegris and CMC Materials, Inc. entered into a definitive Agreement and Plan of Merger pursuant to
which Entegris will acquire CMC Materials in a cash and stock transaction with an enterprise value of approximately
$6.5 billion. The transaction is to be financed with a combination of equity issued to CMC Materials, new debt and cash on
hand. Entegris has obtained fully committed debt financing from Morgan Stanley Senior Funding, Inc. The transaction is
expected to close in the second half of 2022, subject to the satisfaction of customary closing conditions, including regulatory
approval and approval by CMC Materials shareholders.
Precision Microchemicals
On November 30, 2021, the Company completed its acquisition of the Precision Microchemicals business from BASF SE. The
Precision Microchemicals business reports into the Specialty Chemicals and Engineered Materials segment of the Company.
The acquisition was accounted for under the acquisition method of accounting, and the Precision Microchemicals business
results of operations are included in the Company’s consolidated financial statements as of and since November 30, 2021. Costs
associated with the acquisition of the Precision Microchemicals business were $0.2 million for the year ended December 31,
2021 and were expensed as incurred. These costs are included in the selling, general and administrative expenses in the
Company’s consolidated statement of operations. The acquisition does not constitute a material business combination.
The purchase price for the Precision Microchemical business includes cash consideration of $89.7 million (net of cash
acquired), which was funded from the Company’s existing cash on hand.
The purchase price of the Precision Microchemical business exceeds the net of the acquisition-date amounts of the identifiable
assets acquired and the liabilities assumed by $42.8 million. Cash flows used to determine the purchase price included strategic
and synergistic benefits (investment value) specific to the Company, which resulted in a purchase price in excess of the fair
value of identifiable net assets. This additional investment value resulted in goodwill, which is expected to be deductible for
income tax purposes.
The fair value of acquired identifiable intangible assets was determined using Level 3 inputs for the “income approach” on an
individual asset basis. The key assumptions used in the calculation of the discounted cash flows include future revenue growth
rates, future gross margin, future selling, general and administrative expense, royalty rates, and discount rates. The valuations
and the underlying assumptions have been deemed reasonable by the Company’s management. There are inherent uncertainties
and management judgment required in these determinations.
F-13
The following table summarizes the preliminary allocation of the purchase price to the fair values assigned to the assets
acquired and liabilities assumed at the date of the acquisition:
(In thousands):
Inventories, net
Other current assets
Identifiable intangible assets
Right-of-use assets
Property, plant and equipment
Other noncurrent assets
Accounts payable and accrued liabilities
Short-term lease liability
Long-term lease liability
Net assets acquired
Goodwill
Total purchase price, net of cash acquired
November 30, 2021
967
19
44,910
1,912
1,002
18
(43)
(170)
(1,742)
46,873
42,819
89,692
$
$
The Company recognized the following provisional finite-lived intangible assets as part of the acquisition of the Precision
Microchemical business:
(In thousands)
Developed technology
Trademarks and trade names
Customer relationships
Other
Amount
9,600
3,400
31,800
110
44,910
$
$
Weighted
average life in
years
9.0
15.0
15.5
14.1
The final valuation of assets acquired and liabilities assumed is expected to be completed as soon as possible, but no later than
one year from the acquisition date. The determination of the fair value of property, plant and equipment is completed, with the
remaining assets acquired, liabilities assumed and working capital expected to be finalized in the first quarter of 2022. To the
extent that the Company's estimates require adjustment, the Company will modify the fair values.
Other Acquisitions
During the year ended December 31, 2021, the Company completed an acquisition for $2.5 million, substantially all of which
was paid in cash and qualified as a business combination. This acquisition has been included in the Company’s condensed
consolidated results of operations since its acquisition date. The effect of this business combination was not material to the
Company’s condensed consolidated results of operations.
Global Measurement Technologies, Inc.
On July 10, 2020, the Company acquired Global Measurement Technologies, Inc., an analytical instrument provider for critical
processes in semiconductor production, and its manufacturing partner Clean Room Plastics, Inc. (collectively, “GMTI”). GMTI
reports into the Advanced Materials Handling segment of the Company. The acquisition was accounted for under the
acquisition method of accounting, and GMTI’s results of operations are included in the Company’s consolidated financial
statements as of and since July 10, 2020. Costs associated with the acquisition of GMTI were $1.0 million for the year ended
December 31, 2020 and were expensed as incurred. These costs are included in the selling, general and administrative expenses
in the Company’s consolidated statement of operations. The acquisition does not constitute a material business combination.
The purchase price for GMTI included cash consideration of $36.3 million, net of cash acquired, which was funded from the
Company’s existing cash on hand.
The purchase price of GMTI exceeded the net of the acquisition-date amounts of the identifiable assets acquired and the
liabilities assumed by $16.1 million. Cash flows used to determine the purchase price included strategic and synergistic benefits
(investment value) specific to the Company, which resulted in a purchase price in excess of the fair value of identifiable net
assets. This additional investment value resulted in goodwill, which is expected to be deductible for income tax purposes.
F-14
The fair value of acquired identifiable intangible assets was determined using Level 3 inputs for the “income approach” on an
individual asset basis. The key assumptions used in the calculation of the discounted cash flows include future revenue growth
rates, future gross margin, future selling, general and administrative expense, royalty rates, and discount rates. The valuations
and the underlying assumptions have been deemed reasonable by the Company’s management. There are inherent uncertainties
and management judgment required in these determinations.
During the quarter ended September 26, 2020, the Company finalized its fair value determination of the assets acquired and the
liabilities assumed. The following table summarizes the final allocation of the purchase price to the fair values assigned to the
assets acquired and liabilities assumed at the date of the acquisition:
(In thousands):
Trade accounts and note receivable, net
Inventories, net
Identifiable intangible assets
Right-of-use assets
Accounts payable and accrued liabilities
Short-term lease liability
Long-term lease liability
Net assets acquired
Goodwill
Total purchase price, net of cash acquired
July 10, 2020
937
1,079
18,180
337
(28)
(150)
(187)
20,168
16,099
36,267
$
$
The Company recognized the following finite-lived intangible assets as part of the acquisition of GMTI:
(In thousands)
Developed technology
Trademarks and trade names
Customer relationships
Sinmat
Amount
3,570
1,010
13,600
18,180
$
$
Weighted
average life in
years
6.5
11.5
15.5
13.5
On January 10, 2020, the Company acquired Sinmat, Inc. (“Sinmat”), a chemical mechanical polishing slurry manufacturer.
Sinmat reports into the Specialty Chemicals and Engineered Materials segment of the Company. The acquisition was accounted
for under the acquisition method of accounting and Sinmat’s results of operations are included in the Company’s consolidated
financial statements as of and since January 10, 2020. Costs associated with the acquisition of Sinmat were $0.7 million for
year ended December 31, 2020 and were expensed as incurred. These costs are included in the selling, general and
administrative expenses in the Company’s consolidated statement of operations. The acquisition does not constitute a material
business combination.
The purchase price for Sinmat included cash consideration of $76.2 million, or $75.6 million net of cash acquired, which was
funded from the Company’s existing cash on hand.
The purchase price of Sinmat exceeded the net of the acquisition-date amounts of the identifiable assets acquired and the
liabilities assumed by $31.7 million. Cash flows used to determine the purchase price included strategic and synergistic benefits
(investment value) specific to the Company, which resulted in a purchase price in excess of the fair value of identifiable net
assets. This additional investment value resulted in goodwill, which is expected to be deductible for income tax purposes.
The fair value of acquired identifiable intangible assets was determined using Level 3 inputs for the “income approach” on an
individual asset basis. The key assumptions used in the calculation of the discounted cash flows include future revenue growth
rates, future gross margin, future selling, general and administrative expense, royalty rates, and discount rates. The valuations
and the underlying assumptions have been deemed reasonable by the Company’s management. There are inherent uncertainties
and management judgment required in these determinations.
During the quarter ended June 27, 2020, the Company finalized its fair value determination of the assets acquired and the
liabilities assumed. The following table summarizes the provisional and final allocations of the purchase price to the fair values
assigned to the assets acquired and liabilities assumed at the date of the acquisition date and as adjusted as of June 27, 2020,
F-15
respectively:
(In thousands):
Trade accounts and note receivable, net
Inventories, net
Other current assets
Property, plant and equipment
Identifiable intangible assets
Right-of-use assets
Deferred tax asset
Accounts payable and accrued liabilities
Short-term lease liability
Long-term lease liability
Net assets acquired
Goodwill
Total purchase price, net of cash acquired
As of January 10, 2020
As of June 27, 2020
$
$
1,189 $
1,010
8
63
41,680
1,712
—
(58)
(150)
(1,562)
43,892
31,751
75,643 $
1,189
1,010
8
63
41,680
1,712
102
(58)
(150)
(1,562)
43,994
31,651
75,645
The Company recognized the following finite-lived intangible assets as part of the acquisition of Sinmat:
(In thousands)
Developed technology
Trademarks and trade names
Customer relationships
Amount
7,650
130
33,900
41,680
$
$
Weighted
average life in
years
7.0
1.3
15.0
13.5
(4) TRADE ACCOUNTS AND NOTES RECEIVABLE
Trade accounts and notes receivable from customers at December 31, 2021 and 2020 consist of the following:
(In thousands)
Accounts receivable
Notes receivable
Total trade accounts and notes receivable
Less allowance for credit allowances
Trade accounts and notes receivable, net
(5) INVENTORIES
Inventories at December 31, 2021 and 2020 consist of the following:
(In thousands)
Raw materials
Work-in-process
Finished goods (a)
Inventories, net
2021
2020
347,111 $
2,651
349,762
2,349
347,413 $
264,771
2,005
266,776
2,384
264,392
2021
2020
191,986 $
40,257
242,970
475,213 $
97,319
32,316
194,309
323,944
$
$
$
$
(a) Includes consignment inventories held by customers of $16.0 million and $13.0 million at December 31, 2021 and 2020,
respectively.
F-16
(6) PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment at December 31, 2021 and 2020 consists of the following:
(In thousands)
Land
Buildings and improvements
Manufacturing equipment
Canisters and cylinders
Molds
Office furniture and lab equipment
Construction in progress
Total property, plant and equipment
Less accumulated depreciation
Property, plant and equipment, net
Estimated
useful lives in
years
5-35
5-10
3-12
3-5
3-8
2021
24,000 $
281,019
415,985
142,071
77,708
189,258
177,161
1,307,202
653,104
654,098 $
2020
23,901
238,586
365,511
120,113
76,283
165,950
109,280
1,099,624
574,257
525,367
$
$
The table below sets forth the depreciation expense for the years ended December 31, 2021, 2020 and 2019:
(In thousands)
Depreciation expense
2021
2020
2019
$
90,311 $
83,430 $
74,975
(7) GOODWILL AND INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments that carry goodwill, Specialty Chemicals and Engineered
Materials (“SCEM”), Microcontamination Control (“MC”) and Advanced Materials Handling (“AMH”), for the years ended
December 31, 2021 and 2020 is shown below:
(In thousands)
December 31, 2019
Addition due to acquisitions
Purchase accounting adjustments
Foreign currency translation
December 31, 2020
Addition due to acquisitions
Foreign currency translation
December 31, 2021
SCEM
397,952 $
31,751
1,276
(3,266)
427,713
42,819
343
470,875 $
$
$
MC
240,021 $
—
1,769
5,364
247,154
—
1,571
248,725 $
AMH
Total
57,071 $
16,099
—
—
73,170
932
—
74,102 $
695,044
47,850
3,045
2,098
748,037
43,751
1,914
793,702
As of December 31, 2021, goodwill amounted to approximately $793.7 million, an increase of $45.7 million from the balance
at December 31, 2020. The increase in goodwill in 2021 reflects the acquisitions of the Precision Microchemicals business and
the other transaction described in note 3 and foreign currency translation. The increase in goodwill in 2020 reflects the
acquisition of GMTI and Sinmat described in note 3 with additional increases as a result of purchase accounting adjustments
related to Anow and MPD and foreign currency translation.
Identifiable intangible assets at December 31, 2021 and 2020 consist of the following:
(In thousands)
Developed technology
Trademarks and trade names
Customer relationships
Other
2021
Gross carrying
amount
Accumulated
amortization
Net carrying
value
$
$
293,982 $
33,553
481,674
20,505
829,714 $
232,722 $
20,340
227,350
14,189
494,601 $
61,260
13,213
254,324
6,316
335,113
Weighted
average life in
years
7.2
10.6
12.4
6.6
10.3
F-17
(In thousands)
Developed technology
Trademarks and trade names
Customer relationships
Other
2020
Gross carrying
amount
Accumulated
amortization
Net carrying
value
$
$
283,272 $
30,100
449,659
20,396
783,427 $
221,651 $
18,374
193,313
12,457
445,795 $
61,621
11,726
256,346
7,939
337,632
Weighted
average life in
years
7.1
10.1
12.2
6.6
10.1
The table below sets forth the amortization expense for the years ended December 31, 2021, 2020, and 2019:
(In thousands)
Amortization expense
2021
2020
2019
$
47,856 $
53,092 $
66,428
The amortization expense for each of the five succeeding years and thereafter relating to intangible assets currently recorded in
the Company’s consolidated balance sheets is estimated to be the following at December 31, 2021:
(In thousands)
Future amortization expense $
2022
51,041
2023
50,352
2024
37,738
2025
31,293
2026
29,060
Thereafter
Total
135,629 $ 335,113
(8) DEBT
Long-term debt at December 31, 2021 and 2020 consists of the following:
(In thousands)
Senior unsecured notes due 2029
Senior unsecured notes due 2028
Senior secured term loan facility due 2025
Senior unsecured notes due 2026
Unamortized discount and debt issuance costs
Total long-term debt
Less current maturities of long-term debt
Long-term debt less current maturities
2021
2020
$
400,000 $
400,000
145,000
—
945,000
7,973
937,027
—
$
937,027 $
—
400,000
145,000
550,000
1,095,000
9,217
1,085,783
—
1,085,783
Annual maturities of long-term debt, excluding unamortized discount and issuance costs, due as of December 31, 2021 are as
follows:
(In thousands)
Contractual debt obligation maturities* $
2022
2023
2024
—
—
—
2025
145,000
2026
Thereafter
Total
—
800,000 $ 945,000
*Subject to Excess Cash Flow payments to the lenders, see discussion below.
Pending Merger
In connection with the proposed merger with CMC Materials, on December 31, 2021, the Company entered into an amended
and restated commitment letter, which amended and restated the commitment letter with Morgan Stanley Senior Funding, Inc.
and certain other financial institutions (collectively, the “Financing Sources”), dated as of December 14, 2021, among Entegris
and the Financing Sources (as amended and restated, the “Commitment Letter”). Pursuant to the Commitment Letter, the
Financing Sources (a) committed to provide Entegris (i) a senior secured first lien term loan B facility in an aggregate principal
amount of up to $4 billion (the “Term Loan B Facility”), and (ii) a senior unsecured bridge term loan facility in an aggregate
principal amount of up to $895.0 million (the “Bridge Facility” and together with the Term Loan B Facility, the “Facilities”)
and (b) to the extent that such Financing Sources are revolving lenders under Entegris’ existing credit agreement, (i) consented
to the merger and certain amendments to the terms of the Company’s senior secured revolving credit facility (the “Revolving
Facility”) and (ii) committed to provide to Entegris additional revolving credit commitments in an aggregate principal amount
of $175.0 million. Commitments under the Bridge Facility will be reduced by, among other things, the aggregate gross cash
proceeds in excess of $300.0 million resulting from any issuance or sale by Entegris of (x) senior unsecured notes pursuant to a
public offering or a Rule 144A offering or other private placement or certain other debt securities or indebtedness for borrowed
F-18
money, which are collectively referred to as the notes, and (y) equity securities (including common stock and any securities
convertible or exchangeable into or exercisable for equity securities or other equity-linked securities) of Entegris.
2029 Senior Unsecured Notes
On April 30, 2021, the Company issued $400 million aggregate principal amount of 3.625% senior unsecured notes due May 1,
2029 (the “2029 Notes”). The 2029 Notes were issued under an indenture dated as of April 30, 2021 (the “2029 Notes
Indenture”) by and among the Company, certain subsidiaries of the Company and Wells Fargo Bank, National Association, as
trustee (the “Trustee”). Interest on the 2029 Notes is payable semi-annually in arrears on May 1 and November 1 of each year,
commencing on November 1, 2021. The Company incurred debt issuance costs of $4.1 million in connection with the 2029
Notes. These costs are reported in the consolidated balance sheet as a direct deduction from the face amount of the 2029 Notes.
The Company used the net proceeds of the offering, together with cash on hand and $51 million borrowed under the Revolving
Facility, to pay the redemption price for the redemption in full of the $550 million aggregate principal amount of senior
unsecured notes due 2026 (the “2026 Notes”) and to pay certain fees and expenses related to the offering. In connection with
the redemption of the 2026 Notes, the Company incurred a loss on extinguishment of debt of $23.1 million, which is included
in Other expense (income), net on the condensed consolidated statement of operations.
The 2029 Notes are guaranteed, jointly and severally, fully and unconditionally, on a senior unsecured basis, by the Company’s
existing and future domestic subsidiaries, other than certain excluded subsidiaries, to the extent that such subsidiaries guarantee
indebtedness under the Company’s senior secured term loan facility and Revolving Facility (together, the “Senior Secured
Credit Facilities”) or the Company’s 4.375% senior unsecured notes due 2028 (the “2028 Notes”), and any other subsidiary of
the Company, to the extent it incurs certain additional indebtedness (collectively, the “Guarantors”).
The 2029 Notes and the guarantees thereof are the Company’s and the Guarantors’ senior unsecured obligations, respectively,
and will (i) rank equally in right of payment with all of the Company’s and the Guarantors’ existing and future senior
indebtedness (including the 2028 Notes); (ii) rank senior to any subordinated indebtedness that the Company or the Guarantors
may incur; (iii) be effectively subordinated to all of the Company’s or the Guarantors’ existing and future secured indebtedness
(including the Senior Secured Credit Facilities), in each case, to the extent of the value of the assets securing such indebtedness;
and (iv) be structurally subordinated in right of payment to all existing and future obligations of the Company’s subsidiaries
that do not guarantee the 2029 Notes.
At any time prior to May 1, 2024, the Company may, at its option, on any one or more occasions, redeem up to 40% of the
aggregate principal amount of the 2029 Notes, at a redemption price equal to 103.625% of the principal amount of the 2029
Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption, with an amount of cash
equal to the net cash proceeds of an equity offering, as defined in the 2029 Notes Indenture, by the Company; provided that (1)
at least 60% of the aggregate principal amount of 2029 Notes issued under the 2029 Notes Indenture remains outstanding
immediately after the occurrence of each such redemption; and (2) the redemption occurs within 120 days of the date of the
closing of such equity offering.
Additionally, at any time prior to May 1, 2024, the 2029 Notes may be redeemed, in whole or in part, at the option of the
Company, at a redemption price equal to 100% of the principal amount of the 2029 Notes redeemed, plus a “make whole”
premium, plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date.
On or after May 1, 2024, the Company may, on any one or more occasions, redeem all or a part of the 2029 Notes, at its option,
at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if
any, on the 2029 Notes redeemed, to, but not including, the applicable date of redemption, if redeemed during the 12-month
period beginning on May 1 of the years indicated below:
Year
2024
2025
2026
2027 and thereafter
Percentage
102.719%
101.813%
100.906%
100.000%
Upon the occurrence of certain change of control events accompanied by certain ratings events, the Company will be required
to offer to repurchase all of the outstanding 2029 Notes at a purchase price of 101% of the principal amount thereof, plus
accrued and unpaid interest, if any, to, but not including, the date of repurchase.
The 2029 Notes Indenture contains covenants that, among other things, limit the Company’s ability and/or the ability of the
Company’s subsidiaries to:
•
incur liens;
F-19
•
•
engage in sales-and-leaseback transactions; and
consolidate, merge with or convey, transfer or lease all or substantially all of the Company’s and its subsidiaries’
assets to another person.
The 2029 Notes Indenture also, subject to certain exceptions, limits the ability of any non-Guarantor subsidiary of the Company
to incur indebtedness. These covenants are subject to a number of other limitations and exceptions as set forth in the 2029 Notes
Indenture. The Company was in compliance with all of the above covenants at December 31, 2021.
The 2029 Notes Indenture provides for events of default which, if certain of them occur, would permit the Trustee or the
holders of at least 25% in aggregate principal amount of the then-outstanding 2029 Notes to declare the principal of, and
interest or premium, if any, and any other monetary obligations on, all the then-outstanding 2029 Notes to be due and payable
immediately.
2028 Senior Unsecured Notes
On April 30, 2020, the Company issued $400.0 million aggregate principal amount of 4.375% senior unsecured notes due April
15, 2028 (the “2028 Notes”). The 2028 Notes were issued under an indenture dated as of April 30, 2020 (the “2028 Notes
Indenture”) by and among the Company, certain subsidiaries of the Company and Wells Fargo Bank, National Association, as
trustee (the “2028 Notes Trustee”). Interest on the 2028 Notes is payable semi-annually in arrears on April 15 and October 15
of each year, commencing on October 15, 2020. The Company incurred debt issuance costs of $4.0 million in connection with
the 2028 Notes. These costs are reported in the consolidated balance sheet as a direct deduction from the face amount of the
2028 Notes.
The 2028 Notes are guaranteed, jointly and severally, fully and unconditionally, on a senior unsecured basis, by the Company’s
existing and future domestic subsidiaries, other than certain excluded subsidiaries, to the extent that such entities guarantee
indebtedness under the Senior Secured Credit Facilities or the Company’s 3.625% senior unsecured notes due 2029 (the “2029
Notes”) and any other subsidiary of the Company to the extent it incurs certain additional indebtedness (collectively, the
“Guarantors”).
The 2028 Notes and the guarantees thereof are the Company’s and the Guarantors’ senior unsecured obligations, respectively,
and will (i) rank equally in right of payment with all of the Company’s and the Guarantors’ existing and future senior
indebtedness; (ii) rank senior to any subordinated indebtedness that the Company or the Guarantors may incur; (iii) be
effectively subordinated to all of the Company’s or the Guarantors’ existing and future secured indebtedness (including the
Senior Secured Credit Facilities), in each case, to the extent of the value of the assets securing such indebtedness; and (iv) be
structurally subordinated in right of payment to all existing and future obligations of the Company’s subsidiaries that do not
guarantee the 2028 Notes.
At any time prior to April 15, 2023, the Company may, at its option, on any one or more occasions, redeem up to 40% of the
aggregate principal amount of the 2028 Notes, at a redemption price equal to 104.375% of the principal amount of the 2028
Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption, with an amount of cash
equal to the net cash proceeds of an equity offering, as defined in the 2028 Notes Indenture, by the Company; provided that (1)
at least 60% of the aggregate principal amount of 2028 Notes issued under the 2028 Notes Indenture remains outstanding
immediately after the occurrence of each such redemption; and (2) the redemption occurs within 120 days of the date of the
closing of such equity offering.
Additionally, at any time prior to April 15, 2023, the 2028 Notes may be redeemed, in whole or in part, at the option of the
Company, at a redemption price equal to 100% of the principal amount of the 2028 Notes redeemed, plus a “make whole”
premium, plus accrued and unpaid interest to, but not including, the applicable redemption date.
On or after April 15, 2023, the Company may on any one or more occasions redeem all or a part of the 2028 Notes, at its
option, at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid
interest, if any, on the 2028 Notes redeemed, to, but not including, the applicable date of redemption, if redeemed during the
12-month period beginning on April 15 of the years indicated below:
Year
2023
2024
2025 and thereafter
Percentage
102.188%
101.094%
100.000%
Upon the occurrence of certain change of control events accompanied by certain ratings events, the Company will be required
to offer to repurchase all of the outstanding 2028 Notes at a purchase price of 101% of the principal amount thereof, plus
accrued and unpaid interest, if any, to, but not including, the date of repurchase.
F-20
The 2028 Notes Indenture that governs the 2028 Notes contains covenants that, among other things, limit the Company’s ability
and/or the ability of the Company’s subsidiaries to incur liens, engage in sale and leaseback transactions and consolidate, merge
with or convey, transfer or lease all or substantially all of the Company’s and its subsidiaries’ assets to another person. The
2028 Notes Indenture also, subject to certain exceptions, limits the ability of any non-Guarantor subsidiary of the Company to
incur indebtedness. These covenants are subject to a number of other limitations and exceptions as set forth in the 2028 Notes
Indenture. The Company is in compliance with all of the above covenants at December 31, 2021.
The 2028 Notes Indenture provides for events of default which, if certain of them occur, would permit the 2028 Notes Trustee
or the holders of at least 25% in aggregate principal amount of the then outstanding 2028 Notes to declare the principal of, and
interest or premium, if any, and any other monetary obligations on, all the then-outstanding 2028 Notes to be due and payable
immediately.
Senior Secured Credit Facilities
On November 6, 2018, the Company entered into a credit and guaranty agreement with Goldman Sachs Bank USA, as
administrative agent and collateral agent, and added two additional lenders to the lenders party thereto. The credit agreement
was amended in October 2019 (as so amended, the “Credit Agreement”) to change the administrative agent and collateral agent
to Morgan Stanley and add two lenders. The Credit Agreement provides senior secured financing in an aggregate principal
amount of $700 million, consisting initially of (a) term loans in an aggregate principal amount of $400 million (the “New Term
Loan Facility”) and (b) revolving commitments in an aggregate amount of $300 million (the “New Revolving Facility”,
amended with the issuance of the 2029 Notes to $400 million and together with the New Term Loan Facility, the “New Credit
Facilities”). Borrowings under the New Credit Facilities bear interest at a rate per annum equal to, at the Company’s option, a
base rate (such as prime rate or LIBOR) plus an applicable margin. The Company’s interest rate on the term loans under the
New Term Loan Facility is 2.10% at December 31, 2021. In addition to paying interest on the outstanding principal under the
New Credit Facilities, the Company will pay (i) with respect to the New Term Loan Facility, customary agency fees, and (ii)
with respect to the New Revolving Facility, a commitment fee in respect of the unutilized commitments thereunder and
customary letter of credit fees and agency fees. The initial commitment fee is 0.20% per annum.
Debt issuance costs of $5.1 million for the year ended December 31, 2018 were paid to third parties and are capitalized as debt
issuance costs in connection with the New Credit Facilities. These debt issuance costs are being amortized as interest expense in
the Company’s consolidated statements of operations over the term of the debt instrument using the straight-line method.
The Company may voluntarily prepay outstanding term loans and revolving loans under the New Credit Facilities and may
reduce the unutilized portion of the New Revolving Facility at any time without premium or penalty other than customary
“breakage” costs with respect to LIBOR loans.
At present, LIBOR is expected to be published only on a limited basis after 2021. The Credit Agreement includes customary
“hard-wired” LIBOR replacement provisions for when LIBOR becomes unavailable, which would replace LIBOR with Term
SOFR or any prevailing market convention for determining rates of interest for syndicated loans denominated in U.S. dollars in
the United States.
The Credit Agreement also requires the Company to prepay outstanding term loans, subject to certain exceptions, with (a) up to
50% of the Company’s annual Excess Cash Flow (as defined in the Credit Agreement) and (b) 100% of the net cash proceeds of
(i) certain asset sales and casualty and condemnation events, subject to reinvestment rights and certain other exceptions; and (ii)
any incurrence or issuance of certain debt, other than debt permitted under the New Credit Facilities.
The New Term Loan Facility matures on November 6, 2025 and the New Revolving Facility matures on April 30, 2026, which
was amended from November 6, 2023 in connection with the issuance of the 2029 Notes. At December 31, 2021, the only
outstanding amounts under the New Revolving Facility were undrawn outstanding letters of credit of $0.2 million.
All obligations under the New Credit Facilities are unconditionally guaranteed by certain of the Company’s wholly-owned
domestic subsidiaries and are secured, subject to certain exceptions, by substantially all of the Company’s assets and the assets
of the Company’s subsidiaries that have guaranteed the New Credit Facilities.
The New Credit Facilities contain a number of negative covenants that, subject to certain exceptions, restrict the Company’s
ability and each of the Company’s subsidiaries’ ability to incur additional indebtedness; pay dividends on its capital stock or
redeem, repurchase or retire its capital stock or its other indebtedness; make investments, loans and acquisitions, create
restrictions on the payment of dividends or other amounts to the Company from the Company’s restricted subsidiaries; engage
in transactions with its affiliates; sell assets, including capital stock of its subsidiaries; materially alter the business it conducts;
consolidate or merge; incur liens; and engage in sale-leaseback transactions. If at any time, commencing with the fiscal quarter
ending March 31, 2019, the Company has revolving borrowings, unreimbursed letter of credit drawings and undrawn letters of
credit outstanding in an amount in excess of 35.0% of the commitment amount under the New Revolving Facility, the Credit
Agreement requires the Company to maintain a secured net leverage ratio of at least 3.25 to 1.0. The Company is in compliance
with all of the above covenants at December 31, 2021.
F-21
(9) OTHER EXPENSE (INCOME), NET
The table below sets forth the Other (income) expense, net for the years ended December 31, 2021, 2020 and 2019:
(In thousands)
Versum termination fee, net
Loss (gain) on foreign currency remeasurement
Loss on extinguishment of debt and modification
Other, net
Other expense (income), net
2021
2020
2019
$
$
— $
7,857
23,338
500
31,695 $
— $
(9,751)
2,378
717
(6,656) $
(122,000)
(237)
—
1,156
(121,081)
Versum termination fee, net
On January 28, 2019, the Company and Versum announced that they had entered into an Agreement and Plan of Merger, dated
as of January 27, 2019 (the “Versum Merger Agreement”), pursuant to which they agreed to combine in a merger of equals. On
April 8, 2019, Versum announced that its board of directors had received a proposal from Merck KGaA to acquire Versum and
that its board of directors had deemed such proposal as a “Superior Proposal” as defined in the Versum Merger Agreement. On
April 12, 2019, the Company received a termination notice from Versum terminating the Versum Merger Agreement. In
accordance with the terms of the Merger Agreement, Entegris received a $140.0 million termination fee from Versum in the
second quarter of 2019. Also in the second quarter of 2019, the Company paid a fee of $18.0 million to the third-party financial
adviser it had engaged to assist with the transaction.
(10) LEASES
Leases As of December 31, 2021, the Company was obligated under operating lease agreements for certain office space and
manufacturing facilities, manufacturing equipment, vehicles, information technology equipment and warehouse space. Our
leases have remaining lease terms of 1 year to 19 years, some of which may include options to extend the lease for up to 6
years, and some of which may include options to terminate the leases within 1 year.
As of December 31, 2021 and 2020, the Company’s operating lease components with initial or remaining terms in excess of one
year were classified on the consolidated balance sheet as follows, together with certain supplemental balance sheet information:
(In thousands)
Assets
Right-of-use assets
Liabilities
Short-term lease liability
Long-term lease liability
Total lease liabilities
Classification
2021
2020
Right-of-use assets
$
66,563
$
45,924
Other accrued liabilities
Long-term lease liability
10,638
60,101
70,739
$
9,960
39,730
49,690
$
Lease Term and Discount Rate
Weighted average remaining lease term (years)
Weighted average discount rate
9.2
4.2 %
7.9
5.0 %
Expense for leases less than 12 months for the year ended December 31, 2021, 2020 and 2019 were not material. The
components of lease expense for the year ended December 31, 2021, 2020 and 2019 are as follows:
(In thousands)
Operating lease cost
2021
2020
2019
$
13,127 $
13,576 $
12,538
The Company combines the amortization of the right-of-use assets and the change in the operating lease liability in the same
line item in the Statement of Cash Flows. Other information related to the Company’s operating leases for the year ended
December 31, 2021, 2020 and 2019 are as follows:
(In thousands)
2021
2020
2019
Cash paid for amounts included in the measurement of lease
liabilities:
Operating cash flows from leases
Right-of-use assets obtained in exchange for lease obligations:
Operating leases
$
$
11,009
31,492
$
$
10,806
5,133
$
$
11,137
9,077
F-22
Future minimum lease payments for noncancellable operating leases as of December 31, 2021, were as follows:
(In thousands)
One Year
Two Years
Three Years
Four Years
Five Years
Beyond Five Years
Total
Less: Interest
Present value of lease liabilities
2021
13,340
11,612
8,690
7,860
7,473
37,474
86,449
15,710
70,739
$
$
$
(11) ASSET RETIREMENT OBLIGATIONS
The Company has asset retirement obligations (“AROs”) related to environmental disposal obligations associated with
cylinders used to supply customers with gas products, and certain restoration obligations associated with certain of its leased
facilities.
Changes in the carrying amounts of the Company’s AROs for the years ended December 31, 2021 and 2020 are shown below:
(In thousands)
Balance at beginning of year
Liabilities settled
Liabilities incurred
Accretion expense
Revision of estimate
Balance at end of year
2021
2020
$
$
14,500 $
(78)
3,274
166
(368)
17,494 $
13,940
—
218
216
126
14,500
ARO liabilities expected to be settled within twelve months are included in the consolidated balance sheets in other accrued
liabilities, while all other ARO liabilities are included in pension benefit obligations and other liabilities in the consolidated
balance sheets.
(12) INCOME TAXES
Income before income taxes for the years ended December 31, 2021, 2020 and 2019 was derived from the following sources:
(In thousands)
Domestic
Foreign
Income before income tax expense
2021
137,145 $
341,931
479,076 $
2020
86,572 $
267,715
354,287 $
2019
145,215
172,834
318,049
$
$
Income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:
(In thousands)
Current:
Federal
State
Foreign
Deferred (net of valuation allowance):
Federal
State
Foreign
Income tax expense
2021
2020
2019
$
$
9,187 $
2,939
76,257
88,383
(11,726)
(498)
(6,209)
(18,433)
69,950 $
8,107 $
1,151
57,310
66,568
(592)
(407)
(6,251)
(7,250)
59,318 $
35,497
2,625
39,075
77,197
(10,966)
(1,018)
(2,024)
(14,008)
63,189
F-23
Income tax expense differs from the expected amounts based upon the statutory federal tax rates for the years ended
December 31, 2021, 2020 and 2019 as follows:
(In thousands)
Expected federal income tax at statutory rate
State income taxes before valuation allowance, net of federal tax effect
Effect of foreign source income
Tax contingencies
Valuation allowance
U.S. federal research credit
Equity compensation
Foreign derived intangible income
Legal entity restructuring capital loss
Legal entity restructuring dividends received deduction
Other items, net
Income tax expense
2021
2020
2019
$
100,606 $
74,400 $
66,790
(1,333)
(15,862)
4,696
9,984
(8,469)
(8,899)
(6,496)
(5,079)
—
802
(1,539)
(7,877)
1,688
9,281
(7,204)
(8,231)
(1,153)
—
—
(47)
(1,563)
(1,362)
1,785
2,051
(6,514)
(1,411)
(7,851)
—
9,398
1,866
$
69,950 $
59,318 $
63,189
The Company has made employment and spending commitments to Singapore. In return for those commitments, the Company
has been granted a partial tax holiday for eight years starting in 2013. During 2017, this agreement was extended to 2027 in
exchange for revised employment and spending commitments. The income tax benefits attributable to the tax status are $13.9
million ($0.10 per diluted share), $9.4 million ($0.07 per diluted share) and $5.8 million ($0.04 per diluted share) for the years
ending December 31, 2021, 2020 and 2019, respectively. The 2021, 2020 and 2019 effective tax rates include additional
benefits of $8.0 million, $5.4 million and $3.3 million because the corporate tax rate in Singapore is lower than the U.S. rate.
At December 31, 2021, there were approximately $101.3 million of accumulated undistributed earnings of subsidiaries outside
of the United States, all of which are considered to be indefinitely reinvested. Management estimates that approximately $11.6
million of withholding taxes would be incurred if these undistributed earnings were distributed.
The significant components of the Company’s deferred tax assets and deferred tax liabilities at December 31, 2021 and 2020
are as follows:
(In thousands)
Deferred tax assets attributable to:
Accounts receivable
Inventory
Accruals not currently deductible for tax purposes
Net operating loss and credit carryforwards
Capital loss carryforward
Equity compensation
Asset impairments
Other, net
Gross deferred tax assets
Valuation allowance
Total deferred tax assets
Deferred tax liabilities attributable to:
Purchased intangible assets
Depreciation
Total deferred tax liabilities
Net deferred tax liabilities
2021
2020
$
397 $
6,510
19,636
42,599
485
2,630
—
7,786
80,043
(39,383)
40,660
(33,887)
(9,102)
(42,989)
$
(2,329) $
436
4,566
12,828
33,347
—
3,001
452
6,212
60,842
(29,399)
31,443
(38,083)
(13,276)
(51,359)
(19,916)
Deferred tax assets are generally required to be reduced by a valuation allowance if it is more likely than not that some portion
or all of the deferred tax assets will not be realized.
As of December 31, 2021 and 2020, the Company had net U.S. deferred tax assets of $3.0 million and deferred tax liabilities of
$4.7 million, respectively, which are composed of temporary differences and various tax credit carryforwards. Management
believes that it is more likely than not that the benefit from certain state net operating loss carryforwards, state credit
F-24
carryforwards and certain federal foreign tax credit carryforwards will not be realized. In recognition of this risk, management
has provided valuation allowances of $16.1 million and $18.6 million as of December 31, 2021 and 2020, respectively, on the
related deferred tax assets. If the assumptions change and management determines the assets will be realized, the tax benefits
relating to any reversal of the valuation allowance on deferred tax assets at December 31, 2021 will be recognized as a
reduction of income tax expense.
At December 31, 2021, the Company had state operating loss and credit carryforwards of approximately $16.0 million, which
begin to expire in 2022, and foreign operating loss carryforwards of $37.6 million, which begin to expire in 2023.
As of December 31, 2021 and 2020, the Company had net non-U.S. deferred tax assets of $34 million and $14.1 million,
respectively, for which management determined based upon the available evidence a valuation allowance of $23.3 million and
$10.8 million as of December 31, 2021 and 2020, respectively, was required against the non-U.S. gross deferred tax assets. For
other non-U.S. jurisdictions, management relies upon projections of future taxable income to utilize deferred tax assets.
Benefits from tax positions should be recognized in the financial statements only when it is more likely than not that the tax
positions will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant
information. A tax position that meets the more-likely-than-not recognition threshold is measured at the largest amount of
benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that fail to meet the
more-likely-than-not recognition threshold should be recognized in the first subsequent financial reporting period in which that
threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should
be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. The provisions also
provide guidance on the accounting for and disclosure of unrecognized tax benefits, interest and penalties.
Reconciliations of the beginning and ending balances of the total amounts of gross unrecognized tax benefits for the years
ended December 31, 2021 and 2020 are as follows:
(In thousands)
Gross unrecognized tax benefits at beginning of year
Increase in tax positions from prior years
Decrease in tax positions from prior years
Increases in tax positions for current year
Settlement of tax positions for current year
Lapse in statute of limitations
Gross unrecognized tax benefits at end of year
2021
2020
17,395 $
131
(69)
8,476
(286)
(1,858)
23,789 $
16,194
412
(453)
3,463
(532)
(1,689)
17,395
$
$
The total amount of net unrecognized tax benefits that, if recognized, would affect the effective tax rate was $17.1 million at
December 31, 2021.
Penalties and interest paid or received are recorded in other income, net in the consolidated statements of operations. As of
December 31, 2021 and 2020, the Company had accrued interest and penalties related to unrecognized tax benefits of $5.9
million and $4.9 million, respectively. Expenses of $1.0 million, $0.9 million and $0.6 million were recognized as interest and
penalties in the consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019, respectively.
The Company files income tax returns in the U.S. and in various state, local and foreign jurisdictions. The statutes of limitations
related to both the consolidated federal income tax return and state returns are closed for all years up to and including 2017 and
2017, respectively. With respect to foreign jurisdictions, the statute of limitations varies from country to country, with the
earliest open year for the Company’s major foreign subsidiaries being 2015.
Due to the expiration of various statutes of limitations and settlements of audits, it is reasonably possible that the Company’s
gross unrecognized tax benefit balance may decrease within the next twelve months by approximately $1.9 million.
(13) EQUITY
Dividend
Holders of the Company’s common stock are entitled to receive dividends when and if they are declared by the Company’s
board of directors. The Company’s board of directors declared cash dividends of $0.08 per share during each of the first,
second, third and fourth quarters of 2021, payments for which totaled $43.6 million. The Company’s board of directors declared
cash dividends of $0.08 per share during each of the first, second, third and fourth quarters of 2020, payments for which totaled
$43.5 million. During 2019, the Company’s board of directors declared cash dividends of $0.07 per share during each of the
first and second quarters and $0.08 per share during each of the third and fourth quarters of 2019, payments for which totaled
$40.8 million.
F-25
On January 19, 2022, the Company’s board of directors declared a quarterly cash dividend of $0.10 per share to be paid on
February 23, 2022 to shareholders of record as of February 2, 2022.
Future dividend declarations, if any, as well as the record and payment dates for such dividends, are subject to the final
determination of the Company’s board of directors. Furthermore, the credit agreements governing the New Credit Facilities
contain restrictions that may limit our ability to pay dividends.
Share Repurchase Program
On December 14, 2020, the Company’s board of directors authorized a repurchase program, effective February 16, 2021,
covering the repurchase of up to an aggregate of $125.0 million of the Company’s common stock, during a period of twelve
months, in open market transactions and in accordance with one or more pre-arranged stock trading plans to be established in
accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This repurchase program will expire
pursuant to its terms on February 15, 2022. In connection with its proposed acquisition of CMC, the Company suspended this
share repurchase program and does not anticipate authorizing a new program in 2022.
The Company repurchased $67.1 million, $44.6 million and $74.8 million of shares for the years ended December 31, 2021,
2020 and 2019, respectively.
The credit agreement governing the New Credit Facilities contains restrictions that may limit the Company’s ability to continue
to repurchase shares.
2020 Stock Plan
In 2020, the Company’s board of directors and stockholders approved the Entegris, Inc. 2020 Stock Plan (the “2020 Stock
Plan”). The 2020 Stock Plan replaced the Entegris, Inc. 2010 Stock Plan for future stock awards and stock option grants. The
2020 Stock Plan has a term of ten years and provides for the issuance of stock options and other share-based awards to selected
employees, directors, and other individuals or entities that provide services to the Company or its affiliates. Under the 2020
Stock Plan, the board of directors or a committee selected by the board of directors will determine for each award, the term,
price, number of shares, rate at which each award is exercisable and whether restrictions are imposed on the shares subject to
the awards. The exercise price for option awards generally may not be less than the fair market value per share of the
underlying common stock on the date granted. The 2020 Stock Plan provides that after December 31, 2019, any shares subject
to stock awards that were awarded from the Company’s expired plans and that are forfeited, expired or otherwise terminated
without issuance of shares will again be available for issuance under the 2020 Stock Plan.
For all plans, exclusive of the employee stock purchase plan, the Company had shares available for future grants of 8.7 million,
9.0 million, and 8.2 million shares at December 31, 2021, 2020 and 2019, respectively.
Stock Options
Stock option activity for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:
(Shares in thousands)
Options outstanding, beginning of year
Granted
Exercised
Expired or forfeited
Options outstanding, end of year
Options exercisable, end of year
2021
2020
2019
Number of
shares
Weighted
average
exercise
price
Number of
shares
Weighted
average
exercise
price
Number of
shares
Weighted
average
exercise
price
1,082 $
167
(592)
—
657 $
111 $
33.38
98.11
27.32
—
55.32
34.54
1,575 $
216
(709)
—
1,082 $
426 $
21.39
55.72
13.60
—
33.38
24.99
1,410 $
293
(128)
—
1,575 $
788 $
18.22
33.33
13.89
—
21.39
15.75
F-26
Options outstanding under the Company’s stock plans at December 31, 2021 are summarized as follows:
(Shares in thousands)
Options outstanding
Options exercisable
Range of exercise prices
$21.60 to $21.60
$31.10 to $31.10
$33.33 to $33.33
$55.72 to $55.72
$98.11 to $98.11
Number
outstanding
29
101
173
187
167
657
Weighted
average
remaining life
in years
2.1 years $
3.1 years
4.1 years
5.1 years
6.1 years
4.7 years $
Weighted-
average
exercise
price
Number
exercisable
Weighted
average
exercise
price
21.60
31.10
33.33
55.72
98.11
55.32
29 $
31
27
24
—
111 $
21.60
31.10
33.33
55.72
—
34.54
The weighted average remaining contractual term for options outstanding and options exercisable for all plans at December 31,
2021 was 4.7 years and 3.6 years, respectively.
Under the stock plans, the total pre-tax intrinsic value of stock options exercised during the years ended December 31, 2021 and
2020 was $54.7 million and $36.4 million, respectively. The aggregate intrinsic value, which represents the total pre-tax
intrinsic value based on the Company’s closing stock price of $138.58 at December 31, 2021, which theoretically could have
been received by the option holders had all option holders exercised their options as of that date, was $54.7 million and $11.5
million for options outstanding and options exercisable, respectively.
Share-based payment awards in the form of stock option awards for 0.2 million, 0.2 million and 0.3 million shares were granted
to employees during the years ended December 31, 2021, 2020 and 2019, respectively. Compensation expense is based on the
grant date fair value. The awards vest annually over a period of four years and have a contractual term of 7 years. The Company
estimates the fair value of stock options using the Black-Scholes valuation model. Key inputs and assumptions used to estimate
the fair value of stock options include the grant price of the award, the expected option term, volatility of the Company’s stock,
the risk-free rate and the Company’s dividend yield. Estimates of fair value are not intended to predict actual future events or
the value ultimately realized by employees who receive equity awards, and subsequent events are not indicative of
reasonableness of the original estimates of fair value made by the Company.
The fair value of each stock option grant was estimated at the date of grant using a Black-Scholes option pricing model. The
following table presents the weighted-average assumptions used in the valuation and the resulting weighted-average fair value
per option granted for the years ended December 31, 2021, 2020 and 2019:
Employee stock options:
Volatility
Risk-free interest rate
Dividend yield
Expected life (years)
2021
2020
2019
38.0 %
0.4 %
0.3 %
4.6
31.9 %
1.4 %
0.6 %
4.3
31.6 %
2.5 %
0.8 %
4.1
Weighted average fair value per option
$
30.69
$
14.83
$
8.89
A historical daily measurement of volatility is determined based on the expected life of the option granted. The risk-free interest
rate is determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the expected life of the
option granted. Expected life is determined by reference to the Company’s historical experience. The Company determines the
dividend yield by dividing the expected annual dividend on the Company’s stock by the option exercise price.
Employee Stock Purchase Plan
The Company maintains the Entegris, Inc. Amended and Restated Employee Stock Purchase Plan (“ESPP”). The ESPP allows
employees to elect, at six-month intervals, to contribute up to 10% of their compensation, subject to certain limitations, to
purchase shares of the Company’s common stock at a discount of 15% from the fair market value on the first day or last day of
each six-month period. The Company treats the ESPP as a compensatory plan. At December 31, 2021, 1.5 million shares
remained available for issuance under the ESPP. Employees purchased 0.1 million, 0.2 million and 0.2 million shares, at a
weighted-average price of $90.89, $46.58, and $28.67 during the years ended December 31, 2021, 2020 and 2019, respectively.
Restricted Stock Units
F-27
Restricted stock units are awards of common stock made under the Stock Plans that are subject to a risk of forfeiture if the
awardee terminates employment with the Company prior to the lapse of the restrictions. The value of such restricted stock units
is determined using the market price on the grant date. Compensation expense for restricted stock units is generally recognized
using the straight-line single-option method. A summary of the Company’s restricted stock unit activity for the years ended
December 31, 2021, 2020 and 2019 is presented in the following table:
(Shares in thousands)
Unvested, beginning of year
Granted
Vested
Forfeited
Unvested, end of year
2021
2020
2019
Number
of
shares
Weighted
average
grant date
fair value
Number
of
shares
Weighted
average
grant date
fair value
Number
of
shares
Weighted
average
grant date
fair value
1,083 $
293
(439)
(40)
897
41.31
101.04
35.58
57.39
62.69
1,254 $
437
(564)
(44)
1,083
27.48
57.46
23.48
35.86
41.31
1,519 $
514
(679)
(100)
1,254
21.24
34.05
18.89
24.82
27.48
The weighted average remaining contractual term for unvested restricted shares at December 31, 2021 and 2020 was 1.1 years
and 1.2 years, respectively.
During the years ended December 31, 2021, 2020 and 2019, the Company awarded performance-based restricted stock units for
up to 0.1 million, 0.1 million and 0.1 million shares of common stock, respectively, to be issued upon the achievement of
performance conditions under the Company’s stock plans to certain officers and other key employees. Compensation expense is
based on the grant date fair value. The awards vest on the third anniversary of the award date. The Company estimates the fair
value of the performance shares using a Monte Carlo simulation process.
As of December 31, 2021, the total compensation cost related to unvested stock options, performance-based restricted stock
units and restricted stock unit awards not yet recognized was $5.8 million, $4.9 million and $37.9 million, respectively, and is
expected to be recognized over the next 3.4 years on a weighted-average basis.
Valuation and Expense Information
The Company recognizes compensation expense for all share-based payment awards made to employees and directors based on
their estimated fair values on the date of grant. Compensation expense is recognized using the straight-line attribution method to
recognize share-based compensation over the service period of the award, with adjustments recorded for forfeitures as they
occur. The following table summarizes the allocation of share-based compensation expense related to employee stock options,
restricted stock awards, performance-based restricted stock awards and grants under the employee stock purchase plan for the
years ended December 31, 2021, 2020 and 2019:
(In thousands)
Cost of sales
Engineering, research and development expenses
Selling, general and administrative expenses
Share-based compensation expense
Tax benefit
Share-based compensation expense, net of tax
(14) BENEFIT PLANS
401(k) Plan
2021
2020
2019
$
$
3,844 $
3,504
22,536
29,884
5,488
24,396 $
1,463 $
2,359
19,098
22,920
4,129
18,791 $
1,180
1,901
16,548
19,629
3,626
16,003
The Company maintains the Entegris, Inc. 401(k) Savings and Profit Sharing Plan (the “401(k) Plan”) that qualifies as a
deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Under the Plan, eligible employees may defer
a portion of their pre-tax wages, up to the Internal Revenue Service annual contribution limit. Entegris matches employees’
contributions to a maximum match of 4% of the employee’s eligible wages. Beginning on January 1, 2022, the maximum match
contribution increased to 5% of the employee’s eligible wages. The employer matching contribution expense under the 401(k)
Plan was $10.1 million, $8.2 million and $7.1 million in the fiscal years ended December 31, 2021, 2020 and 2019,
respectively.
Defined Benefit Plans
F-28
The employees of the Company’s subsidiaries in Japan, Taiwan and Germany are covered in defined benefit pension plans. The
Company uses a December 31 measurement date for its pension plans.
The tables below set forth the Company’s estimated funded status as of December 31, 2021 and 2020:
(In thousands)
Change in benefit obligation:
Benefit obligation at beginning of year
Service cost
Interest cost
Actuarial (gain) loss
Benefits paid
Foreign exchange impact
Benefit obligation at end of year
Change in plan assets:
Fair value of plan assets at beginning of year
Return on plan assets
Employer contributions
Benefits paid
Foreign exchange impact
Fair value of plan assets at end of year
Funded status:
Plan assets less than benefit obligation - Net amount recognized
Amounts recognized in the consolidated balance sheets consist of:
(In thousands)
Noncurrent liability
Accumulated other comprehensive loss, net of taxes
Amounts recognized in accumulated other comprehensive loss, (pre-tax):
(In thousands)
Net actuarial loss
Prior service cost
Gross amount recognized
2021
2020
7,278 $
35
28
547
(455)
(383)
7,050
1,042
16
74
(157)
(6)
969
6,946
31
37
137
(322)
449
7,278
910
31
73
(41)
69
1,042
(6,081) $
(6,236)
2021
2020
(6,081) $
1,222
(6,236)
840
2021
2020
1,195 $
422
1,617 $
713
454
1,167
$
$
$
$
$
Information for pension plans with a projected benefit obligation and an accumulated benefit obligation in excess of plan assets:
(In thousands)
Projected benefit obligation
Accumulated benefit obligation
Fair value of plan assets
$
2021
2020
7,050 $
5,995
969
7,278
6,480
1,042
The components of the net periodic benefit cost for the years ended December 31, 2021, 2020 and 2019 were as follows:
(In thousands)
Pension benefits:
Service cost
Interest cost
Expected return on plan assets
Curtailments
Settlements
Amortization of prior service cost
Amortization of plan loss
Net periodic pension benefit cost
2021
2020
2019
$
$
35 $
28
(12)
—
—
38
41
130 $
31 $
37
(15)
—
21
36
38
148 $
26
54
(16)
95
—
67
17
243
F-29
Assumptions used in determining the benefit obligation and net periodic benefit cost for the Company’s pension plans for the
years ended December 31, 2021, 2020 and 2019 are presented in the following table as weighted-averages:
Benefit obligations:
Discount rate
Rate of compensation increase
Net periodic benefit cost:
Discount rate
Rate of compensation increase
Expected return on plan assets
2021
2020
2019
0.47 %
3.94 %
0.70 %
2.51 %
1.32 %
0.39 %
2.33 %
0.98 %
2.33 %
1.82 %
0.53 %
2.91 %
1.29 %
3.51 %
1.51 %
The pension plans’ expected return on assets as shown above is based on management’s expectations of long-term average rates
of return to be achieved by the underlying investment portfolios. In establishing this assumption, management considers
historical and expected returns for the asset classes in which the plans are invested, as well as current economic and capital
market conditions. The discount rate primarily used by the Company is based on market yields at the valuation date on
government bonds as well as the estimated maturity of benefit payments.
Plan Assets
At December 31, 2021, the majority of the Company’s pension plan assets were deposited with the Bank of Taiwan in the form
of money market funds, where the Bank of Taiwan is the assigned funding vehicle for the statutory retirement benefit. The
remaining portion of the Company’s plan assets is deposited in a German insurance company’s investment fund.
The fair value measurements of the Company’s pension plan assets at December 31, 2021, by asset category are as follows:
(In thousands)
Asset category
Taiwan plan assets (a)
Germany plan assets (b)
Quoted prices
in active
markets for
identical
assets
(Level 1)
712
257
969
Total
712 $
257
969 $
$
$
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
—
—
—
—
—
—
(a) This category includes investments in the government of Taiwan’s pension fund. The government of Taiwan is
responsible for the strategy and allocation of the investment contributions.
(b) This category includes investments in an insurer’s balanced asset fund. The insurer is responsible for the strategy and
allocation of the investment contributions. The Company selects a pre-packaged portfolio pooled investment fund that
is conservative. The majority of the funds are invested broadly in German mortgage bonds, construction loans and
government bonds with good credit ratings.
The fair value measurements of the Company’s pension plan assets at December 31, 2020, by asset category are as follows:
(In thousands)
Asset category
Taiwan plan assets (a)
Germany plan assets (b)
Quoted prices
in active
markets for
identical
assets
(Level 1)
827
215
1,042
Total
827 $
215
1,042 $
$
$
Significant
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
—
—
—
—
—
—
(a) This category includes investments in the government of Taiwan’s pension fund. The government of Taiwan is
responsible for the strategy and allocation of the investment contributions.
(b) This category includes investments in an insurer’s balanced asset fund. The insurer is responsible for the strategy and
allocation of the investment contributions. The Company selects a pre-packaged portfolio pooled investment fund that
is conservative. The majority of the funds are invested broadly in German mortgage bonds, construction loans and
government bonds with good credit ratings.
Cash Flows
F-30
The Company expects to make the following contributions and benefit payments:
(In thousands)
2022
2023
2024
2025
2026
Years 2027-2031
$
Contributions
Payments
70 $
—
—
—
—
—
42
200
317
251
467
935
(15) EARNINGS PER SHARE (EPS)
Basic EPS is computed by dividing net income by the weighted average number of shares of common stock outstanding during
each period. The following table presents a reconciliation of the share amounts used in the computation of basic and diluted
earnings per share:
(In thousands)
Basic earnings per share—Weighted common shares outstanding
Weighted common shares assumed upon exercise of options and vesting of
restricted stock units
Diluted earnings per share—Weighted common shares outstanding
2021
135,411
1,163
136,574
2020
134,837
1,429
136,266
2019
135,137
1,431
136,568
The Company excluded the following shares underlying stock-based awards from the calculations of diluted EPS because their
inclusion would have been anti-dilutive for the years ended December 31, 2021, 2020 and 2019:
(In thousands)
Shares excluded from calculations of diluted EPS
2021
2020
2019
136
195
273
(16) SEGMENT INFORMATION
The Company’s financial segment reporting reflects an organizational alignment intended to leverage the Company’s unique
breadth of capabilities to create mission-critical microcontamination control products, specialty chemicals and advanced
materials handing solutions that maximize manufacturing yields, reduce manufacturing costs and enable higher device
performance for its customers. While these segments have separate products and technical know-how, they share a common
business systems and processes, technology centers, and strategic and technology roadmaps. The Company’s business is
reported in the following three segments:
•
•
•
Specialty Chemicals and Engineered Materials: SCEM provides high-performance and high-purity process
chemistries, gases and materials and safe and efficient delivery systems to support semiconductor and other
advanced manufacturing processes.
Microcontamination Control: MC offers solutions to filter and purify critical liquid chemistries and gases
used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling: AMH develops solutions to monitor, protect, transport, and deliver critical
liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-
technology industries.
Segment profit is defined as net sales less direct and indirect segment operating expenses, including certain general and
administrative costs for the Company’s human resources, finance and information technology functions. The Company
accounts for inter-segment sales and transfers as if the sales or transfers were to third parties, that is, at approximate market
prices. Inter-segment sales are presented as an elimination below. The remaining unallocated expenses consist mainly of the
Company’s corporate functions as well as interest expense, amortization of intangible assets and income tax expense.
Corporate assets consist primarily of cash and cash equivalents, deferred tax assets and deferred tax charges.
F-31
Summarized financial information for the Company’s reportable segments is shown in the following tables.
(In thousands)
Net sales:
SCEM
MC
AMH
Inter-segment elimination
Total net sales
(In thousands)
Segment profit:
SCEM
MC
AMH
Total segment profit
(In thousands)
Total assets:
SCEM
MC
AMH
Corporate
Total assets
(In thousands)
Depreciation and amortization:
SCEM
MC
AMH
Corporate
Total depreciation and amortization
(In thousands)
Capital expenditures:
SCEM
MC
AMH
Corporate
Total capital expenditures
2021
2020
2019
$
711,291 $
609,532 $
919,363
704,946
742,186
538,682
526,519
633,664
458,290
(36,707)
2,298,893 $
(31,087)
1,859,313 $
(27,407)
1,591,066
$
2021
2020
2019
$
167,807 $
127,969 $
321,300
159,995
649,102 $
248,910
111,028
487,907 $
$
98,327
194,398
75,173
367,898
2021
2020
2019
$
1,191,465 $
1,022,357 $
946,336
598,547
819,602
437,322
936,609
786,131
372,849
455,548
3,191,896 $
638,415
2,917,696 $
420,497
2,516,086
2021
2020
2019
66,983 $
41,536
29,648
—
138,167 $
71,417 $
39,775
25,231
99
136,522 $
75,391
41,917
23,911
184
141,403
2021
2020
2019
74,410 $
69,120
67,096
—
210,626 $
54,989 $
40,656
36,107
—
131,752 $
57,585
28,549
25,212
1,009
112,355
$
$
$
$
$
F-32
The following table reconciles total segment profit to income before income taxes and equity in net loss of affiliate:
(In thousands)
Total segment profit
Less:
Amortization of intangibles
Unallocated general and administrative expenses
Operating income
Interest expense
Interest income
Other expense (income), net
Income before income tax expense
2021
649,102 $
2020
487,907 $
2019
367,898
$
47,856
49,478
551,768
41,240
53,092
39,370
395,445
48,600
(243)
31,695
479,076 $
(786)
(6,656)
354,287 $
$
66,428
62,192
239,278
46,962
(4,652)
(121,081)
318,049
In the following tables, revenue is disaggregated by country or region based on the ship to location of the customer for the years
ended December 31, 2021, 2020 and 2019:
2021
AMH
Inter-segment
2020
AMH
Inter-segment
219,853 $
111,968
105,493
51,267
97,157
89,121
30,087
704,946 $
164,576 $
94,339
92,623
45,209
61,458
52,321
28,156
538,682 $
145,150 $
70,864
69,352
43,832
48,170
53,622
27,300
458,290 $
(36,707) $
—
—
—
—
—
Total
525,796
454,110
317,272
302,603
364,419
209,268
125,425
(36,707) $ 2,298,893
Total
466,513
372,205
273,200
242,896
247,863
154,438
102,198
(31,087) $ 1,859,313
(31,087) $
—
—
—
—
—
—
Total
380,864
309,829
244,367
205,490
214,740
132,223
103,553
(27,407) $ 1,591,066
(27,407) $
—
—
—
—
—
—
2019
AMH
Inter-segment
(In thousands)
North America
Taiwan
South Korea
Japan
China
Europe
Southeast Asia
(In thousands)
North America
Taiwan
South Korea
Japan
China
Europe
Southeast Asia
(In thousands)
North America
Taiwan
South Korea
Japan
China
Europe
Southeast Asia
SCEM
208,997 $
117,056
97,568
89,767
102,791
50,136
44,976
711,291 $
SCEM
189,009 $
106,665
88,580
73,366
77,817
35,027
39,068
609,532 $
SCEM
149,570 $
94,561
76,447
57,456
67,877
33,147
47,461
526,519 $
$
$
$
$
$
$
MC
133,653 $
225,086
114,211
161,569
164,471
70,011
50,362
919,363 $
MC
144,015 $
171,201
91,997
124,321
108,588
67,090
34,974
742,186 $
MC
113,551 $
144,404
98,568
104,202
98,693
45,454
28,792
633,664 $
F-33
The following table summarizes property, plant and equipment, net, attributed to significant countries for the years ended
December 31, 2021, 2020 and 2019:
(In thousands)
Property, plant and equipment:
North America
South Korea
Japan
Malaysia
China
Taiwan
Other
2021
2020
2019
$
$
417,549 $
58,725
56,357
29,443
32,133
58,444
1,447
654,098 $
348,363 $
55,404
41,044
32,727
29,528
17,050
1,251
525,367 $
329,323
43,540
37,851
34,339
16,473
16,264
1,754
479,544
The Company reported net sales of 10 percent or more for one customer in the amount of $271.9 million, $208.3 million and
$187.0 million for the years ended December 31, 2021, 2020 and 2019, respectively, all of which include sales from all the
Company’s segments.
(17) COMMITMENTS AND CONTINGENT LIABILITIES
We are involved in certain legal actions. The outcomes of these legal actions are not within our complete control and may not
be known for prolonged periods of time. In some actions, the claimants seek damages, as well as other relief, that could require
significant expenditures or result in lost revenues. We record a liability for these legal actions when a loss is known or
considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a
range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss
is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is
disclosed. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. As of
December 31, 2021, there were no litigation matters that we consider to be probable or reasonably possible to have a material
adverse outcome.
(18) QUARTERLY INFORMATION-UNAUDITED
$
$
(In thousands, except per share data)
Net sales
Gross profit
Net income
Basic net income per common share
Diluted net income per common share
(In thousands, except per share data)
Net sales
Gross profit
Net income
Basic net income per common share
Diluted net income per common share
(19) SUBSEQUENT EVENTS
Fiscal quarter ended
April 3, 2021
July 3, 2021
October 2, 2021
512,844 $
234,986
84,676
0.63
0.62
571,352 $
265,384
88,770
0.66
0.65
579,493 $
264,204
117,461
0.87
0.86
December 31, 2021
635,204
295,090
118,219
0.87
0.87
Fiscal quarter ended
March 28, 2020
June 27, 2020
September 26, 2020
412,327 $
185,478
61,006
0.45
0.45
448,405 $
207,372
68,036
0.51
0.50
480,987 $
226,000
79,303
0.59
0.58
December 31, 2020
517,594
230,872
86,624
0.64
0.63
We have evaluated subsequent events through February 4, 2022 and determined that no events or transactions met the definition
of a subsequent event for purposes of recognition or disclosure in the accompanying financial statements.
F-34